var title_f41_47_42736="mechanics hands";
var content_f41_47_42736=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F56057&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F56057&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mechanic's hands in a patient with polymyositis, and the anti-synthetase syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 331px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John H. Stone, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42736=[""].join("\n");
var outline_f41_47_42736=null;
var title_f41_47_42737="US post tib tendon RA";
var content_f41_47_42737=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F86266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F86266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 533px\">",
"   <div class=\"ttl\">",
"    Transverse ultrasonograpy of the posterior tibial tendon in a patient with rheumatoid arthritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 513px; height: 189px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel shows a grey-scale transverse sonogram of the posterior tibial tendon (T) of a patient with rheumatoid arthritis as it passes near the medial malleolus (M) and talus (Ta). The tendon sheath is distended with fluid (arrowheads.) The right panel shows a power Doppler sonogram of the same patient. Both pictures show an extensive inflammation of both the tendon and the tendon sheath.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of George AW Bruyn, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42737=[""].join("\n");
var outline_f41_47_42737=null;
var title_f41_47_42738="CT pulmonary aspergillosis";
var content_f41_47_42738=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56195&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56195&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT pulmonary aspergillosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Halo sign (A) converting to an air-crescent sign (B) after neutrophil recovery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Maertens J, Meersseman W, Van Bleyenbergh P. New therapies for fungal pneumonia. Curr Opin Infect Dis 2009; 22:183. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42738=[""].join("\n");
var outline_f41_47_42738=null;
var title_f41_47_42739="Abortion (pregnancy termination)";
var content_f41_47_42739=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Abortion (pregnancy termination) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?41/47/42739/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/47/42739/contributors\" id=\"au3209\">",
"       Katherine Simmonds, MS, MPH, WHNP-BC",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?41/47/42739/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/47/42739/contributors\" id=\"se7462\">",
"       Mimi Zieman, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?41/47/42739/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/47/42739/contributors\" id=\"de1930\">",
"       Sandy J Falk, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?41/47/42739?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ABORTION OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Abortion, also known as pregnancy termination, is a procedure that is performed to end a pregnancy. In the United States, abortion is a safe and legal option for women who cannot or choose not to continue with a pregnancy.",
"    </p>",
"    <p>",
"     Deciding to have an abortion is a very personal decision. Any woman considering abortion should understand the risks and benefits of the various types of abortion, as well as the alternatives to abortion, including parenting and adoption.",
"    </p>",
"    <p>",
"     This article will help to explain these issues and will briefly discuss legal abortion procedures, including the recommended follow up. If you have questions or concerns about abortion after reading this article, find a supportive healthcare provider or clinic that provides abortion services. (See",
"     <a class=\"local\" href=\"#H20\">",
"      'Where to get more information'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      IS ABORTION RIGHT FOR ME?",
"     </span>",
"    </p>",
"    <p>",
"     In the United States, almost 50 percent of pregnancies are unintended, and almost half of these end through abortion [",
"     <a class=\"abstract\" href=\"mobipreview.htm?41/47/42739/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Women have many reasons for considering abortion. Some of the most common reasons include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Having a baby would interfere with family, work, school, or other responsibilities",
"      </li>",
"      <li>",
"       Unable to afford raising a child",
"      </li>",
"      <li>",
"       Do not want to be a single parent",
"      </li>",
"      <li>",
"       Having problems with husband or partner",
"      </li>",
"      <li>",
"       Find out that something is wrong with the fetus",
"      </li>",
"      <li>",
"       Have health problems that make pregnancy a problem",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If you are not sure if abortion is the right decision for you, talk to a supportive healthcare provider or a clinic that provides abortion services. You may also want to talk to a friend, family member, or your partner. It is important to share your thoughts and feelings about this decision with people who you can trust and who will support you, no matter what you decide. (See",
"     <a class=\"local\" href=\"#H20\">",
"      'Where to get more information'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     Most states allow abortion until the pregnancy has reached &ldquo;viability&rdquo; or 24 weeks. If you are under age 17 or 18 and live in the United States, you may need one or both of your parents' permission to have an abortion. In most states, if it is not possible to get your parents' permission, you can speak with a judge to get permission for an abortion without your parents' or guardian's approval. Healthcare providers who provide abortions can help you with this process, if needed. The laws for each state are available on the websites of some",
"     <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/sfaa.html\">",
"      organizations",
"     </a>",
"     . (See",
"     <a class=\"local\" href=\"#H20\">",
"      'Where to get more information'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      TYPES OF ABORTION PROCEDURES",
"     </span>",
"    </p>",
"    <p>",
"     There are two basic ways abortions are performed:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       One is called \"medical\" or \"medication abortion,\" meaning that you take medicine to end the pregnancy.",
"      </li>",
"      <li>",
"       The other is called \"surgical\" or &ldquo;aspiration&rdquo; abortion, meaning that a health care provider does a procedure to remove the pregnancy.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Medication or surgical abortion?",
"     </span>",
"     &nbsp;&mdash;&nbsp;The type of abortion procedure you have depends on a number of factors, including how far along you are in your pregnancy, what type of abortions are available in your area, and your personal preferences. &ldquo;Early&rdquo; medication abortion, in which a woman takes medicine by mouth, is most effective if she is less than 8 to 9 weeks pregnant. If your pregnancy is later (beyond 14 to 16 weeks), you may be given medicines that induce labor to cause an abortion. This type of abortion would be performed in a hospital and is usually called &ldquo;labor induction.&rdquo; It is not as common as surgical or &ldquo;early medication&rdquo; abortion.",
"    </p>",
"    <p>",
"     Reasons that you might prefer an early medication abortion:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       You would prefer to be in the privacy of your home when you pass the pregnancy tissue",
"      </li>",
"      <li>",
"       You would prefer to avoid having anesthesia",
"      </li>",
"      <li>",
"       You would prefer to avoid medical instruments being inserted into your uterus to remove the pregnancy. In 2 percent of cases, medication abortion does not end or completely remove the pregnancy tissue from inside the uterus and a surgical procedure is needed. (See",
"       <a class=\"local\" href=\"#H11\">",
"        'How effective is early medication abortion?'",
"       </a>",
"       below.)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Reasons that you might prefer surgical abortion:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       You prefer to have the abortion completed in one visit",
"      </li>",
"      <li>",
"       You are not comfortable with the idea of heavy vaginal bleeding and passing pregnancy tissue at home",
"      </li>",
"      <li>",
"       You would prefer to have anesthesia to minimize pain",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Initial evaluation",
"     </span>",
"     &nbsp;&mdash;&nbsp;With both medication and surgical abortion, you will need the following before the procedure.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A pregnancy test or ultrasound to confirm that you are pregnant and determine how far along your pregnancy is. To determine the current length of your pregnancy, you can use this calculator (",
"       <a class=\"calc calc_patient\" href=\"mobipreview.htm?21/15/21759?source=see_link\">",
"        calculator 1",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       A blood test to determine your blood count (to make sure you do not have anemia) and blood type. If you have a negative blood type (eg, A negative), you will be given an injection of a medication called Rh immune globulin (Rhogam&reg;) after the abortion. This helps to prevent complications in future pregnancies.",
"      </li>",
"      <li>",
"       You may be offered testing for sexually transmitted infections. Commonly performed tests include gonorrhea, chlamydia, and HIV. Testing for syphilis and hepatitis A, B, and C may also be recommended.",
"      </li>",
"      <li>",
"       You will discuss the risks and benefits of abortion, the available procedures (medication and surgical), and alternatives to abortion (parenting, adoption) with a counselor, doctor, or nurse. This is an important step; if you have any questions or concerns, this is the time to ask.",
"      </li>",
"      <li>",
"       In some states, women must wait for a certain amount of time (usually 24 hours) between the counseling, described above, and the abortion. In other states, the abortion can be performed on the same day as the counseling. For information about your state, see",
"       <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_MWPA.pdf\">",
"        www.guttmacher.org/statecenter/spibs/spib_MWPA.pdf",
"       </a>",
"      </li>",
"      <li>",
"       You will discuss options for birth control. After medication or surgical abortion, you can become pregnant again quickly, even before your next menstrual period. You can start using most methods (pill, patch, vaginal ring, injection, intrauterine device [IUD], implants) on the day of an aspiration abortion.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     With medication abortion, you can start birth control after your pregnancy has ended, usually within a few days after your first visit. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/60/9157?source=see_link\">",
"      \"Patient information: Birth control; which method is right for me? (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      EARLY MEDICATION ABORTION",
"     </span>",
"    </p>",
"    <p>",
"     Early medication abortion usually involves taking two different medications to end an early pregnancy. In the United States, early medication abortion may be an option if you are 7 to 9 weeks or less (49 to 63 days) pregnant (clinics vary in their policies on this). Medication can also be used for women who are 14 or more weeks, but for this type of abortion, the woman is in the hospital under the supervision of a doctor or nurse. To determine if you can have an early medication abortion, use this calculator (",
"     <a class=\"calc calc_patient\" href=\"mobipreview.htm?21/15/21759?source=see_link\">",
"      calculator 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Early medication abortion is available in some medical offices and hospitals and in most clinics that provide abortion services. The following steps are involved in most cases:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A healthcare provider will confirm how many days pregnant you are, either by using a calculator or by using ultrasound measurements of the pregnancy.",
"      </li>",
"      <li>",
"       You will be given two medications, usually mifepristone and misoprostol. Information about these medications is available online (see www.earlyoptionpill.com or",
"       <a class=\"external\" href=\"file://www.prochoice.org/about_abortion/facts/medical_abortion.html\">",
"        www.prochoice.org/about_abortion/facts/medical_abortion.html",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       You will take the mifepristone at the clinic or medical office. You will take the misoprostol several hours or days later, usually at home.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Expected side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Abdominal pain, cramps, and vaginal bleeding are expected side effects with early medication abortion. Some women also have fever, nausea, vomiting, or diarrhea.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h3\">",
"      Pain and cramps",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most women will have abdominal pain and cramps after taking the second medication (misoprostol). These cramps may be mild or strong. The pain usually improves after the pregnancy has passed out of your uterus, within 4 to 6 hours after taking the misoprostol.",
"    </p>",
"    <p>",
"     You can take 600 to 800 mg of ibuprofen (Advil, Motrin) every 6 to 8 hours for pain, if needed. Some doctors and nurses also give a prescription for a stronger pain medication to use if needed. You can also use a heating pad on your abdomen. If you have severe pain that is not relieved by these treatments, call your clinic immediately.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Vaginal bleeding",
"     </span>",
"     &nbsp;&mdash;&nbsp;It is normal to experience vaginal bleeding with an early medication abortion. The bleeding may be heavy, especially in the first few hours after you take the misoprostol. The bleeding usually decreases after you pass the pregnancy tissue out of your uterus, and then continues for several weeks. It should be lighter than a menstrual period after the first few days.",
"    </p>",
"    <p>",
"     If you are bleeding so heavily that you soak through one menstrual pad per hour for two hours in a row and you are still bleeding, you should call your healthcare provider or clinic immediately. If you do not have bleeding at all after you take the medications, you should also call your doctor or nurse.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h3\">",
"      Fever, nausea, vomiting, diarrhea",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some women experience a mild fever, nausea, vomiting, or diarrhea after taking the second medication (misoprostol). This usually goes away quickly on its own without treatment. If you develop a fever higher than 100.4&ordm;F (38&ordm;C), or if you have chills, vomiting, or diarrhea that does not go away within several hours, call your doctor or nurse.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      How effective is early medication abortion?",
"     </span>",
"     &nbsp;&mdash;&nbsp;Early medication abortion is very effective in ending pregnancies that are up to 49 days (less than 7 weeks). It is nearly as effective in ending pregnancies up to 56 or 63 days (8 or 9 weeks).",
"    </p>",
"    <p>",
"     If early medication abortion is not effective in ending your pregnancy, you will need to have an aspiration abortion to remove the pregnancy. Continuing a pregnancy after taking mifepristone or misoprostol is not safe due to the risk of birth defects from the medications. For signs that your abortion was not effective, (see",
"     <a class=\"local\" href=\"#H16\">",
"      'When to seek help after abortion'",
"     </a>",
"     below).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      SURGICAL ABORTION",
"     </span>",
"    </p>",
"    <p>",
"     Surgical abortion is a procedure that is done in a clinic or hospital to end a pregnancy. The procedure is done by removing the pregnancy tissue from the uterus through the opening, called the cervix. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/22/4453?source=see_link\">",
"      \"Surgical termination of pregnancy: First trimester\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     In most cases, you can choose to have a surgical abortion while you are awake, using only local anesthesia, or while you are sedated. Some providers also offer other medicines to reduce pain and anxiety, including medicines you take by mouth. If you are more than 14 weeks pregnant, you will probably require sedation. To determine how far along your pregnancy is, use this calculator (",
"     <a class=\"calc calc_patient\" href=\"mobipreview.htm?21/15/21759?source=see_link\">",
"      calculator 1",
"     </a>",
"     ). (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/47/28409?source=see_link\">",
"      \"Termination of pregnancy: Second trimester\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     A health care provider gives local anesthesia by injecting your cervix with anesthetic medication. This usually causes some mild pain that passes quickly. You will not require an intravenous (IV) line if you have only local anesthesia.",
"    </p>",
"    <p>",
"     If you have sedation, you will have an IV line placed in a vein, and medication will be given to make you feel sleepy. Many people do not remember much about the procedure after the sedative medication is given. You will also be given local anesthesia, after the sedative. General anesthesia (where you are completely unconscious) is not recommended for abortion in most cases.",
"    </p>",
"    <p>",
"     The procedure usually takes between 5 and 20 minutes, and is usually shortest in early pregnancy. You will be monitored in a recovery area for about an hour after the procedure (longer if you are given a sedative).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Expected side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Vaginal bleeding, abdominal pain, and cramping are expected side effects after a surgical abortion.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Abdominal pain and cramping",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most women have some abdominal pain and cramping after a surgical abortion. You can take 600 to 800 mg ibuprofen (Advil, Motrin) every 6 to 8 hours for pain, if needed. Some doctors give a prescription for a stronger pain medication that you can take if needed.",
"    </p>",
"    <p>",
"     The pain usually lasts several hours. If you have severe pain that does not get better with these treatments or if your pain continues for more than a few days after the procedure, call your doctor or nurse.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Vaginal bleeding",
"     </span>",
"     &nbsp;&mdash;&nbsp;It is normal to have some vaginal bleeding after a surgical abortion. Usually the bleeding is less than what you have with a normal menstrual period. The bleeding usually lasts a few days to two weeks, and should become lighter after the first few days. You may pass also pieces of tissue or blood clots.",
"    </p>",
"    <p>",
"     If you are bleeding so heavily that you soak through one menstrual pad per hour for two hours in a row and you are still bleeding, you should call your healthcare provider or clinic immediately.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      WHEN TO SEEK HELP AFTER ABORTION",
"     </span>",
"    </p>",
"    <p>",
"     Call your doctor or clinic immediately if:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       You are bleeding so heavily that you soak through one menstrual pad per hour for two hours in a row and you are still bleeding.",
"      </li>",
"      <li>",
"       You have severe pain that is not relieved by pain medications.",
"      </li>",
"      <li>",
"       You have shaking chills or develop a temperature higher than 100.4&ordm;F or 38&ordm;C (use a thermometer to measure your temperature).",
"      </li>",
"      <li>",
"       You have foul-smelling or pus-like vaginal discharge.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     In addition, you should be aware of signs that your abortion was not complete. Call your healthcare provider if:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       You do not have vaginal bleeding after a medication abortion.",
"      </li>",
"      <li>",
"       Your pregnancy symptoms (breast tenderness, nausea) do not resolve within one week after your abortion. You should not do a home pregnancy test, even if you still feel pregnant, because it is likely to be positive for up to 6 weeks after having an abortion.",
"      </li>",
"      <li>",
"       You continue to bleed for more than 2 weeks after your abortion.",
"      </li>",
"      <li>",
"       You do not have a menstrual period within 6 weeks after your abortion.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      FOLLOW UP CARE",
"     </span>",
"    </p>",
"    <p>",
"     You should not have sex or put anything in your vagina (tampons, douches) for two weeks after an abortion. Putting anything in the vagina before this time could lead to an infection.",
"    </p>",
"    <p>",
"     About one week after a medication abortion, you should have a follow up visit with your doctor or nurse. It is very important to go to this visit to be sure you are no longer pregnant.",
"    </p>",
"    <p>",
"     Approximately two weeks after a surgical abortion, you should have a follow up visit with your primary care provider or a provider at the site where you had the abortion. At this visit, your will have a pelvic examination and can review how you are feeling.",
"    </p>",
"    <p>",
"     If you have not already started using birth control, you should discuss what method is best at this follow up visit. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/60/9157?source=see_link\">",
"      \"Patient information: Birth control; which method is right for me? (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      ABORTION COMPLICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     Legal abortions are safe and usually cause no serious complications. However, complications do sometimes occur, as with any medical or surgical procedure. Complications can include excessive bleeding, injury to the cervix or uterus, infection, and the potential need for more surgery to remove pregnancy tissue. These complications occur in a very small number of cases [",
"     <a class=\"abstract\" href=\"mobipreview.htm?41/47/42739/abstract/2\">",
"      2",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      MYTHS AND FACTS ABOUT ABORTION",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Abortion is not safe &ndash;",
"       <strong>",
"        MYTH",
"       </strong>",
"       . Legal abortions are one of the safest medical procedures available today. While abortion is not risk-free, the risk of having an abortion is far less than the risk of carrying a pregnancy and giving birth. Abortions done early in pregnancy (before 13 weeks of pregnancy) have fewer risks than abortions done later in pregnancy [",
"       <a class=\"abstract\" href=\"mobipreview.htm?41/47/42739/abstract/2,3\">",
"        2,3",
"       </a>",
"       ].",
"      </li>",
"      <li>",
"       Abortions that are performed by someone without training are not safe and can lead to serious complications, including bleeding, infection, infertility, and even death &ndash;",
"       <strong>",
"        FACT",
"       </strong>",
"       .",
"      </li>",
"      <li>",
"       Abortion will make me infertile &ndash;",
"       <strong>",
"        MYTH",
"       </strong>",
"       . Legal abortions do not make it more difficult to become pregnant in the future.",
"      </li>",
"      <li>",
"       Abortion increases my risk of breast cancer &ndash;",
"       <strong>",
"        MYTH",
"       </strong>",
"       . Several studies have conclusively shown that having an abortion does NOT increase the risk of developing breast cancer [",
"       <a class=\"abstract\" href=\"mobipreview.htm?41/47/42739/abstract/4\">",
"        4",
"       </a>",
"       ].",
"      </li>",
"      <li>",
"       Abortion increases my chance of miscarriage &ndash;",
"       <strong>",
"        PROBABLE MYTH",
"       </strong>",
"       . There have been a number of studies that have tried to determine if abortion increases the risk of miscarriage with future pregnancies. Most well-designed studies have not found that legal abortion in the first trimester increases the risk of miscarriage, preterm delivery, or other pregnancy complications [",
"       <a class=\"abstract\" href=\"mobipreview.htm?41/47/42739/abstract/5-7\">",
"        5-7",
"       </a>",
"       ].",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2413398829\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11443476\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/11/29874?source=see_link\">",
"      Patient information: Abortion (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/59/4019?source=see_link\">",
"      Patient information: Pregnancy in Rh-negative women (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/15/13555?source=see_link\">",
"      Patient information: Spina bifida (myelomeningocele) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11443493\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/60/9157?source=see_link\">",
"      Patient information: Birth control; which method is right for me? (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/45/1750?source=see_link\">",
"      Induced fetal demise",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/38/33386?source=see_link\">",
"      Mifepristone for the medical termination of pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/42/28330?source=see_link\">",
"      Misoprostol as a single agent for medical termination of pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/2/19498?source=see_link\">",
"      Overview of pregnancy termination",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/8/24713?source=see_link\">",
"      Postpartum and postabortion contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/22/4453?source=see_link\">",
"      Surgical termination of pregnancy: First trimester",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/47/28409?source=see_link\">",
"      Termination of pregnancy: Second trimester",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/abortion.html\">",
"        www.nlm.nih.gov/medlineplus/abortion.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Guttmacher Institute",
"       <br/>",
"       <br/>",
"       (www.guttmacher.org)",
"      </li>",
"      <li>",
"       Planned Parenthood",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.plannedparenthood.org/\">",
"        www.plannedparenthood.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       National Abortion Federation",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.prochoice.org/\">",
"        www.prochoice.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Reproductive Health Technologies Project",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.rhtp.org/abortion/default.asp\">",
"        www.rhtp.org/abortion/default.asp",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?41/47/42739?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42739/abstract/1\">",
"      Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011; 84:478.",
"     </a>",
"    </li>",
"    <li>",
"     Lichtenberg ES, Grimes DA. Surgical Complications: Prevention and Management. In: Management of Unintended and Abnormal Pregnancy, Paul M, Lichtenberg ES, Borgatta L, et al.  (Eds), Blackwell Publishers, 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42739/abstract/3\">",
"      Raymond EG, Grimes DA. The comparative safety of legal induced abortion and childbirth in the United States. Obstet Gynecol 2012; 119:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42739/abstract/4\">",
"      Beral V, Bull D, Doll R, et al. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet 2004; 363:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42739/abstract/5\">",
"      Atrash HK, Hogue CJ. The effect of pregnancy termination on future reproduction. Baillieres Clin Obstet Gynaecol 1990; 4:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42739/abstract/6\">",
"      Zhou W, Nielsen GL, Larsen H, Olsen J. Induced abortion and placenta complications in the subsequent pregnancy. Acta Obstet Gynecol Scand 2001; 80:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42739/abstract/7\">",
"      Kalish RB, Chasen ST, Rosenzweig LB, et al. Impact of midtrimester dilation and evacuation on subsequent pregnancy outcome. Am J Obstet Gynecol 2002; 187:882.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f41_47_42739=[""].join("\n");
var outline_f41_47_42739=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ABORTION OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           IS ABORTION RIGHT FOR ME?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           TYPES OF ABORTION PROCEDURES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           EARLY MEDICATION ABORTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           SURGICAL ABORTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           WHEN TO SEEK HELP AFTER ABORTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           FOLLOW UP CARE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           ABORTION COMPLICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           MYTHS AND FACTS ABOUT ABORTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H20\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        CALCULATORS",
"       </h1>",
"       <div id=\"relatedCalculators\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a class=\"calc calc_patient\" href=\"mobipreview.htm?21/15/21759?source=related_link\" title=\"calculator 1\">",
"           Calculator: Estimated Date of Delivery (EDD) (Patient information)",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f41_47_42740="Leiomyoma uterus A";
var content_f41_47_42740=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hysterectomy specimen showing multiple leiomyomas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Aron Schuftan, MD. Copyright &copy; Aron Schuftan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42740=[""].join("\n");
var outline_f41_47_42740=null;
var title_f41_47_42741="Port wine stain - V2 infant";
var content_f41_47_42741=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F59124%7EPEDS%2F58831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F59124%7EPEDS%2F58831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Port wine stain",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A port wine stain in the V2 distribution is present on the face of this infant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Port wine stain affecting an adult with Sturge-Weber syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 248px; height: 342px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFWAPgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5hcRJb4UsXJGcjgetRYVYjlSXJ4J6Yq4bcQ5kmZJPlDAA5GT0zVK5lM0hY4HYAdBURdzaVkiCiiirMQooooAKeVwMkge1MooAcSCBgYwMH3pBTy+YgmOhJz9cf4UwUAJRRRQAUUoBpQCelADaWkooAecEcAA02kooAKcAD1IH1ptFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGzdQiSQCEYj4AOemOpP41lSqFchSCB3FTXcu6QhM7RkDHf1NVwcVEE0tTWrNSeggGaSlGe1BGKsyAdatNaMoXd94gEA+hGau6dZiJEvJ2CxBuOMkkexq1cEXZYrthiySSegAHAz1yfSspVLOyOinSTV2ZJsnEatuQ5xgBhnmoJYnibDjBIz1BqedY0ZwSW/u46frVQ81cbszmknZCU5VLkKoJJ6ADJNNpwJByCQfUVRmPlikiIEsbITyAwIz+dRU8sWOWJJ9zTKAFFSRKWVyP4Ru/UD+tRmnpna/sP6igESIhdHIGSB26jkc1Bip4G2AtgleFJBxjP/AOo0t00TyFosgE9CKXUt2auQOpViD2pBSUUyBaVcfxZxTaKAHkLxgn3zTcflSUUDuFFLxS0CG06m0UAFFFFABRRRQAUUUUAKetSwQPMSEGQOpJ4FRGrFrGZHIDIAFLHccAgDOPc+1J7DW42SPZIyqwcA4yOhqIDnFat6ttHDGIXDyuMuR29vaoo44IIy0q75MkBQ3QY6moU9DZ0uxLbK021LhmCgYUA4x/jUl1IiQFFwCD0JySfX0qBpXuZUjiJVeAB0A/Kp7y2EFuoYkt32gYzz1/KsnurnQtjHkYsxJ60ynNwxpDXSjhe4lFFFAhxxgc0lBpy8mge46NQT82QOenejcUDhSQrDBHqMg/0FSRsEkjMg3ICCR6jPIqMgsScYHWlfuU0tkAciFkx1YH8gf8aipaSmQWEjLqdoJO3PHt/+qoO9XdNn8mYkngqQPqQR/U1UYYYjFJbtFvZMZRRRTICiiigBTQOeKSnY6GgAII696KkOAAD6Z49aZilcpxGU6jB7c0n0pkiUopcH/wDXSd6AEopcfWigCSVQrEKc+9R06Rtzk02hbFS30LFqfnIJAA5OT6U2aYyMSfWoKKVtbhztKyJo5TG2QOR056VLJcPLyxJyfX/PrVUVe09ljlVinmSZ+VT0z6mlJJalwlLYiktnj5kUjPOD/WojEQM/pW5Mq3MrS3D8Acn1I7CoL62MCbXADHB6dR2rJVejN3QTMWinMME0lbnI1YM0qsQcjqKMcUgGaAH5JIzTlyV9v5VGAasBNsYIzyOtSzSCbZWPWkqZo8AEjg9KjxzTTIcWtx8aZBPcDNLKCVVvXj8qtRwgpM24Dagx7nIBA/M1GBsU5AO4VPMbezdinRT3GDSGrMGrDaKKnijEkczE4MaBh7/MBj9aBEFKDg0qg5pZBhzxj2oHZ7khO7GMc44Ap8TAMSwG08EAdB61HDnOcZAqYgZxkgk9MZqH2NOVtXIpUMbkdCP8imHPT8e1SyEnaCOVGMH09ajbBJwPypk2ExgZ4I96bSgkAjsfagD0OfrTJEx24oo7c+tFAWAjnBpCCDzViROvoDxx1/zii7KtIpTn5EH4hQD+tCZUoWK1FKacEJwe1MlK+wgFTxMyFWXhh3/OmiPGGIyuRmrtvEWXfsByRgk8DnniolJJG1ODubuiWaQBbu8UnYN0UZH5kj+VZ2t3AnuCwQrHk7QTzV2W6chuSWIALEcn0GOmKqzWbKokk+d25CjoK44v3+aR2RjZWMGQGowKt3KbJCCQT3x2qNYwSOQPU+ldqehxyptyIwvenbTmpSmOSMDHGe9NHLAn/wDXSuNQsIAAQevtVy3VQjSspZF4xnAqqoyfQCpYl3sqEgKeSamRrBWGykuzNjGScADAAqEpjHrWrHEskbqBggjb9O/9KZHbguQQcYAyPU8ZqVUSNHR5hLaBpbclUyFPLAe3/wCqn31r5RiAB5UE/mf8K2bWBordChKq0RY5HQkkD9APzq5rNoggiZFxK8QIJ6d8/wAzXM69pWNVT0szjBECeagZMEgV0jacy6YJFGTnkj+VYk0eG5xmuinVUtjGrRVrorhfk6c8063jLsQDgEYJ7YqQJk0MuBgVpzGapbNkbIA+Bzjim3AAclQce9TRDLDjPOaZMMcfjn8KE9SZw90ZFwRzVl03KSmSR1HpVeMc1qWCAtKUOSF3AHuByRSm7ajpr3bFB498YK8kcE1AF4DbSR0NbFzCIpTjASQAqBzz3FZZQjKnIZTyO1OMroymrMjU7SSM49qZnnIqQDkZ5BB6cUDP3WA47k9KpMgiANFSkDGADnviii4rGjqMTvIfLQhB0I6Y7fyqhyAQo4xgnH+fStnUpGnCqR5ZVQAo6AAck+prP8omPcmcHqPcVjTl7qudsqdykFyTz/n0qyqZjjGDkDP61N9kIiRsHcQG6ep4/QZ/GtK5tAoyQFYLgjHXnrTnVS0FSpa3ZnW6+bP5ZYBW457HGM/zrpTYxeWDGAI84Ukctgc8elZ1jaLCy3EoyACQGGB3/Otq0DsnmtlUJ4Yj9B6Vx153ehslbcILCJn3sxcLjK46n6+ntVi6tEt0LmMecR8iZ49jV+0mi3OIxlYx0A6n1NZtwXnnbDEuTgZPBz/SuRuV9Sk+xyV3anz/AJyC5JLY6CkxHGquqg88EjoR/Pv+Vaep2aRyJDDIXdzlmHT359qrXESJsiPCxhiTn7xAyP5V6MZ3SJcTHmYuAT6np0FLGMLkjg9KFBAyenOBUiADDMcAdB3Nbt2VjKMdbscYti7WBDEjI7gHpViK22oCwxnpnGaZHm4mycdcYJ/nV9F3yITnPCjI4rKcmjeEU9R1pCViJYYLDYPqSM/yqdbYvI4XIGcfgOamhi3yqCcLGSSfWtWKz2lWUErtDHnqTz+g4riqVbG9tBSBDZKZRh2KqgAzkKAP1OD+FP1aLzDboxAYqowT0wcmpJUMt3bADCx/MR2zwf6/pT7iJpJgxG5gMkehIz/IYrm5tmIpSKotFhJwDEWHscj/ABNcrfW6+fhTxXaXFqP3hZSAiqhHuSCf5VkXlksULOwO7GPx9a2oVVFj5brU5hYyXAj9Tz/n2qZoC5woycc4q3YWzy3KpGuVJ5Pp2zV4WxtrjAOTggD3Ndk6yTsSoaHOSKI5ygbvjNRSYLY7DjirWpWzw3m0jg8ioGX94A3A710RkmkzkcW7pkK8HA/WtDSJfLvUwgfJxgiob6HypcYxycfTtUcJYNhOueMUO0oiirOxv3NuWQq5AYKWTI645P6H9KxNRQLIuBneMgg+naujkkWSKzkOCCecc8Hgj9TXOX0ZR2iI5ViRk9jWdF9DKquxUGQCDgcYGTSckdAeelGCGIIAIFOILEdM49K6TGw3BIwOtFLjcQMnNFA7HRC1ecySEZDkLnvnOTV8aaHidGwgQqc56jvW81oEAWFACAQMnjJGM1C8Ma4iiUkYKuzDjnIOK8iVWVz07qxl2NsZpnkKARxoDtxwx6Afz/KpLyNGmUOcM/zHjsOcVpRq0ULqMDcRz3OOlKIEjKyXJCsh4Uj9azc7u4bIqtAGKb0ARcYz0Huaqz3BnlUCU4U7VVOQfwqvqupLK5iiJIJ5boPwqxpMSRLmMDzMHDE5rRRcVdkXubMCvHbIioA7dEAHX1Y9arXrR2VuqoN8gBy3qT2HrRBMY1Cb23MDnHJb8+lIIXmKySkAg4Reyjufc1n11GZc1s1laSSXDL5snOD0QHt9TWLJslR96fvNwKAdx3rW1JGuZQCSyqeWzkE+gH+NZ89q1udz5VscL7V1U2t3uK1zNmOBswBz071AcZx1/DpU8yZfGST1Jx0qe1tUkYszYQDJzXVzKKuxcrZZ0+3EaKxGWPJPbFSu25gMgdeBRM6Mm1CQoxjHGau6dbq0iyshOBgD3rklK3vM6oReyLkMPlWixsDuckn3GOK14tpUwqQCvyHHbnJ/XA/GqMoMO93BLHpzwD2qXTmR/wB0pBIAZySeQOcZril72pclZamgvlRLkrnIDEHg4z939alVgkDyzABw54Hcjr+uBVSa4Hm/MVLk7if5VHczbokhXDEAjGfU/wCNZWuZ2EaY7XRjlnbcSe1VNQiM7ZJJLdcdPSpJWZ7hUChVAAwTxmrxjAiUNyx46YGPanfks0aJaFPSbIW5YgfNg856e9La2AnumkKk4O4Y6DJ4FXoVTbsQhmPBHfHpW3pVpgFQCGYgkkcdMVDqybZpFaHEeItPDnzBHnaRgD071zCWjmfaylT8o6dCSP8AGvaLiwiJbgHA5HWuH8Q2qpfCWIEJvJcgdgAQf0rswuJaXIzKrBPU5XxAQblgAFAO4fQjP+FUbIHzCQAQMH9RV3V1OIw33yFx9AMf4Uyxj/eojDIJI4r0IytA5La3L1qgl05o+jRk4x6jnFZWqtulbIwxIyfbtWtpG/bNuI5dSQfU8VmaqP8ASpEIxjAA/L+uaKfxswqlBQHGAcMO+KRgMkqTkcD3qRVIyBxjrTOTt56Z610XOVjWXIBxgjknNFKwAYEgBfp1opjR6o5EjBW4iU8ADr7Z61OlsW8uMYBOSfYf5NVoJwpwqgsSAAeufWrAcwQsCDJIx3HnGB6V40jvWpEYwZ2LDdFH2Pciqt6DdwsY3U5O3J6E9gPYd6lkkNwgAJEbdDkDPqfwp0xhitkfYQB8qKo7nvUpFXuYEmjGOUvLIjEDhV6/Qe9S2kUULIJnyQcnnAH/ANf2q9ezxW8QDAPcPzgdhWeoaZsCMOxPCqP5/wCNaOTe4IkmnjlyIAVUH7+ec/0pYrlmUR4wjHhgeV9TU/2AIqiVdjYOQOc9eP0/WpLWzEjY2EAkbcnqOx/EZP4VF0D2CGBDgACNACS3rWXd20t3K0pPyKcKGGMD3/pXQ3kLxrHFEAXlJwD2HQfrWTfCRIvIViAPvHnk+lOMmnoCMCeGNdwjBJwQWP8ASkWFgBHECTznjORitJIC5ywwvQd8mtnTdNYHz5FAJPBrSVflR006TZjadpTzTKjkjcN3I64rqILO3sogShJA7jvWjb2qqFbA3KDjjpVO/VjFt3E5ySc1yTrOe53wp8qMK9Zri4YujKrEYA71cxHBbpGoA3As2OpPbJ7VE0bmQO4cogzx2FQiCaaVdyOIyc5PHFNO5jODbJV8qJl80gyEbjz1B6Cp7cosvCh5GII9qW30p5ZHklR2Od2AOtX4bMMT5WAwGCrqRx9amZUaFtynOFU72Cgk8qDk1T1K+fyCEQbwQFGegrR/spoJPncgH5i3bPpW9a+HraWzWUKWfOWHr/hUpqLu9SZ0ZdDjLG6ltbN7iZVDMcAHqae3iW7ijAAHJ2gg9Peu2m0O2cfcIVcYZhkA+lYXiDwyDagQoFk6DHcVpCpTlLVGDjKxmWHiO5mZ9o+Rvl57+pz7VWur8XcMpBGJMAD0GaV4F07T5InKiVsY9Rzyax4I3xEFAChOB6c5rVU4N80dBSUralK/ButX8uMZUEL+HWrDIqySGI48gbhj3IH9aj2NaySXJIDAE/0/nTPO2QSgDDMQoH+zwf6Cuy10ktjlm0iW2YlJjngyKSc9gT/SqGqMXaKR8ZIyWA5PJ/xqRXJjkIIAJ6E/X/GqcrEkgkFQAAM9BWtOL5jlqO5CQwGeQDTQCjZJGAOO+KdjAOCMn3NIQQ2CRkjrXQjFLuMIzyzgg+1FKx2sOhHpmigZ6BasFZZZCTIflQdhn+tOkuNz5ZhtIwdvO72U/wA6yHmeU4U8k7QDxn/PrTmcNuKEhQNqKeASeuMV5Kg+p3JaI0xdK23ICgA4Zf4R346VTk1F5Z1fIKx5CKO57E1QM7vG6ooGeD6mrGnWLM2SCMck9OKLKKuy1EtW1uZAJ7g5JJYgnFXbaVIWDRBQScZqjdXAIWFMlQDk0sEoY72UhT8qrxyahpvVhY1GaQuqngsCzMegH+RVqwVDGWHAU4AJ5P8An/GsmVmiIQkh3GZN3QD0FSRSvJceVnYqrl/QD/P9ajYOW5vrFGImuMkyuAqDPIUdT+FUDYmUvJIwWPOSQc7j6D+tT2zPMwlkBRGACqRgkDv9KS7ZpWwuABwFHAFNvQ0hSbZShtsSLIi8A4wfSt63tS9uufx9qrWURS0UuVD89q2LLBUqRnOBWZ6FKPKNe13x7YyRkflVcaSu1RznAY5J55rcgMcZJkBBJHQcGr8VsZWxImAAAP8AaFTY1empziWAVQkMJV+xxnJ9s1aXQCWUyESS9eTwo/xrbEQgwdwLtkDJ/lTwHCsxADgEhQBzTElrcypbQ2cDAA7cfeXrmqcFofNcusoQv8okOHH1HpW4sjSSDz+E6BVHJ+tR3U6RKx2hn5wW5P4+tDNb30MPUrEybnRAS4Iwz8Lx1xV/w7vjZkkcEqMYB6+lUpVnvZ8IFWEEMTtwcj09q2rFrO2OGceaQMkgVlIc9I2RaljDDBAAJzjHesfVWMEbSYBABxmr1/qVugwrZPtzXM6vqLTgQIjAE8sw6j2qEn0OVK7szn72yXUbgSzk7T8uFGKmGmxKyEISMADnsKtRXECbuC+0YIH8P1rQjtQzqQ4OM4Q8YBHXNbKT0TOipRThfyPMNelKXRjUqVbGQPTdkj8xWM8hZgCRkkmr2ro6X8u4YIcj171RkUEhj0A7CvbpJKKPlqkm2JvKsehJoJBJLHJPoKQDawCknPdh0pWwrA9jwa2SMWR/xEk5444pWGSCMbehGKdyOD3PBpADjB7daBxI9gGOBjNFSMN24enSigZqtOGfCgsccD0NXQD5WUV2cfKqjue5x0qHTrdVhe4lGQDtQZ5Y+v4VejlZpxHFgTEhSQOg7Ads+9cE3Z2R6EUFrblJVMmHcYKqvTJ7H3rUlj8iANMT5jnJCn9KWBIbMB5cMUGdq9WJ9adHBJfXHnzkDJACg9F+lcsm5PU12RnQwh5sNlAASzY6Cr1sqW8gkKjLcohAyAO/Parl20dpEEIUkjzJR1OOwFVorK7uhI7xAu45XPKr2/D2pvbUhNsphXaVpDl3GeMdOOvvzir1vb/Z4xvBaR/m2k/rn09q2LPRZCiliTKecDoOc/zrUn0dYbVlBBkPzH2rFzvsbwpu+piKzsigNltp79PYU9Idu13B3ZBHHU1YNm0LZ7L0471o2drvkVt2fm5Wlc74U1FaEZiRpCTkKAM+5NbmmW6+U4JBY4we4FQW8AGRsJOfToK2LdNuCyAADGR6UmaONircwv8AIgKKhIGWHP6VegAiwmSxA4INSAp5eCS3PIJFRyyRqrPtY4I4XrUpiaugk8tmUsQSvYdQabNuVWwpI67s9BUgKNg7M7ucjg/jVe6b5GDOQhPQc1V7ErsNjcNHv43YHP41TuGigiaR4yxznA5qbcixfLyvTn0rK1B3YgqRtIPFS2bQV2MuNT2gLChTPVpGwAPwrCuNStSd3mG5kx82w4C8+nerU9q06yRucAjIJHSsebw9AG3pIyMo6g8GnBRb94c4ya90x7vxTK87R2MRQk7ct296ns7TX55BKZAVbknOQKrSaPLBdia2IkYnJ3DIyK6HRdQuHhKzhF2HGAMZronKEY/u0jmp0pc37wv6ZoSQrme5Z3kwXCjGfatjVrUNbgQttIXqOp4qvb6kWZUZMAfxE4FO+0h9wJO4jrjjr2rmlK+p2xj0ex5b4l057e7L7iySZ5bsawwuDjJwDn616rrGkR3oO5wxb+6DkGvN9TtJLOdopBhgTjPcV6eExCmuV7nz2PwrpS5o7FAgrknOD0zSBSQQcEGpCCQMnrSEcgZH5V3I8sjxyAfpSfeBz1z+dSYBYA8e9IQM49KAG8YORiil28DI5znOe1FMRr3FysQEFuAZAcc9jWvp1p9lQO7tvIzu65J9Km0fw7M8ysYi8jHhcZzmusi8MzG5iSRSXUf6sdFHqa8ipXitInsRoPqc/b2+796yncBwPX3q9GH3MI4yxUZHH3j6Zrf13R5dPtR5aDIGS2Ogrc8I6MlxZRPsIDAkE849a5ZVjaOGb1ZzGheGnubtJr3JbO7bjgk9K7Q6OkUISKMIe7HGa3ILEQuI0UkDocVeW03x9Mt64rL2spbmjppao45bUW2VAySeWq1b2AuNxYHJHFb0ulhiCwOAc1p6bYhAMAH6jpQky20onKSeGi0fTO7nFZeoaa1nIqRA7icnA6V6fKixxZCksTgY9a5K/UfatkqsGJzuHStFoaUJ3epm2duI0JkDEjHNWEiVXYZyWBwT0FSyY8pwSeoAqvK/lw5By3TkVTNpPUqytsJAXJOcso4pEeL+8S+PmqW3kM0OGGc5GVqJmCzsIkDAfeLYGT6VIh5JYKEGUwSWrPnuUtzkghV7dqtPIUjJQhUzk4/lWZd3KXC5WF1ZTyW6EU7XHFXZHcXsWWZHBBGQqjkVUmudxXABToCv3gailYSNJGqGORiAGzgEVW1O3itNssMmASAVBzn161FmWvdZJM5d3VZGOMYU+nfpVSVlXIzz3HpSM8csfnQuxIThVP8AF2z7VFKXaZUcAMDgjHUetGqNL3IJCFXHTnINVY2CM4bhW6nPT3q1eIfMYqBtxtAJ4Ge9Yt7OIdwIPpg9DVQi5aFPuaCXzxsE3hiOd3tV201MGUeYCMjaAP51ysV47OdsZJJzxjp2rZ0y4E0OSpIBBzxxnitJ0uXUPac2hvC5Rwzxk8EDg8fjWTr+jLqEeISUnAJAYHB9s1qoWJZ1ijDAYIGAMeuPWpIJ5YGwqPIx6K3r2waxTdOXNEirSjVhys8nnieKRo3BDA4PHTFRbQT0PHvXoevaKmrq1zZo0N0vMkR7471wU0bxu4ZSrA7SCOle1QrKqvM+UxFCVGT00IeM9c46U1gTnjFTEKoyTUTA8Ecg10o5RhOcYHNFO4HPIopgfYeg+F4rCB52jDBVxyOeR1FMS3trWzunUIHMi4dhyexGfrWnqmo4+SHIAGNoPU1nXEZuo4IYxkKTvIGSxY5r5bTofTxi27yMnUNMl1e18hEIVjgsP51qrDBoljbwZAZiEA9zxW9HbSWtiBGMDaeCOScV554yjubq6gcSECFw2AfQ5pSiNPmdkd5bWQypYHcRn8KtpagAhcZzU2lMZ9MtJWHzmJc+/vUoBXJxnJraMbLU5Zz1sVDAM4wCaaqhMhQMk4PtU0mQcgcmoyxH3vyqiU7jJuMc9OtYGtQjCPsJOeSO1bzru5PftVedAVIYcdTUX7m0JcruclMyK7GI5YjBB9aroCceYF5BypqfUlMN2gdGG49h19KpXCkzoxB4GDninc7N9RG2xMFB6HccDHFQTSW4DyEhSwwT3NV9QupUjzEgIJAbjkD1pYTE6kqo28Z3etUh7D32GJnAIUdOMk/hWReTyB2dfLRVUkLLlS2OwXuT6VsXBVoQgIwTyFrKGnmW4Zm3eQO7HPP0qgi7MisNtwHOxFbfjDKeP1qG7tcxtEIAzSBsMwxt46j3rZtYVjjfYiEAkksMc1HeYVm80YU4wM9B3J/pQkHM7nM2lsyRAbPLdAMnA5561WmfzBncCcnA5zn/AOvWlqk5glV9hzjBK84HYmqZeOSVVI4kwx9gec/hU2sVzsxLuUpIyMTyOaymCNMGkJIB6HnFbeoWjK20OsigKwb1yOlZiW5EgLkqARnAzgVcGkUp33HymKzulmhijVgADG2SB059+Qa1dFhYTACKNgsbKQgGCOuaoxwXC2jXiCKSFcFt2PlySAM9c81vaddRabowlIPnsuQxHAGaqTEt7lm3slETzQxOGJwVOefz6VLZr56y7mAkUjC5yRXNzeIbqR22E7TwDjAzUtrrE6PjZEWI5YDBqGmjdXa1OotoX84Ssm8KMFlGP5Vg+NPDKzCS7tRiVRllA+8K09MuJjJ5tvKWLctGScGuxigE9n5hAIYc5HQ1nCo6cro5cVRjOOp83SqVJVicqSDkfpULAdK6/wCIGlCx1fdGuElG4Y9c81yLAnOOCDXv0p+0jc+VqU/Zy5WMCnJByc9KKeTgAnqOaK0IPsK/iKXayKNy8ZrWtLqyitVlR1M4O3a2OKjaNZA+wE+got7W2mRt0IVwcHj9a+Wg7No+knJOOo+W7eflWH51zmoWO5ZZJHGMA/rXVf2ZbFSAWBI7cVjatpUvkP8AZH3g8FWrVtrcmE4rRE3hXVA0S2TsA8QwB6rW8z7GPPB6VwXhbRb+31dru9aNIlUgKDya7SKXzlwp5BpKfcitBc10WHw4ypwAOaqMcN9KRJxlgBypwRQWGQcdaq5CjZAck5zio5CowCck9qczAKxPOBkVEQGXcBgmpZSMbWUfymC/MSc4I6fjXOEhlcNkMADyfeuyu0zHgnnuR6Vi6hYxmFmQENjk00zqpzurHKXcO/eN5AB/OowdqmVwAQMYPQj1rRcNMrIVHynkjuKzblXjQRqCd2ck9RV3NSCacS4aI5QAk7cgZp9lKigxyE5Y4Unpx3p0dsTAEBxFnk9yfrTWsy8ZEZwFGMk5OO9K+pVla5qyFBExQggjILDgkdhWReToxhSVghIOeM59KvW8Ty2AEqEbMqOTnHr9ay3tH+0hmlZo4wcKwGRV3IVihNCb65KFiIlbnAIJA7VB9kMV+HCgqoIbBzuz6jtW4EKxsQCG5bceKqw2672LEhOpOeo70XFdnPiM8qcYHUemP/rVWaBXDuSxCgggYzntW3MnO8AHlsjHUHjNUZyHnedsRhgF2gYAxUWLM2aFkhZQQYmGSBnr7jpU+s2wi0m2llLmNlTAB6DHP61LqCo+3BIkA2kqcAg98H0rT0/SpNS8PtbTPhFcrGzdhVJ2epS01Oe0WGC5GxiNykbIyfvEHOSR+VatzYxWoLFI3wxDHPI9OnuP1qKCw1HQradIRFJA7KS2wbmwcgA4yPwobUru8inRIdiSqqvv6cdMH8KptdDZS5kauixoNRWFThkYseeMAjH5V3cF0ioEQDC9+xrzKwtNSlXOnYDAnfK3v1AzWlqWvJoel7LmRZLxgRtU9/esvZuo7I48VVUXdnPfFi6ie/toYiC8YJYj+VedvyeOOauaheSXt280zkySEk+w7VSJPcZ5617tCHJDlPmq0+ebYmQTz0opCOfX0ora5kfXXh3XrXUbdZIJwCRnBPIPpXQ2crvmQgBfXPWvHdC0ySBwUPAI4U4rubSe7tQgDGRMZ57e1fMWs7n0b1O1MpK5/i7VU3OqsPU81kxauhjxKCr5544FTJqcTnAdatu6IUGtizdNlcDAPfAqSwBWMjOc1TkuImy28Yx36ZqDTL8XV1MsRBC/Lx0rJbjcXa7NVl/fkgfK3WlbAYAnIBpAxCkMM1GW7471dyVsKWDHknGaazDY20EjtyOlDbR1HyHrUQCnjptP6UXuMbIw8sPgjnGM1mXSOwYufkPStOQgNnaCo5qlOokjO1iMnr6CovqXB2MZbXy0ZtuQ2c4OKgktgz8ZOBnkdK2IYGUKGfdyckiorqCVpUKEBACW96rmNeYw7iFSAhydxxgDiovLSElSAAvT0rWu7ZhvkGAAM5Y4H4VzGo3jLeIjOEjYjLkcEe1XFmi1NCWXeu0EBc5yM1k3DRJdo8kkhyMA9BnsKuQsJ4yF+dgeTkgD0Bx2NUDaRy6hHLI0hWM4IB+XdnjGaq90CikzSaMNGATgEZBNQyWpQdc7hyBzxV+EwtHzuIBxTWALqwOQAaRN9dTFntXIEagLk5J46Vhaujwx7kcM0gOVIGEI6D8a62eMF/MAwT8ua5iaN2aTcRhdy8jrmnc0WpSvFHmQZA3FBk9RW7HcmO1WKM4IGQfTNYrALNCDyR0709p2ErKTnPQVL1NIK50cFwXVRIQExznmsrUGjidgNqRAkgDnIx15qvJdBIwFOWHYmsm9vlkjYY5BJIpxWtivhTZk6t4ruog9tYnyowSNw6muWubiWdi80jM5OSWOSfzpbtgZpGABBJ45qtIQMAjOe/pXtUqcYpNHyeIrSnN3YrA5OBjjrUbgrgdQetOJAfGTtIoJGeua6TnGg447UUpGRxxRQB9Q+Hog2UYDcD6dq7C2tFZBkDGPSsiwtBEwJxk10NqAqgBe3rXzaPflLsRvptuyDcAfwph0S0cDIx9OK0sDy8Oee1VpJCDgGnoQpS7mRd6HCRhHcKD65pum2K6ezCHBDHnPU1oXD7l4OCOaht3w2e/vSdjZXa1LBLLz2Pamk7gcEjHJ4pWddvHL9+e1Vyx3HGRmsmJIeSCCD07UhOHGMc8D60MQAMDJAzTdxKfdA5oCwrLuyByR1FMYDao2nkGlZm29QPeoSSZBySoFSwuNClrhSuPLAIYnrmnMiO2M+1N3csR3p6ZIzgDHNA7kFxCGUxscoxxjGapz6LZvAsbRgp23DOCa1m2FQynJB6e9VhDiSRmlJBIKr2WqTGpNGaNNhtYAkQAYHggVh6pbur+XGPnYEgEcL7muxI3bd44weRWfdQKzszEEHrTU7Fwqa6nORIYQEYjdjJI6fhTJnYJFHGP3jHkH07mp5oJTfHau2E8Bs96rySeRMEODIc8HsO9aRkaWu7obqLBCq4B3AqMnGDiuYkZJFl3Ek7Scju3ar2t3YlljRRIGQkknGOlUQm4E7cIB+dW9TSKsUYlAlYqcyRqcqfXtUEn+sSVeoBDDOcGpwQss5b7zEdeM1XILyI8aKu4FX4PPvSSNU7bFeSbcxSQkbhw2Ko3cJVAEb7wOd39KvTWroN+9SGBIQHJUDqTUMihAvRwR37Vovd1ZFR3VjhpgVlZSSOTk5prAbMcAdjV/W7YQXZIA2NyPas0gDr0NezTkpRTR8pWg4TcWKfmxxyO9NOOTjkU7rgelMAO5vpWiMWKcMAQcUUznkMOlFMR9e2F7FNtORjGMZrftcMmSf17V434W1JsoWYnp1Oea9Y0mbzLdSx5Ir5q9j6KUdDTYjI5FVZPvMc59BTmYZzVZjhie5NNsUIjLg4OcYHeqrSBXBYHB6EVLOdzbF6dxUEu0rgkhh0GajmN4xRZMw4BOGPQ0oJ9VP41kzrKZ0OSQO1Wbd2Y4dSGz1zUtjcLFwN83Jx71JxjDdPWqrMQcA/pUicLnNK5k0L95WA57VFIRGSFGAR65z606QgEgdCOah3c4IyvQZpN2BIdG4ZDgYbNPJGCM9qrgFdzHj0poYmUbevvUuRRYBUJt9T+tSj7uQQcDkY7VXZlYYbCtSorZAz8v86LiY9gQcZGMcZ4/CqjoSMsAOeKm3BgyMc4PPsKrXTFeFHyY4OaYJFS6TJ2qMgc4z1rB1WzdmMqOoyMEt/KtiSQCRix5x60zcrjkKR7804ysbRdjjLtMu6k5Pc44HqRUEqmTZEPlWP5nb0ror6yPmlwDyc9OKoXkUdtauzgbzk49a0UrmqkjntTkiichcFhgg9zVWAvOxPJHftisrUL6M38jthsEAKD0pYtXCRkAqpzxXQoM0TT2NJ4JvMYnBONvA7H3pCI41/ebN45+tZcuss4lRXYsxHQcfzrPl1JfN/fMQQPukYz7Vfs5S0BuMNZC+JGR1YYHyk446c1zMg4FX9QvDPKwB4IPas8kk9elenQi4xsz53MKkKlW8BAwzweRSMwyR0zwacF6nNMdT2NdCPOE4bAz0ooIyAAOaKYz6U0bw39m2nZhevSu40+Axxru4I4Bq2sSLlcDAAxSBQp5GRXzR9Bz3HS4C4HJqpK6rCxYMcAnjrUzHGCPXmoJ1Qg7WJz1HpSZa0IBKGZMZPceo+tR5O9gVHtTioVARzk9ajlYvxmoNESOqlc5w2OfamqwGCmCAOTio0cj5SM4pHZkB2gYPY96gbJWkDcAZNLyoBY8GqhkKqSRtJHSlEm4gNnOPu/1oJaLSyKYye4PX2oIUkEkkdQKrAgRlc8Zpyuu45yVAPFKxL0CZkbguAAc8GgMACevHBqKRVyDgnv06UrMgUEkEelFgQFwqktzkcU4SbowCSAP0qBMs3XIz39KUkLKRuwPTHWlsDHyAKN7Nx296rS3CkHJOegFLIxZgQQQDVKT96QAMHPWgaISpdmYgDH96nFlXaW6kgAKO9JI4Vtg645PWnSNuRuQCo4600aXsh1zL8gJA4H51hyhbrUUDAGNPmII4qe7uHYeWpGelSWMfkxsSBubkkjrVIzK+oeHtJvxvnt40Y9WQbSfyrFuPA2mbtyMSnoTXTyMducdOvvXNa5qBtt7K6oFBJZjgCtqbm9ExOryC3GiabZKGggjBQdcZNcJ42aBTEigCUE5AA5GOKi1fxNcvKyW05MR6kgZz7e1c5cTvPKZJmLsTnJNelQw8k+aTOHFY5ShyoiZSyEqcHNR7SAc4z3q0Cu3oKikAzkEYIxXppI8fzIScA+lNJG0ngenNOYgcetRkAkAnjPpQAZweB2ooyO5yTwKKAPtxvu5zyaYG4weajDAjB5pgcgNjivmG9T6GMRxAO0HoetQSKEJweh608sCPvDIFRsQy4JpNmqRFIxCEBcr1NVpcYBUZU9as4HTJxUTAKwyPkz2qWWiuAfz6U7axADDP1pWUKCy5yTwKYXO8DOP6VLGRE5JBGCDTCcqOOc4zSspYsVOVzxTQwHy4470ADKQVKsRg5pWkaMAsOGPWm+YxU7V3AVGxDkZJBHb0pollguFxzw3UUkjpkBQeeOlVFPmSkgHaOMZ/WleRlJDD8T6UWJuWmxuAzjjrmofNU8kkuTxx0qLz0YYbAx79acZUdsYGO+KLC1QSvnAAGSeTUbDaQQcr6U7ICk45z69qgMyrkVFh3sIy4kOc8jrioblsrhSfpmlZiwKg8nnNNVDxuYE96ewc1yisYaXfj6irMhcgBRgdOadHCPmBBznORVhY0CgEtk9M09eg00Zd3I8abRnmvO/HFpctZiVQxTPzL1r066iUgsSDtrG1aGOWGQMQVIwVNb4ebjK7Ma8FOOjPDmOMgEn69qaCcgEjGKva5aGyv54TwoORx1BrNkJwO3ocV9DGSkrnhSjZ2HFn4xwO9MJIBJ6GkBOOTkCmszcZwQegq0QxzHjgH8KYFIbqD3qQ5C9dvtUfRTmqEKSSOQOOetFMCkkY4GaKYH2cHODinL0zj680yNwYyMYPrTCSoODya+UufSpEsgCkEAE5prZLgsAAe9NBaZCAcEcY9acrlFxJz2pNlpDJPlk4OR1OBUTDGcdD2qUFZNxGV49KYoySAQaRRCVKyAknaOagdgZWbPXirLkFwpOSePpVZoxllzz/eoYyJiAoA+XB9aYpUsQD1/WnyoNuPTvUR+6cjp2qUA9VKAgA4NOL4Awo461ESVAOT06GjduHX61SJYgVnDsMKfWmT5MY3csB1FEjhQFY4BOBVa8YsgAcDtxTRk9yhdud2M4x7U6OUlcqRwOdxqFdpZxjcQO/ekDAqQqYOeQTSHe5cW5RBk8kdQD0qJZlmQt0OcCqbBdxACrkU4SgDJPA4wBRYG7F1GAGAC578cUEssvzjgkHioDdAN8g+QAZBBFI18AoRSCSep7Vajcyc7FxN7MQpAPXB9KezArt35k+lUFmdQQyEoRncDnNBvSrYRhkDoRzWqgS53FlyWUZ4J5+tUbyIFWAUAk+v606W7SWQhSNoySPQY/xrN1HUEVS5OCoOcZwB60+VvRC50tWee+PABqqlQM7ASfU1yjD5vqK1NevjqGoSSjG0napz0ArOIzj1Fe1Ri4wSZ49V3m2hgwvDU05JG3BH0p5XPJOcUwEZOTgCt4mQuT0qM9wfwp2Txnp6jvTHyCDmqQDgRuxnnFFNJJORye5opgfYquGjIx3pc4APpUCsecDHOMU+NtzYZse2K+RPqUSsxTDg8mhn3ED1oAL8HgA9KWYbGGOmKYXA7jgqcKO2KRjlsqMjHNORPkyWwvXHrUXmja+OCD1oDqQyMQQQrbge1LuAiw4+buO5qAyksSpO4HIIqIRFSAobBOeSTzQUx5JJIx8o6A8ZqIN8qhwA/OcGp0cMdhOSPUUyVgG+VRkdTQBBIyjA554qNiwB2jA71IcSKpOAc9aRgRGwU7mweKBFOSN1VnzuHXPpUMil0AwV5596syuQVJznoV7VEYw0mdxGe3pQiWisyKigAYYnGagkG0EKPm65xVxYyQ2MlQcVIUHBYAHFUZmLMrMw4wTwTioWVw4OPl6ZzWxPC+cqAD1x6is24UbSCdpzzTRMjNnupI2YYZueuarnUkCMrgZ7YHeppxGCwDDJBrMlXaRhAee/etoWRzyuXJNaPlARsTjgqeKqS6rkfO4D+gPasfUL9LYscIo6Et/T1rkr/UnnLKpATPUDBNddOi56nPUq8p2U2vRQRE78ZBUjPJFcpqetS3QKByEzztJyfrWO7lhhiTxxk1GzHG3dx9K7aeGitWckq7loOOC2QOc0FsHk4pitnOaaxNdVjnJN2T7UjgfwjrTM4GO5oDHjnpQMFJBOSOfQUjnIODg9qeTkZGc/WmSKSck4OOhxTQDUyWO4jpRSHIxkD60UCufYM/ykMe1LasCxLAbfSh18wEZBBGaghJBKk8g8V8l0PquhoEkgOFyRxShi69fm6YPaiPPl7hxk8j1pG9R9aCWCKN5yePrUE65bCjjOT71K+GXb0PWmMxUADrTQFR1+XCrg5pUU7TjJbHTNSSgqFJIwetRyMAvB/KgpMibBONpDDrUBYbjinNIScHIB4qBjt7dTgH1oKRJIitGASR6YqWGHCruPsKaCCAPapdhcqAcAU0SwuLUJwATkcHHeopICYwGwCB6VaEj8BjwtMuzu4X0oI1KZCqoAAyO9RTfeDNggVLJhYyG6kVTm+XacEKD+ZoE0EnPygkZ7+lYl6M5BbkGtJ5HVCWPU8e1Zd6wdDlu+TVIh6mNdko4dccHgGub1rV47XcGbdMeir0FT+KNVSy+SNg85GAuelcBNM8rO0hBcnJ9q9HDYbnfNI8/E11HRE97fSXUrM5AXsKou2Ril3HPzYx2NNOBkkZr1YRUVZHnOTluI2Tg+lNckDOc0pbOMHg9qaSMLkZ681QhQCCCRnIobr1xSE4INIWHfp3oAU43AAZpCcN6e1J3yeh4FL1GcYHSmABj0A4okHGeM4wOOlPQbTzyKYzAEg9TQA3IBIJJHAopPXsDyaKCT6rsL1mBRgcADGDVoyDepweTiiivkVufWTNODlU3E5yOlTOAGx2xRRT6mb3IZCBIDg7umaiLElgQM4oopgV5WO1gec1DwCoxn60UU0WhkxITsTzVRZG3dutFFJmiWhPG25gT1qzGTuIB5x1oooRi9xzE45OaY7jIODzxRRVoRQnlzMV5wvIqpMxwcnK4ziiijqORnyS5BJB/Oua8Tat9gsWkRGLnKjpgH1oorelFOaOTENqOh5XczNcySTSElmOeTUBP8WORRRXupJJWPEk7tjeD261GeGx1ooq4iEHBJPNG4Y4GKKKoBOAR3pWGaKKBMaVBLD0ppU9c0UUCHhiE/CmuNwDdD7UUUAIwwCB1x1NFFFAH//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The appearance of the facial port wine stain changes with age. In the newborn, the lesion is flat and usually light pink in color. It typically darkens with age to a deep red, port wine appearance, and vascular ectasias develop as depicted above.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John Bodensteiner, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42741=[""].join("\n");
var outline_f41_47_42741=null;
var title_f41_47_42742="Mobitz type I second degree atrioventricular block";
var content_f41_47_42742=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1046px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mobitz type I second degree atrioventricular (AV) block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 358px; height: 105px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Several characteristic features of Wenckebach second degree AV block are noted on this ECG (P waves are marked by arrows): 1) The PR interval after the second P wave is longer than the preceeding PR interval; the third P wave is not conducted at all. 2) The PP intervals are constant; however, the RR interval surrounding the completely blocked P wave is longer than the preceeding normal RR interval. 3) The fourth P wave (after the blocked beat) is conducted normally; this PR interval is shorter than the PR interval that immediately preceeded the pause.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 456px\">",
"   <div class=\"ttl\">",
"    Sinus rhythm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 103px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The normal P wave in sinus rhythm is slightly notched since activation of the right atrium precedes that of the left atrium. The P wave is upright in a positive direction in leads I and II. A P wave with a uniform morphology precedes each QRS complex. The rate is between 60 and 100 beats per minute and the cycle length is uniform between sequential P waves and QRS complexes. In addition, the P wave morphology and PR intervals are identical from beat to beat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42742=[""].join("\n");
var outline_f41_47_42742=null;
var title_f41_47_42743="Lovastatin: Pediatric drug information";
var content_f41_47_42743=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lovastatin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42312?source=see_link\">",
"    see \"Lovastatin: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/61/6101?source=see_link\">",
"    see \"Lovastatin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F13842374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      HMG-CoA Reductase Inhibitors and Risk of Increased Blood Glucose Concentrations and Diabetes",
"     </span>",
"     <span class=\"collapsible-date\">",
"      January 2013",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Health Canada has notified healthcare professionals of updates to the product monographs of HMG-CoA reductase inhibitors (aka, &ldquo;statins&rdquo;) marketed in Canada regarding the risk of increased blood glucose concentrations and a small increased risk of diabetes mellitus following administration of these agents. The risk appears to be greatest in patients already at risk for diabetes (eg, patients with increased blood glucose concentration, hypertriglyceridemia, obesity, hypertension).  However, Health Canada continues to acknowledge that the benefits of statin therapy far outweigh the risk of dysglycemia. It is recommended that clinicians carefully monitor the use of statins in patients at high risk of developing diabetes mellitus.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For additional information, please refer to file://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/16949a-eng.php.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Altoprev&reg;;",
"     </li>",
"     <li>",
"      Mevacor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F190413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Lovastatin&reg;;",
"     </li>",
"     <li>",
"      CO Lovastatin;",
"     </li>",
"     <li>",
"      Dom-Lovastatin;",
"     </li>",
"     <li>",
"      Gen-Lovastatin;",
"     </li>",
"     <li>",
"      Mevacor&reg;;",
"     </li>",
"     <li>",
"      Mylan-Lovastatin;",
"     </li>",
"     <li>",
"      Novo-Lovastatin;",
"     </li>",
"     <li>",
"      Nu-Lovastatin;",
"     </li>",
"     <li>",
"      PHL-Lovastatin;",
"     </li>",
"     <li>",
"      PMS-Lovastatin;",
"     </li>",
"     <li>",
"      PRO-Lovastatin;",
"     </li>",
"     <li>",
"      RAN&trade;-Lovastatin;",
"     </li>",
"     <li>",
"      ratio-Lovastatin;",
"     </li>",
"     <li>",
"      Riva-Lovastatin;",
"     </li>",
"     <li>",
"      Sandoz-Lovastatin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1059933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antilipemic Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       HMG-CoA Reductase Inhibitor",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1059926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42312?source=see_link\">",
"      see \"Lovastatin: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Heterozygous familial hypercholesterolemia: Note:",
"     </b>",
"     Begin treatment if after adequate trial of diet the following are present: LDL-C &gt;189 mg/dL or LDL-C remains &gt;160 mg/dL and positive family history of premature cardiovascular disease or meets NCEP classification. Females must be &ge;1 year postmenarche.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children and Adolescents 10-17 years: Oral: Immediate release tablet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     LDL reduction &lt;20%: Initial: 10 mg once daily with evening meal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     LDL reduction &ge;20%: Initial: 20 mg once daily with evening meal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Usual range: 10-40 mg once daily with evening meal; may titrate at 4-week intervals; maximum daily dose: 40 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"     <b>",
"      Dyslipidemia and primary prevention of CAD: Note:",
"     </b>",
"     Doses should be individualized according to the baseline LDL-cholesterol levels, the recommended goal of therapy, and patient response. For patients requiring smaller reductions in cholesterol, the use of the extended release tablet is not recommended; consider use of immediate release formulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Immediate release tablet: Oral: Initial: 20 mg once daily with evening meal; adjust dosage at 4-week intervals; maximum daily dose: 80 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Extended release tablet: Oral: Initial: 20, 40, or 60 mg once daily at bedtime; adjust dosage at 4-week intervals; maximum daily dose: 60 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in patients who are concomitantly receiving amiodarone:",
"     </b>",
"     Adults: Dose should not exceed 40 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in patients who are concomitantly receiving danazol, diltiazem, or verapamil:",
"     </b>",
"     Adults: Initial: 10 mg once daily, not to exceed 20 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Immediate release:",
"     </b>",
"     Children &ge;10 years, Adolescents, and Adults: Doses exceeding 20 mg/day should be carefully considered and implemented cautiously",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Extended release:",
"     </b>",
"     Adults: Initial: 20 mg once daily at bedtime; doses exceeding 20 mg/day should be carefully considered and implemented cautiously",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     there are no dosage adjustment provided in manufacturer's labeling (has not been studied); use is contraindicated in active liver disease or unexplained transaminase elevations.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F190384\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 10 mg, 20 mg, 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mevacor&reg;: 20 mg, 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Altoprev&reg;: 20 mg, 40 mg, 60 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F190368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes extended release tablet",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1059937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immediate release tablets: Take with the evening meal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Extended release tablets: Take at bedtime; do not crush or chew.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1059929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immediate release tablets: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); protect from light.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Extended release tablets: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); avoid excessive heat and humidity.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1059936\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of heterozygous familial hypercholesterolemia as adjunct to dietary therapy to decrease elevated serum total and low density lipoprotein and apolipoprotein B levels [immediate release tablets: FDA approved in males and postmenarcheal (&gt;1 year) females ages 10-17 years]",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Treatment of primary hypercholesterolemia as adjunct to dietary therapy to decrease elevated serum total and low density lipoprotein cholesterol (LDL-C) (immediate and extended release tablets: FDA approved in adults); to reduce the risk of myocardial infarction, unstable angina, and coronary revascularization procedures in patients without symptomatic disease with average to moderately elevated total and LDL-C and below average HDL-cholesterol (primary prevention) and slow progression of coronary atherosclerosis in patients with coronary heart disease (immediate and extended release tablets: FDA approved in adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F190459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lovastatin may be confused with atorvaSTATin, Leustatin&reg;, Livostin&reg;, Lotensin&reg;, nystatin, pitavastatin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Mevacor&reg; may be confused with Benicar&reg;, Lipitor&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lovacol [Chile and Finland] may be confused with Levatol brand name for penbutolol [U.S.]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lovastin [Malaysia, Poland, and Singapore] may be confused with Livostin brand name for levocabastine [multiple international markets]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Mevacor [U.S., Canada, and multiple international markets} may be confused with Mivacron brand name for mivacurium [multiple international markets]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F190457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, constipation, diarrhea, dyspepsia, flatulence, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Increased CPK (&gt;2x normal), muscle cramps, myalgia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Acid regurgitation, alopecia, amnesia (reversible), arthralgia, blood glucose increased, chest pain, cognitive impairment (reversible), confusion (reversible), dermatomyositis, diabetes mellitus (new onset), eye irritation, glycosylated hemoglobin (Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     ) increased, insomnia, leg pain, memory disturbance (reversible), memory impairment (reversible), paresthesia, pruritus, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Additional class-related events or case reports (not necessarily reported with lovastatin therapy): Alkaline phosphatase increased, alteration in taste, anaphylaxis, angioedema, anorexia, anxiety, arthritis, cataracts, chills, cholestatic jaundice, cirrhosis, depression, dryness of skin/mucous membranes, dyspnea, eosinophilia, erectile dysfunction, erythema multiforme, ESR increased, facial paresis, fatty liver, fever, flushing, fulminant hepatic necrosis, GGT increased, gynecomastia, hemolytic anemia, hepatic failure (fatal and nonfatal), hepatitis, hepatoma, hyperbilirubinemia, hypersensitivity reaction, immune-mediated necrotizing myopathy (IMNM), impaired extraocular muscle movement, impotence, interstitial lung disease, leukopenia, libido decreased, malaise, myopathy, nail changes, nodules, ophthalmoplegia, pancreatitis, peripheral nerve palsy, peripheral neuropathy, photosensitivity, polymyalgia rheumatica, positive ANA, psychic disturbance, purpura, renal failure (secondary to rhabdomyolysis), rhabdomyolysis, skin discoloration, Stevens-Johnson syndrome, systemic lupus erythematosus-like syndrome, thrombocytopenia, thyroid dysfunction, toxic epidermal necrolysis, transaminases increased, tremor, urticaria, vasculitis, vertigo",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1059941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to lovastatin or any component; active liver disease; unexplained persistent elevations of serum transaminases; concomitant use of strong CYP3A4 inhibitors [eg, clarithromycin, erythromycin, itraconazole, ketoconazole, nefazodone, posaconazole, protease inhibitors (including boceprevir and telaprevir), telithromycin]; pregnancy; breast-feeding",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1059925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution and modify dose in patients with renal impairment. HMG-CoA reductase inhibitors have a high potential for drug interactions; concomitant use of lovastatin with some drugs may require cautious use, may not be recommended, may require dosage adjustments, or may be contraindicated. Increases in Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     and fasting blood glucose have been reported with HMG-CoA reductase inhibitors; however, the benefits of statin therapy far outweigh the risk of dysglycemia. Lovastatin is less effective in patients with rare",
"     <b>",
"      homozygous",
"     </b>",
"     familial hypercholesterolemia and may be more likely to elevate serum transaminases.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1059924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients receiving HMG-CoA reductase inhibitors have developed rhabdomyolysis with or without acute renal failure and/or myopathy; patients should be monitored closely; risk is dose-related and is increased with concurrent use of other lipid-lowering medications (eg, fibric acid derivatives or niacin at doses &gt;1 g/day) or during concurrent use with potent CYP3A4 inhibitor (contraindication) and large quantities of grapefruit juice (&gt;1 quart/day). The manufacturer recommends temporary discontinuation for elective major surgery, acute medical or surgical conditions, or in any patient experiencing an acute or serious condition predisposing to renal failure (eg, sepsis, hypotension, trauma, uncontrolled seizures). However, based upon current evidence, HMG-CoA reductase inhibitor therapy should be continued in the perioperative period unless risk outweighs cardioprotective benefit.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Postmarketing reports of fatal and nonfatal hepatic failure are rare; if serious hepatotoxicity with clinical symptoms and/or hyperbilirubinemia or jaundice occurs during treatment, interrupt therapy. If an alternate etiology is not identified, do not restart lovastatin. Liver enzyme tests should be obtained at baseline and as clinically indicated; routine periodic monitoring of liver enzymes is not necessary. Use with caution in patients with history of heavy alcohol use or a previous history of liver disease.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F190446\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (major), P-glycoprotein;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2C9 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F190377\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: May decrease the metabolism of HMG-CoA Reductase Inhibitors. Management: Dose of HMG-CoA reductase inhibitor may need to be reduced (limit simvastatin adult maximum dose to 20 mg/day, limit lovastatin adult maximum dose to 40 mg/day).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bezafibrate: May enhance the myopathic (rhabdomyolysis) effect of HMG-CoA Reductase Inhibitors. Bezafibrate may increase the serum concentration of HMG-CoA Reductase Inhibitors. More specifically, bezafibrate may increase the serum concentration of fluvastatin Management: Monitor patients closely for myopathy with concomitant use of bezafibrate and HMG-CoA reductase inhibitors. Concomitant use is contraindicated in patients predisposed to myopathy and alternative therapy should be considered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Boceprevir: May increase the serum concentration of Lovastatin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosentan: May increase the metabolism of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: May enhance the myopathic (rhabdomyolysis) effect of HMG-CoA Reductase Inhibitors. Colchicine may increase the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): May increase the serum concentration of Lovastatin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of Lovastatin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May increase the serum concentration of HMG-CoA Reductase Inhibitors. Management: Avoid use of statins metabolized by CYP3A4 (eg, simvastatin) and consider avoiding fluvastatin as well in patients receiving high dose cyproterone (300 mg/day). Consider use of pravastatin, rosuvastatin, or pitavastatin if statin therapy is needed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Danazol: May increase the serum concentration of HMG-CoA Reductase Inhibitors. Management: Concurrent use of simvastatin with danazol is contraindicated.  Initiate lovastatin at an adult maximum dose of 10 mg/day, and do not exceed 20 mg/day, when danazol is given concomitantly.  Fluvastatin, pravastatin and rosuvastatin may pose lower risk.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DAPTOmycin: HMG-CoA Reductase Inhibitors may enhance the adverse/toxic effect of DAPTOmycin. Specifically, the risk of skeletal muscle toxicity may be increased.  Management: Consider temporarily stopping HMG-CoA reductase inhibitor therapy prior to daptomycin.  If used together, regular (i.e., at least weekly) monitoring of CPK concentrations is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diltiazem: May increase the serum concentration of Lovastatin. Lovastatin may increase the serum concentration of Diltiazem. Management: Initiate lovastatin at a maximum adult dose of 10 mg/day, and do not exceed 20 mg/day, in patients receiving diltiazem. Monitor closely for signs of HMG-CoA reductase inhibitor toxicity (e.g., myositis, rhabdomyolysis).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dronedarone: May increase the serum concentration of Lovastatin. Management: Limit lovastatin to a maximum of 20 mg/day (in adults).  Increase monitoring for signs of lovastatin toxicity (e.g., myopathy, rhabdomyolysis).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Efavirenz: May decrease the serum concentration of Lovastatin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erythromycin (Systemic): May increase the serum concentration of Lovastatin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etravirine: May decrease the serum concentration of HMG-CoA Reductase Inhibitors. This applies to atorvastatin, lovastatin and simvastatin. Conversely, levels of fluvastatin may be increased. Management: Dose adjustment of the HMG-CoA reductase inhibitor may be warranted. No interaction is expected with rosuvastatin, pravastatin, or pitavastatin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fenofibrate: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fenofibric Acid: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May increase the serum concentration of Lovastatin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fusidic Acid: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors. Specifically, the risk for muscle toxicities, including rhabdomyolysis may be significantly increased. Management: Avoid concurrent use of HMG-CoA reductase inhibitors (statins) with fusidic acid if possible.  If treatment with fusidic acid is necessary, consider temporarily stopping the statin.  With any concurrent use monitor patients closely for statin toxicity.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gemfibrozil: May enhance the myopathic (rhabdomyolysis) effect of Lovastatin. Gemfibrozil may increase the serum concentration of Lovastatin. More specifically, gemfibrozil may increase the serum concentrations of lovastatin acid (active form of parent drug).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May increase the serum concentration of HMG-CoA Reductase Inhibitors. Management: Consider avoiding concurrent use of GFJ (especially larger amounts) with lovastatin, simvastatin, or atorvastatin.  Consider using a lower statin dose or a statin that is less likely to interact when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lanthanum: HMG-CoA Reductase Inhibitors may decrease the serum concentration of Lanthanum.  Management: Administer HMG-CoA reductase inhibitors at least two hours before or after lanthanum.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: May increase the serum concentration of Lovastatin. Management: Consider reducing lovastatin doses during concomitant treatment with lomitapide, and monitor for signs and symptoms of muscle toxicity.  Specific dosing recommendations are not presently available.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of HMG-CoA Reductase Inhibitors. Management: Avoid lovastatin or simvastatin with erythro-, clarithro-, or telithromycin. Limit pitavastatin to a 1 mg/day maximum adult dose with erythromycin.  Atorvastatin dose adjustments may be required. Increase monitoring for toxicity with any such combination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of Lovastatin. Management: Avoid lovastatin during and 2 weeks following mifepristone for treatment of hyperglycemia in Cushing's syndrome. The interaction magnitude could be lower with single doses used to terminate pregnancy, but neither effect has been studied clinically.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Niacin: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors. Management: This is of greatest concern with niacin doses of 1 g or greater daily.  Avoid simvastatin 80 mg in combination with niacin 1 g or greater in Chinese patients. Canadian labeling contraindicates use of niacin with rosuvastatin 40 mg.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Niacinamide: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pazopanib: HMG-CoA Reductase Inhibitors may enhance the hepatotoxic effect of Pazopanib. Specifically, the risk for increased serum transaminase concentrations may be increased.  Management: Simvastatin is specifically implicated in this interaction.  There is a lack of data regarding the risk with other statins, but caution appears warranted with any statins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May increase the serum concentration of Lovastatin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: May increase the serum concentration of HMG-CoA Reductase Inhibitors. Management: Consider using a lower starting dose and lower maintenance/maximum doses of atorvastatin, simvastatin, or lovastatin when used together with quinine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ranolazine: May enhance the myopathic (rhabdomyolysis) effect of Lovastatin. Ranolazine may increase the serum concentration of Lovastatin. Ranolazine may also enhance the distribution of lovastatin to specific cells/tissues/organs where P-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Red Yeast Rice: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May decrease the serum concentration of HMG-CoA Reductase Inhibitors. Management: Consider use of noninteracting antilipemic agents (note: pitavastatin concentrations may increase with rifamycin treatment).  Monitor for altered HMG-CoA reductase inhibitor effects. Rifabutin and fluvastatin, or possibly pravastatin, may pose lower risk.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sildenafil: May decrease the metabolism of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May increase the metabolism of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: May increase the serum concentration of Lovastatin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ticagrelor: May increase the serum concentration of Lovastatin. Management: Avoid using doses of lovastatin greater than 40 mg/day with ticagrelor.  This specific recommendation is found in the U.S. prescribing information but not in the Canadian product monograph.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trabectedin: HMG-CoA Reductase Inhibitors may enhance the myopathic (rhabdomyolysis) effect of Trabectedin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Verapamil: May increase the serum concentration of Lovastatin. Management: Initiate lovastatin at a maximum adult dose of 10 mg/day, and do not exceed 20 mg/day, in patients receiving verapamil. Monitor closely for signs of HMG-CoA reductase inhibitor toxicity (e.g., myositis, rhabdomyolysis).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): HMG-CoA Reductase Inhibitors may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1059944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food",
"     <b>",
"      increases",
"     </b>",
"     the absorption of lovastatin immediate release tablets (serum concentrations of active drug under fasting conditions are approximately two-thirds of that when administered with food). Food",
"     <b>",
"      decreases",
"     </b>",
"     the absorption of lovastatin extended release tablets. Lovastatin serum concentrations may be increased if taken with grapefruit juice; the risk of myopathy/rhabdomyolysis is increased with daily intake of large quantities of grapefruit juice (&gt;1 quart/day); avoid concurrent use.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F190380\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F190395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cholesterol biosynthesis may be important in fetal development. Contraindicated in pregnancy. Administer to women of childbearing potential only when conception is highly unlikely and patients have been informed of potential hazards.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1059932\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pediatric patients: Baseline: ALT, AST, and creatine phosphokinase levels (CPK); fasting lipid panel (FLP) and repeat ALT and AST should be checked after 4 weeks of therapy; if no myopathy symptoms or laboratory abnormalities, then monitor FLP, ALT, and AST every 3-4 months during the first year and then every 6 months thereafter (NHLBI, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults: Baseline CPK (recheck CPK in any patient with symptoms suggestive of myopathy; discontinue therapy if markedly elevated); baseline liver function tests (LFTs) and repeat when clinically indicated thereafter. Patients with elevated transaminase levels should have a second (confirmatory) test and frequent monitoring until values normalize; discontinue if increase in ALT/AST is persistently &gt;3 times ULN (NCEP, 2002).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Lipid panel (total cholesterol, HDL, LDL, triglycerides):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      ATP III recommendations (NCEP, 2002):",
"     </i>",
"     Baseline; 6-8 weeks after initiation of drug therapy; if dose increased, then at 6-8 weeks until final dose determined. Once treatment goal achieved, follow-up intervals may be reduced to every 4-6 months. Lipid panel should be assessed at least annually, and preferably at each clinic visit.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Manufacturer recommendation:",
"     </i>",
"     Analyze lipid panel at intervals of 4 weeks or more.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1059923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lovastatin acts by competitively inhibiting 3-hydroxyl-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the rate-limiting step in cholesterol biosynthesis",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1059939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: LDL-cholesterol reduction: 3 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: LDL-cholesterol reduction: 4-6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     LDL-C reduction: 40 mg/day: 31% (for each doubling of this dose, LDL-C is lowered by &sim;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Average HDL-C increase: 5% to 15%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Average triglyceride reduction: 7% to 30%",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1059940\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: 30% absorbed but less than 5% reaches the systemic circulation due to an extensive first-pass effect; absorption increased with extended release tablets",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 95%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 1.1-1.7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Immediate release: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Extended release: 12-14 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: ~80% to 85% of dose excreted in feces and 10% in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1059931\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/61/6101?source=see_link\">",
"      see \"Lovastatin: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid grapefruit juice and the herbal medicine, St John's wort. Report severe and unresolved gastric upset, any vision changes, unexplained muscle pain or weakness, changes in color of urine or stool, yellowing of skin or eyes, and any unusual bruising. Female patients of childbearing age must be counseled to use two effective forms of contraception simultaneously, unless absolute abstinence is the chosen method; this drug may cause severe fetal defects.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Nutrition, &ldquo;Cholesterol in Childhood,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1998, 101(1 Pt 1):141-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/47/42743/abstract-text/11345978/pubmed\" id=\"11345978\" target=\"_blank\">",
"        11345978",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics, &ldquo;National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1992, 89(3 Pt 2):525-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/47/42743/abstract-text/1538956/pubmed\" id=\"1538956\" target=\"_blank\">",
"        1538956",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Daniels SR, Greer FR, and Committee on Nutrition, \"Lipid Screening and Cardiovascular Health in Childhood,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008, 122(1):198-208.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/47/42743/abstract-text/18596007/pubmed\" id=\"18596007\" target=\"_blank\">",
"        18596007",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Duplaga BA, &ldquo;Treatment of Childhood Hypercholesterolemia With HMG-CoA Reductase Inhibitors,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1999, 33(11):1224-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/47/42743/abstract-text/10573325/pubmed\" id=\"10573325\" target=\"_blank\">",
"        10573325",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Grundy SM, Cleeman JI, Merz CN, et al, &ldquo;Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2004, 110(2):227-39.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/47/42743/abstract-text/15249516 /pubmed\" id=\"15249516 \" target=\"_blank\">",
"        15249516",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lambert M, Lupien PJ, Gagne C, et al, &ldquo;Treatment of Familial Hypercholesterolemia in Children and Adolescents: Effect of Lovastatin. Canadian Lovastatin in Children Study Group,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1996, 97(5):619-28.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/47/42743/abstract-text/8628597/pubmed\" id=\"8628597\" target=\"_blank\">",
"        8628597",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McCrindle BW, Urbina EM, Dennison BA, et al, \"Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2007, 115(14):1948-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/47/42743/abstract-text/17377073/pubmed\" id=\"17377073\" target=\"_blank\">",
"        17377073",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Heart, Lung, and Blood Institute, \"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents,\"",
"      <i>",
"       Clinical Practice Guidelines",
"      </i>",
"      , 2011, National Institutes of Health. Available at file://www.nhlbi.nih.gov/guidelines/cvd_ped/peds_guidelines_full.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stein EA, Illingworth DR, Kwiterovich PO Jr, et al, &ldquo;Efficacy and Safety of Lovastatin in Adolescent Males With Heterozygous Familial Hypercholesterolemia: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1999, 281(2):137-44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/47/42743/abstract-text/9917116/pubmed\" id=\"9917116\" target=\"_blank\">",
"        9917116",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),&rdquo; May 2001, www.nhlbi.nih.gov/guidelines/cholesterol.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12566 Version 49.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-9F69235DB9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42743=[""].join("\n");
var outline_f41_47_42743=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13842374\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190412\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190413\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059933\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059926\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190384\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190368\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059937\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059929\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059936\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190459\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190457\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059941\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059925\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059924\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190446\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190377\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059944\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190380\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190395\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059932\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059923\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059939\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059940\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059931\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12566\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12566|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42312?source=related_link\">",
"      Lovastatin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/61/6101?source=related_link\">",
"      Lovastatin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_47_42744="Disorders that cause hypothyroidism";
var content_f41_47_42744=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Disorders that cause hypothyroidism",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/47/42744/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/47/42744/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/47/42744/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/47/42744/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/47/42744/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/47/42744/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/47/42744/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypothyroidism can result from a defect anywhere in the hypothalamic-pituitary-thyroid axis. In the vast majority of cases, it is caused by thyroid disease (primary hypothyroidism). Much less often it is caused by decreased secretion of thyrotropin (TSH) from the anterior pituitary gland or by decreased secretion of thyrotropin-releasing hormone (TRH) from the hypothalamus (",
"    <a class=\"graphic graphic_table graphicRef67769 \" href=\"mobipreview.htm?2/8/2188\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The cause of hypothyroidism should be identified in every patient for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypothyroidism may be transient and require no or only short-term therapy, as in patients with painless thyroiditis or postpartum thyroiditis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43830?source=see_link\">",
"       \"Overview of thyroiditis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      It may be caused by a drug, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      or an iodine-containing drug, and disappear when the drug is discontinued.",
"     </li>",
"     <li>",
"      It may be the first or only manifestation of hypothalamic or pituitary disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The cause can often be identified, or at least strongly inferred, from the history and physical examination.",
"   </p>",
"   <p>",
"    This topic will review the major causes of hypothyroidism. The diagnostic approach to and treatment of hypothyroidism are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26744?source=see_link\">",
"     \"Diagnosis of and screening for hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=see_link\">",
"     \"Treatment of hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PRIMARY HYPOTHYROIDISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with hypothyroidism caused by disease of the thyroid gland, decreased secretion of thyroxine (T4) and triiodothyronine (T3) leads to a reduction in the serum concentrations of the two hormones, which results in a compensatory increase in TSH secretion. Thus, the combination of a low serum T4 and a high serum TSH concentration both confirms the diagnosis of hypothyroidism and indicates that it is due to primary thyroid disease.",
"   </p>",
"   <p>",
"    We recognize two forms of primary hypothyroidism:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Subclinical hypothyroidism &mdash; Subclinical hypothyroidism is defined as a high serum TSH concentration in the presence of normal serum free T4 and T3 concentrations. This combination of findings reflects the great sensitivity of TSH secretion to very small reductions in thyroid secretion. These patients have few if any symptoms and signs of hypothyroidism. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/48/3850?source=see_link\">",
"       \"Subclinical hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Overt hypothyroidism &mdash; Overt hypothyroidism is defined as a high serum TSH concentration in the presence of a low serum free T4 concentration. Most of these patients have symptoms and signs of hypothyroidism. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14503?source=see_link\">",
"       \"Clinical manifestations of hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All of the thyroid disorders considered below can cause either subclinical or overt hypothyroidism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Chronic autoimmune (Hashimoto's) thyroiditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common cause of hypothyroidism in iodine-sufficient areas of the world is chronic autoimmune (Hashimoto's) thyroiditis, which is caused by cell- and antibody-mediated destruction of thyroid tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/1\">",
"     1",
"    </a>",
"    ]. The disorder has two forms: goitrous and atrophic. They differ in the extent of lymphocytic infiltration, fibrosis, and thyroid follicular cell hyperplasia of the thyroid gland, but not in their pathophysiology.",
"   </p>",
"   <p>",
"    Both cellular and humoral factors may contribute to the thyroid injury and hypothyroidism in chronic autoimmune thyroiditis. Cytotoxic T cells may directly destroy thyroid cells. In addition, more than 90 percent of patients with chronic autoimmune thyroiditis have high serum concentrations of autoantibodies to thyroglobulin, thyroid peroxidase (thyroid microsomal antigen) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], or the thyroid",
"    <span class=\"nowrap\">",
"     Na/I",
"    </span>",
"    transporter (",
"    <a class=\"graphic graphic_table graphicRef76522 \" href=\"mobipreview.htm?31/7/31867\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/4\">",
"     4",
"    </a>",
"    ]. These antibodies have little, if any, functional activity. Many patients also have antibodies that block the action of TSH on the TSH receptor or that are cytotoxic to thyroid cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/11/27833?source=see_link\">",
"     \"Pathogenesis of Hashimoto's thyroiditis (chronic autoimmune thyroiditis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serum antithyroid antibodies need",
"    <strong>",
"     not",
"    </strong>",
"    be measured routinely in patients with overt primary hypothyroidism, because almost all have chronic autoimmune thyroiditis. However, a test for antithyroid peroxidase antibodies may be useful to predict the likelihood of progression to permanent overt hypothyroidism in patients with subclinical hypothyroidism or those with painless (silent) thyroiditis or postpartum thyroiditis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;In community surveys, high serum antithyroid peroxidase antibody concentrations are found in about 5 percent of adults and about 15 percent of older women (",
"    <a class=\"graphic graphic_table graphicRef76522 \" href=\"mobipreview.htm?31/7/31867\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. The frequency of subclinical hypothyroidism is similar, and that of overt hypothyroidism varies from 0.1 to 2 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/10\">",
"     10",
"    </a>",
"    ]. In one population-based study, the overall incidence of autoimmune thyroiditis was 46.4 per 1000 subjects during a 20-year period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypothyroidism is much (five to eight times) more common in women than men. The majority of those who are hypothyroid have a goiter, but not all who have a goiter and circulating antithyroid antibodies have hypothyroidism.",
"   </p>",
"   <p>",
"    In the United States National Health and Nutrition Examination Survey (NHANES III), 13,344 people without known thyroid disease had measurements of serum TSH, T4, thyroglobulin antibodies, and thyroid peroxidase antibodies with the following results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypothyroidism was found in 4.6 percent (0.3 percent overt and 4.3 percent subclinical).",
"     </li>",
"     <li>",
"      Hyperthyroidism was found in 1.3 percent (0.5 percent overt and 0.7 percent subclinical).",
"     </li>",
"     <li>",
"      Serum thyroglobulin antibody concentrations were high in 10 percent and serum thyroid peroxidase antibody concentrations were high in 11 percent. The latter were associated with hypo- or hyperthyroidism, while the former were not.",
"     </li>",
"     <li>",
"      Mean serum TSH concentrations were significantly lower in blacks (1.7 percent) than in whites or Mexican-Americans.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, a significant proportion of the US population has laboratory evidence of thyroid disease, suggesting that routine screening would be useful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Natural history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual course of Hashimoto's thyroiditis is gradual loss of thyroid function. Among patients with this disorder who have mild (subclinical) hypothyroidism, exhibited as slight increases in TSH and the presence of thyroid antibodies, overt hypothyroidism occurs at a rate of about 5 percent per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/8,13\">",
"     8,13",
"    </a>",
"    ]. Chronic autoimmune thyroiditis is usually but not always permanent. Repeat biopsies reveal little histological change, nor do serum antithyroid antibody concentrations change in most patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/14\">",
"     14",
"    </a>",
"    ]. However, a few patients have remissions and no longer need T4 therapy, indicating that the hypothyroidism is not always caused by destruction of the thyroid gland. One study, as an example, evaluated 15 Japanese patients with TSH-receptor blocking antibodies in whom the antibodies later disappeared; six remained euthyroid for several years after T4 therapy was discontinued [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/5\">",
"     5",
"    </a>",
"    ]. Whether disappearance of antithyroid peroxidase antibodies can be used to predict remission of hypothyroidism is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Susceptibility and risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic autoimmune thyroiditis is more common in women, especially older women. Whether the increase in risk in the latter group is due to estrogen deficiency or age is not known. Chronic autoimmune thyroiditis is also the most common cause of hypothyroidism in children, being reported as early as one and two years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic autoimmune thyroiditis is associated with several polymorphisms in the genes for HLA, T-cell antigen receptors, and other immunomodulatory molecules, suggesting a role for genetic susceptibility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. However, the relative risk is about two for most of the associations, which also vary considerably among different racial and ethnic groups. Turner's syndrome and Down syndrome are both associated with a higher than expected rate of autoimmune thyroiditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whatever the factors mediating genetic susceptibility, patients with chronic autoimmune thyroiditis are more likely to have a personal or family history of other autoimmune diseases, such as adrenal insufficiency and insulin-dependent diabetes mellitus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/42/9896?source=see_link\">",
"     \"Pathogenesis of autoimmune adrenal insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no well-defined environmental risk factors for chronic autoimmune thyroiditis. There is evidence linking a high iodine intake with this disorder; as an example, serum antithyroid antibody concentrations increase after dietary iodine intake is increased in endemic goiter regions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/20\">",
"     20",
"    </a>",
"    ]. Pharmacologic amounts of iodine are known to cause hypothyroidism in patients with chronic autoimmune thyroiditis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20568?source=see_link\">",
"     \"Iodine-induced thyroid dysfunction\"",
"    </a>",
"    .) There is also an association between cigarette smoking and the risk of hypothyroidism in patients",
"    <strong>",
"     with",
"    </strong>",
"    autoimmune thyroid disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/21\">",
"     21",
"    </a>",
"    ]. In contrast, in a population-based study, smoking was associated with a lower prevalence of hypothyroidism and a higher prevalence of hyperthyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Hashimoto's encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hashimoto's encephalopathy (HE) is an uncommon syndrome thought to be an autoimmune vasculitis; positive TPO antibodies are likely a surrogate marker for autoimmunity in these patients. It is most often characterized by a subacute onset of confusion, with altered level of consciousness, seizures, and myoclonus. In contrast to the cognitive dysfunction associated with hypo- or hyperthyroidism, the manifestations are not due to a direct effect of an altered thyroid state on the central nervous system. This topic is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/47/33527?source=see_link\">",
"     \"Hashimoto's encephalopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     latrogenic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroidectomy, radioiodine treatment, and external radiation therapy are well-known causes of hypothyroidism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Thyroidectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of thyroxine's seven-day half-life, hypothyroidism occurs within two to four weeks after total thyroidectomy. The time course after subtotal thyroidectomy in patients with Graves' hyperthyroidism is more variable. It occurs within the first year after surgery in the majority of patients; among those who are euthyroid at one year, approximately 0.5 to 1 percent become hypothyroid each year thereafter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The late onset is presumably due to superimposed chronic autoimmune thyroiditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=see_link\">",
"     \"Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Radioiodine therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radioiodine (I-131) therapy for Graves' hyperthyroidism can cause hypothyroidism months or years later. The high-dose regimens preferred in most centers (to reduce the need for retreatment) result in hypothyroidism in the majority of patients within the first year after therapy; the remainder become hypothyroid at a rate of 0.5 to 2 percent per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/23,24,26\">",
"     23,24,26",
"    </a>",
"    ]. A significant minority of patients with toxic or nontoxic multinodular goiter or autonomously functioning thyroid adenomas also become hypothyroid after radioiodine therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/7/12410?source=see_link\">",
"     \"Radioiodine in the treatment of hyperthyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     External neck irradiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;External irradiation of the neck (in doses of 25 Gy [2500 rads] or more) also causes hypothyroidism. The effect is dose-dependent, the onset is gradual, and many patients have subclinical hypothyroidism for several years before developing overt disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hodgkin lymphoma &mdash; One study evaluated 1677 patients with Hodgkin lymphoma who were treated with neck radiation and were followed for up to 20 years: the cumulative incidence of hypothyroidism was 30 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/27\">",
"       27",
"      </a>",
"      ], and in one study was more common in patients who had lymphangiography [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hyperfractionated radiation therapy &mdash; Data from children suggest that hyperfractionated radiation may cause fewer cases of hypothyroidism than conventional therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Head and neck cancer &mdash; A thyroid-destructive effect is also seen with total body irradiation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/30\">",
"       30",
"      </a>",
"      ] and external radiation therapy in patients with head and neck cancer. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30378?source=see_link&amp;anchor=H3822622#H3822622\">",
"       \"Management of late complications of head and neck cancer and its treatment\", section on 'Thyroid disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nuclear accident &mdash; Thyroid irradiation also may promote the formation of antithyroid antibodies. Studies in children and adolescents from Belarus who were exposed to radioactive fallout after the nuclear accident at Chernobyl have noted an increased prevalence of antithyroglobulin or antithyroid peroxidase antibodies at six to eight years (19.5 versus 3.8 percent in unexposed children) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/31\">",
"       31",
"      </a>",
"      ]. Thyroid function was normal in these children; their future risk of hypothyroidism is not known. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/49/1818?source=see_link&amp;anchor=H12520341#H12520341\">",
"       \"Radiation-induced thyroid cancer\", section on 'Autoimmune thyroid disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Iodine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both iodine deficiency and excess can cause hypothyroidism. Iodine deficiency is the most common cause of hypothyroidism (and goiter) worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/32\">",
"     32",
"    </a>",
"    ]. When defined as an iodine intake less than 100",
"    <span class=\"nowrap\">",
"     mcg/day,",
"    </span>",
"    it affects approximately two billion people, many of whom live in mountainous areas. Iodine deficiency is rare in North America because iodized salt is ubiquitous and there are many other sources of iodine in the diet; it persists in parts of Europe because iodized salt is less frequently consumed in some countries. In certain regions (Africa, South America), the effect of iodine deficiency is magnified by consumption of foodstuffs such as cassava roots that contain cyanoglucosides; these substances are metabolized to thiocyanate, which has antithyroid properties and magnifies the effects of iodine deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/59/39864?source=see_link\">",
"     \"Iodine deficiency disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Iodine excess also can cause hypothyroidism by inhibiting iodide organification and T4 and triiodothyronine (T3) synthesis (the Wolff-Chaikoff effect). Normal subjects quickly \"escape\" from this effect of iodine. However, patients with abnormal thyroid glands do not, and they can become hypothyroid if given iodine for more than a few days. Patients at risk for iodine-induced hypothyroidism include those with chronic autoimmune thyroiditis and those who have had a partial thyroidectomy, or a history of radioiodine therapy, painless, postpartum or subacute granulomatous thyroiditis. The excess iodine can be derived from health tonics, cough medicines, kelp tablets and other dietary supplements, iodine-containing substances (eg, Betadine) applied to the skin or vagina, drugs such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    , and radiographic contrast agents (see below) (",
"    <a class=\"graphic graphic_table graphicRef60901 \" href=\"mobipreview.htm?18/26/18861\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20568?source=see_link\">",
"     \"Iodine-induced thyroid dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The drugs given intentionally to decrease thyroid secretion (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/9/5271?source=see_link\">",
"     propylthiouracil",
"    </a>",
"    [and perchlorate]) can cause hypothyroidism. None have other uses, and therefore should not be the cause of hypothyroidism in patients who do not have a history of hyperthyroidism.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/16/42244?source=see_link\">",
"     Ethionamide",
"    </a>",
"    , an antimycobacterial drug used as a second-line agent for the treatment of multidrug-resistant tuberculosis, is structurally similar to methimazole and is a rare cause of hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Drugs used to treat non-thyroid conditions that can cause hypothyroidism include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    carbonate,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    (an iodine-containing drug), interferon alfa, and interleukin-2 (",
"    <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"     table 4",
"    </a>",
"    ). Serum TSH should be measured every 6 to 12 months in patients taking these drugs. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42453?source=see_link\">",
"     \"Lithium and the thyroid\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25065?source=see_link\">",
"     \"Amiodarone and thyroid dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43830?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of thyroiditis\", section on 'Drug-induced thyroiditis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/41/36505?source=see_link&amp;anchor=H5#H5\">",
"     \"Principles of interferon therapy in liver disease and the induction of autoimmunity\", section on 'Thyroid disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Oral tyrosine kinase inhibitors (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/10/44200?source=see_link\">",
"     sunitinib",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/45/9944?source=see_link\">",
"     sorafenib",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/1/17434?source=see_link\">",
"     imatinib",
"    </a>",
"    , motesanib) used for the treatment of gastrointestinal stromal tumors, renal cell carcinoma, hepatocellular cancer, chronic myeloid leukemia, and in other cancers can cause hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/35\">",
"     35",
"    </a>",
"    ]. Of the kinase inhibitors, sunitinib appears to cause thyroid dysfunction most frequently, occurring in 15 of 42 patients (36 percent) in one report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/36\">",
"     36",
"    </a>",
"    ], and 21 of 40 patients in another report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/40/42632?source=see_link\">",
"     \"Drug interactions with thyroid hormones\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43882?source=see_link&amp;anchor=H1651229244#H1651229244\">",
"     \"Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects\", section on 'Thyroid dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, patients with hypothyroidism who are taking T4 may become hypothyroid again if given drugs that decrease T4 absorption (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    and iron salts), increase its clearance (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ), or decrease T4 to T3 conversion (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/40/42632?source=see_link\">",
"     \"Drug interactions with thyroid hormones\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Infiltrative disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infiltrative diseases, such as fibrous thyroiditis (Reidel's thyroiditis), hemochromatosis, scleroderma, leukemia, and cystinosis, are rare causes of hypothyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/38\">",
"     38",
"    </a>",
"    ]. Amyloid goiter is likewise uncommon, although when present it often results in hypothyroidism. In one series, as an example, 5 of 19 patients (26 percent) with amyloid goiter were hypothyroid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/39\">",
"     39",
"    </a>",
"    ]. Infections of the thyroid, as with M. tuberculosis and Pneumocystis carinii, occasionally damage the thyroid enough to cause hypothyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/15/43257?source=see_link\">",
"     \"Infiltrative thyroid disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sarcoid infiltration can cause goiter. However, patients with sarcoidosis have a higher than expected prevalence of thyroid antibodies; thus, hypothyroidism in these patients also may have an autoimmune etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Hypothyroidism in infants and children",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of congenital hypothyroidism are agenesis and dysgenesis of the thyroid, but a few have inherited defects in thyroid hormone biosynthesis or are delivered by mothers who were receiving an antithyroid drug for hyperthyroidism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/41\">",
"     41",
"    </a>",
"    ]. Among children who become hypothyroid later, the most common cause is chronic autoimmune thyroiditis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/39/2682?source=see_link\">",
"     \"Clinical features and detection of congenital hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Transient hypothyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypothyroidism occurs transiently during the course of several types of thyroiditis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43830?source=see_link\">",
"     \"Overview of thyroiditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with silent (or postpartum) thyroiditis and subacute (or granulomatous) thyroiditis have inflammation of thyroid tissue with transient hyperthyroidism, frequently followed by transient hypothyroidism, then recovery of thyroid function. The hypothyroidism is usually more severe in patients with subacute thyroiditis, while occasional patients with painless thyroiditis will present during the hypothyroid phase of the illness.",
"      <br/>",
"      <br/>",
"      Transient hypothyroidism can last from a few weeks to as long as six months in these disorders. Patients with minimal symptoms may not require therapy. Those with symptomatic hypothyroidism should be treated with T4, which can be given for several months, then discontinued. A normal serum TSH value six weeks later will confirm the recovery of thyroid function.",
"     </li>",
"     <li>",
"      Among women with postpartum thyroiditis, about 20 to 30 percent have hyperthyroidism followed by transient hypothyroidism, and 40 to 50 percent have only transient hypothyroidism. In either instance, the hypothyroidism lasts several weeks to a few months. These figures are based on serial biochemical testing; the proportion of women with symptoms is smaller and fewer need replacement therapy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/15/248?source=see_link\">",
"       \"Postpartum thyroiditis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Some patients who undergo subtotal thyroidectomy become hypothyroid after four to eight weeks, but recover several weeks or months later. The probable explanation is that they have enough remaining thyroid tissue to maintain normal thyroid secretion once its growth has been stimulated by TSH.",
"     </li>",
"     <li>",
"      Many patients with Graves' hyperthyroidism whose glands were not completely ablated by radioiodine and who have some remaining thyroid tissue may have transient hypothyroidism after radioactive iodine therapy because TSH secretion, previously low, does not increase appropriately in response to low serum T4 concentrations for several weeks or months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Withdrawal of exogenous thyroid therapy in patients who do not have hypothyroidism, and in whom the therapy suppressed endogenous pituitary-thyroid function, is sometimes followed by transient hypothyroidism until TSH secretion and then thyroid secretion resumes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SECONDARY AND TERTIARY (CENTRAL) HYPOTHYROIDISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary hypothyroidism is that caused by TSH deficiency, and tertiary hypothyroidism is caused by TRH deficiency. Less than 1 percent of patients with hypothyroidism have one of these forms of central hypothyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/6/18536?source=see_link\">",
"     \"Central hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients with central hypothyroidism have low or normal serum TSH concentrations (but inappropriately low in the presence of low serum T4 and T3 concentrations). However, a few patients with TSH deficiency have slightly high serum TSH values because they secrete TSH that is less glycosylated and therefore has less biological activity than normal TSH (but is normally immunoreactive).",
"   </p>",
"   <p>",
"    Secondary hypothyroidism can be caused by any of the causes of hypopituitarism, most often a pituitary tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/38/9833?source=see_link\">",
"     \"Causes of hypopituitarism\"",
"    </a>",
"    .) Most patients with pituitary microadenomas are euthyroid, whereas 10 to 25 of those with macroadenomas are hypothyroid, either initially or after surgical or radiation therapy. (A few patients who are initially hypothyroid become euthyroid after resection of a pituitary macroadenoma.)",
"   </p>",
"   <p>",
"    Other causes of secondary hypothyroidism include postpartum pituitary necrosis (Sheehan's syndrome), trauma, hypophysitis, nonpituitary tumors such as craniopharyngiomas, infiltrative diseases, and inactivating mutations in the gene for either TSH or the TSH receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/44-48\">",
"     44-48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/8/16518?source=see_link\">",
"     \"Resistance to thyrotropin and thyrotropin-releasing hormone\"",
"    </a>",
"    .) TSH deficiency may be isolated, but more often it occurs in association with other pituitary hormone deficiencies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/38/9833?source=see_link\">",
"     \"Causes of hypopituitarism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/39/31348?source=see_link\">",
"     \"Clinical manifestations of hypopituitarism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tertiary hypothyroidism can be caused by any disorder that damages the hypothalamus or interferes with hypothalamic-pituitary portal blood flow, thereby preventing delivery of TRH to the pituitary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/43\">",
"     43",
"    </a>",
"    ]. It can also be caused by mutations in the gene for the TRH receptor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/49\">",
"     49",
"    </a>",
"    ]. Like TSH deficiency, TRH deficiency can be isolated or occur in combination with other hormonal deficiencies. Hypothalamic damage results from tumors, trauma, radiation therapy, or infiltrative diseases.",
"   </p>",
"   <p>",
"    TSH deficiency and TRH deficiency cannot be distinguished by biochemical tests. Any patient with findings suggestive of central hypothyroidism should undergo magnetic resonance imaging of the hypothalamus and pituitary. The results allow inferences to be made as to which hormone is deficient, but the distinction is of no practical importance with respect to the patient's hypothyroidism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     GENERALIZED RESISTANCE TO THYROID HORMONE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized resistance to thyroid hormone (GRTH) is a rare disorder, usually inherited as an autosomal dominant trait. It is caused by mutations in the gene for the beta form of the T3 nuclear receptor. The abnormal receptors have a decreased affinity for T3, the physiologically active hormone within cells; they can also inhibit the action of the normal receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/8/16518?source=see_link\">",
"     \"Resistance to thyrotropin and thyrotropin-releasing hormone\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This disorder is included here because a few patients with the syndrome have had findings indicating the presence of hypothyroidism in infancy, such as short stature, deafness, and mental retardation. However, most patients with this disorder are euthyroid (some have a suggestion of hyperthyroidism, such as tachycardia). There may be an association between this disorder and attention deficit hyperactivity disorder (ADHD), and learning disabilities and hearing loss are significant problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These patients are often discovered by accident as a result of a thyroid test; the characteristic findings are high serum T4 and T3 concentrations, with a normal or high serum TSH concentration. These biochemical findings indicate that the pituitary thyrotroph cells are relatively resistant to T4 and T3, as are other tissues, and also that high serum T4 and T3 concentrations can overcome the resistance.",
"   </p>",
"   <p>",
"    Treatment is usually unnecessary, but T4 or T3 may be given if symptoms of hypothyroidism occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     CONSUMPTIVE HYPOTHYROIDISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consumptive hypothyroidism is a very rare form of hypothyroidism characterized by excessive degradation of thyroid hormone due to the ectopic production of the type 3 deiodinase, which metabolizes T4 to reverse T3 and T3 to T2. This has been described in vascular and fibrotic tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42744/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/54/3938?source=see_link\">",
"       \"Patient information: Hypothyroidism (underactive thyroid) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/54/15203?source=see_link\">",
"       \"Patient information: Hypothyroidism (underactive thyroid) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The cause of primary hypothyroidism in most patients is Hashimoto's thyroiditis. Other common causes should be evident because of a history of surgery, radioiodine, or external radiation to the neck, or the use of drugs associated with hypothyroidism (",
"      <a class=\"graphic graphic_table graphicRef67769 \" href=\"mobipreview.htm?2/8/2188\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef50439 \" href=\"mobipreview.htm?21/19/21820\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Primary hypothyroidism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infiltrative disorders, inherited defects in biosynthesis of thyroid hormone, and generalized resistance to thyroid hormone are rare causes of hypothyroidism. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Infiltrative disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Hypothyroidism in infants and children'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Generalized resistance to thyroid hormone'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Causes of transient hypothyroidism, such as painless or postpartum thyroiditis, should also always be considered to avoid unnecessary lifelong treatment with thyroxine. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Transient hypothyroidism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is critical that secondary or central hypothyroidism is not missed; measurement of both a TSH and free T4 should avoid misdiagnosis. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Secondary and tertiary (central) hypothyroidism'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/1\">",
"      Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994; 15:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/2\">",
"      Mariotti S, Caturegli P, Piccolo P, et al. Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 1990; 71:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/3\">",
"      Nordyke RA, Gilbert FI Jr, Miyamoto LA, Fleury KA. The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Med 1993; 153:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/4\">",
"      Endo T, Kaneshige M, Nakazato M, et al. Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity. Biochem Biophys Res Commun 1996; 228:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/5\">",
"      Takasu N, Yamada T, Takasu M, et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992; 326:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/6\">",
"      Bogner U, Heged&uuml;s L, Hansen JM, et al. Thyroid cytotoxic antibodies in atrophic and goitrous autoimmune thyroiditis. Eur J Endocrinol 1995; 132:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/7\">",
"      Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/8\">",
"      Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/9\">",
"      Sawin CT, Castelli WP, Hershman JM, et al. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985; 145:1386.",
"     </a>",
"    </li>",
"    <li>",
"     Vanderpump MP, Tunbridge WM. The epidemiology of thyroid diseases. In: The thyroid: A fundamental and clinical text, 8th, Braverman LE, Utiger RD (Eds), Lippincott Williams and Wilkins, Philadelphia 2000. p.467.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/11\">",
"      Rallison ML, Dobyns BM, Meikle AW, et al. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med 1991; 91:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/12\">",
"      Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/13\">",
"      Huber G, Staub JJ, Meier C, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002; 87:3221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/14\">",
"      Hayashi Y, Tamai H, Fukata S, et al. A long term clinical, immunological, and histological follow-up study of patients with goitrous chronic lymphocytic thyroiditis. J Clin Endocrinol Metab 1985; 61:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/15\">",
"      Foley TP Jr, Abbassi V, Copeland KC, Draznin MB. Brief report: hypothyroidism caused by chronic autoimmune thyroiditis in very young infants. N Engl J Med 1994; 330:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/16\">",
"      Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/17\">",
"      Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003; 24:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/18\">",
"      Chiovato L, Larizza D, Bendinelli G, et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner's syndrome. Eur J Endocrinol 1996; 134:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/19\">",
"      Karlsson B, Gustafsson J, Hedov G, et al. Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 1998; 79:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/20\">",
"      Boukis MA, Koutras DA, Souvatzoglou A, et al. Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab 1983; 57:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/21\">",
"      Fukata S, Kuma K, Sugawara M. Relationship between cigarette smoking and hypothyroidism in patients with Hashimoto's thyroiditis. J Endocrinol Invest 1996; 19:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/22\">",
"      Asvold BO, Bj&oslash;ro T, Nilsen TI, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med 2007; 167:1428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/23\">",
"      Sridama V, McCormick M, Kaplan EL, et al. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease. N Engl J Med 1984; 311:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/24\">",
"      Franklyn JA, Daykin J, Drolc Z, et al. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 1991; 34:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/25\">",
"      McHenry CR, Slusarczyk SJ. Hypothyroidisim following hemithyroidectomy: incidence, risk factors, and management. Surgery 2000; 128:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/26\">",
"      Cunnien AJ, Hay ID, Gorman CA, et al. Radioiodine-induced hypothyroidism in Graves' disease: factors associated. J Nucl Med 1982; 23:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/27\">",
"      Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991; 325:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/28\">",
"      Fein DA, Hanlon AL, Corn BW, et al. The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1996; 36:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/29\">",
"      Chin D, Sklar C, Donahue B, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer 1997; 80:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/30\">",
"      Littley MD, Shalet SM, Morgenstern GR, Deakin DP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q J Med 1991; 78:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/31\">",
"      Pacini F, Vorontsova T, Molinaro E, et al. Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet 1998; 352:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/32\">",
"      Andersson M, Takkouche B, Egli I, et al. Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bull World Health Organ 2005; 83:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/33\">",
"      Bourdoux P, Delange F, Gerard M, et al. Evidence that cassava ingestion increases thiocyanate formation: a possible etiologic factor in endemic goiter. J Clin Endocrinol Metab 1978; 46:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/34\">",
"      McDonnell ME, Braverman LE, Bernardo J. Hypothyroidism due to ethionamide. N Engl J Med 2005; 352:2757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/35\">",
"      Hamnvik OP, Larsen PR, Marqusee E. Thyroid dysfunction from antineoplastic agents. J Natl Cancer Inst 2011; 103:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/36\">",
"      Desai J, Yassa L, Marqusee E, et al. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 2006; 145:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/37\">",
"      Wong E, Rosen LS, Mulay M, et al. Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. Thyroid 2007; 17:351.",
"     </a>",
"    </li>",
"    <li>",
"     Barsano CP. Other forms of primary hypothyroidism. In: The thyroid: A fundamental and clinical text, 7th, Braverman LE, Utiger RD (Eds), Lippincott-Raven, Philadelphia 1996. p.768.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/39\">",
"      Kimura H, Yamashita S, Ashizawa K, et al. Thyroid dysfunction in patients with amyloid goitre. Clin Endocrinol (Oxf) 1997; 46:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/40\">",
"      Nakamura H, Genma R, Mikami T, et al. High incidence of positive autoantibodies against thyroid peroxidase and thyroglobulin in patients with sarcoidosis. Clin Endocrinol (Oxf) 1997; 46:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/41\">",
"      Fisher DA, Klein AH. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 1981; 304:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/42\">",
"      Vagenakis AG, Braverman LE, Azizi F, et al. Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N Engl J Med 1975; 293:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/43\">",
"      Samuels MH, Ridgway EC. Central hypothyroidism. Endocrinol Metab Clin North Am 1992; 21:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/44\">",
"      Doeker BM, Pf&auml;ffle RW, Pohlenz J, Andler W. Congenital central hypothyroidism due to a homozygous mutation in the thyrotropin beta-subunit gene follows an autosomal recessive inheritance. J Clin Endocrinol Metab 1998; 83:1762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/45\">",
"      Medeiros-Neto G, Herodotou DT, Rajan S, et al. A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest 1996; 97:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/46\">",
"      Sunthornthepvarakui T, Gottschalk ME, Hayashi Y, Refetoff S. Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 1995; 332:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/47\">",
"      Abramowicz MJ, Duprez L, Parma J, et al. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 1997; 99:3018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/48\">",
"      Gagn&eacute; N, Parma J, Deal C, et al. Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities? J Clin Endocrinol Metab 1998; 83:1771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/49\">",
"      Collu R, Tang J, Castagn&eacute; J, et al. A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 1997; 82:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/50\">",
"      Brucker-Davis F, Skarulis MC, Grace MB, et al. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med 1995; 123:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/51\">",
"      Hauser P, Zametkin AJ, Martinez P, et al. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 1993; 328:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42744/abstract/52\">",
"      Ruppe MD, Huang SA, Jan de Beur SM. Consumptive hypothyroidism caused by paraneoplastic production of type 3 iodothyronine deiodinase. Thyroid 2005; 15:1369.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7886 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-D201336892-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42744=[""].join("\n");
var outline_f41_47_42744=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PRIMARY HYPOTHYROIDISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Chronic autoimmune (Hashimoto's) thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Prevalence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Natural history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Susceptibility and risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Hashimoto's encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      latrogenic disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Thyroidectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Radioiodine therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - External neck irradiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Iodine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Infiltrative disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Hypothyroidism in infants and children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Transient hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SECONDARY AND TERTIARY (CENTRAL) HYPOTHYROIDISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      GENERALIZED RESISTANCE TO THYROID HORMONE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      CONSUMPTIVE HYPOTHYROIDISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7886\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7886|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/8/2188\" title=\"table 1\">",
"      Causes of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?31/7/31867\" title=\"table 2\">",
"      Prevalence antithyroid Ab",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/26/18861\" title=\"table 3\">",
"      Sources of iodine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/19/21820\" title=\"table 4\">",
"      Drugs and thyroid function",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/30/25065?source=related_link\">",
"      Amiodarone and thyroid dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/38/9833?source=related_link\">",
"      Causes of hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/6/18536?source=related_link\">",
"      Central hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/39/2682?source=related_link\">",
"      Clinical features and detection of congenital hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/39/31348?source=related_link\">",
"      Clinical manifestations of hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/7/26744?source=related_link\">",
"      Diagnosis of and screening for hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/40/42632?source=related_link\">",
"      Drug interactions with thyroid hormones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/47/33527?source=related_link\">",
"      Hashimoto's encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/15/43257?source=related_link\">",
"      Infiltrative thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/59/39864?source=related_link\">",
"      Iodine deficiency disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20568?source=related_link\">",
"      Iodine-induced thyroid dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42453?source=related_link\">",
"      Lithium and the thyroid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/42/30378?source=related_link\">",
"      Management of late complications of head and neck cancer and its treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43830?source=related_link\">",
"      Overview of thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/11/27833?source=related_link\">",
"      Pathogenesis of Hashimoto's thyroiditis (chronic autoimmune thyroiditis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/42/9896?source=related_link\">",
"      Pathogenesis of autoimmune adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/54/15203?source=related_link\">",
"      Patient information: Hypothyroidism (underactive thyroid) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/54/3938?source=related_link\">",
"      Patient information: Hypothyroidism (underactive thyroid) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/15/248?source=related_link\">",
"      Postpartum thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/41/36505?source=related_link\">",
"      Principles of interferon therapy in liver disease and the induction of autoimmunity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/49/1818?source=related_link\">",
"      Radiation-induced thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/7/12410?source=related_link\">",
"      Radioiodine in the treatment of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/8/16518?source=related_link\">",
"      Resistance to thyrotropin and thyrotropin-releasing hormone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/48/3850?source=related_link\">",
"      Subclinical hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=related_link\">",
"      Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/54/43882?source=related_link\">",
"      Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_47_42745="Treatment of adrenal insufficiency in adults";
var content_f41_47_42745=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of adrenal insufficiency in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/47/42745/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/47/42745/contributors\">",
"     Lynnette K Nieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/47/42745/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/47/42745/contributors\">",
"     Andre Lacroix, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/47/42745/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/47/42745/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/47/42745/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary adrenal insufficiency (Addison's disease) is due to adrenocortical disease, while secondary and tertiary adrenal insufficiency are due to disorders of the pituitary gland (ACTH secretion) or the hypothalamus (corticotropic-releasing hormone secretion), respectively. Primary adrenal insufficiency is associated with both cortisol and mineralocorticoid deficiency. In contrast, secondary and tertiary adrenal insufficiency are associated with cortisol, but not mineralocorticoid deficiency, because aldosterone is regulated primarily by the renin-angiotensin system, which is independent of the hypothalamus and pituitary. This distinction accounts for the different clinical presentation and management of these disorders.",
"   </p>",
"   <p>",
"    The management of all forms of adrenal insufficiency is reviewed here. The causes, clinical manifestations, and diagnosis of adrenal insufficiency in adults are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/0/40969?source=see_link\">",
"     \"Causes of primary adrenal insufficiency (Addison's disease)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33800?source=see_link\">",
"     \"Clinical manifestations of adrenal insufficiency in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/46/44777?source=see_link\">",
"     \"Diagnosis of adrenal insufficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ADRENAL CRISIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal crisis refers to acute adrenal insufficiency; it is most common in patients with primary adrenal insufficiency, but may also occur in those with secondary or tertiary adrenal insufficiency. It is a life-threatening emergency that requires immediate treatment (",
"    <a class=\"graphic graphic_table graphicRef67329 \" href=\"mobipreview.htm?8/56/9100\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In patients with primary adrenal insufficiency, the major clinical features of adrenal crisis are volume depletion and hypotension, usually resulting from mineralocorticoid deficiency.",
"   </p>",
"   <p>",
"    While secondary or tertiary adrenal insufficiency (isolated glucocorticoid deficiency) does not lead to volume depletion, it decreases vascular tone, which contributes further to hypotension. Thus, adrenal crisis occurs less frequently in patients with secondary or tertiary adrenal insufficiency. When they do have adrenal crisis, it tends to be during acute stress, or with acute cortisol deficiency due to pituitary infarction or after surgical cure of Cushing's syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33800?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations of adrenal insufficiency in adults\", section on 'Pituitary apoplexy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Adrenal crisis may also occur in patients who are abruptly withdrawn from exogenous glucocorticoids. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33800?source=see_link\">",
"     \"Clinical manifestations of adrenal insufficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The biochemical features of adrenal crisis in primary adrenal insufficiency include hyperkalemia and hyponatremia. Hyponatremia occurs because of mineralocorticoid deficiency and also due to inappropriate secretion of antidiuretic hormone (vasopressin) that is caused by cortisol (not aldosterone) deficiency. In these patients, combined mineralocorticoid and glucocorticoid deficiency lead to urinary sodium loss, plasma volume depletion with increased serum urea. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/17/25876?source=see_link\">",
"     \"Hyponatremia and hyperkalemia in adrenal insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with pure cortisol deficiency (eg, secondary or tertiary adrenal insufficiency) have slightly increased blood volume, dilutional hyponatremia, and less urinary sodium loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal crisis requires urgent diagnosis and intervention (",
"    <a class=\"graphic graphic_table graphicRef67329 \" href=\"mobipreview.htm?8/56/9100\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment of patients who present in possible adrenal crisis should not be delayed while diagnostic tests are performed. Blood for serum cortisol, renin, ACTH and serum chemistry should be drawn and therapy initiated immediately. The serum chemistry results guide initial treatment; the hormone values return later and are used to confirm the diagnosis (cortisol) or evaluate the differential diagnosis (ACTH and renin).",
"     </li>",
"     <li>",
"      1 to 3 liters of 0.9 percent saline solution or 5 percent dextrose in 0.9 percent saline (to correct possible hypoglycemia) should be infused intravenously within the first 12 to 24 hours based on assessment of volume status and urine output.",
"     </li>",
"     <li>",
"      Hypotonic saline should not be used because it can worsen the hyponatremia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Choice of glucocorticoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a patient without a previous diagnosis of adrenal insufficiency,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    (4 mg intravenous bolus) is preferred because, in contrast to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    , it is not measured in serum cortisol assays [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with a known diagnosis of adrenal insufficiency who present with adrenal crisis,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    (4 mg intravenous bolus),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    100 mg IV bolus, or any intravenous glucocorticoid preparation may be used (",
"    <a class=\"graphic graphic_table graphicRef64138 \" href=\"mobipreview.htm?41/61/42972\">",
"     table 2",
"    </a>",
"    ). This can rapidly decrease the inappropriate vasopressin production with increased clearance of free water and correction of hyponatremia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In contrast to glucocorticoid replacement, mineralocorticoid replacement is not necessary acutely because it takes several days for its sodium-retaining effects to appear, and adequate sodium replacement can be achieved by intravenous saline alone. However, in patients with known primary adrenal insufficiency with potassium &gt;6.0",
"      <span class=\"nowrap\">",
"       meq/L,",
"      </span>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      is preferred because of its mineralocorticoid activity.",
"     </li>",
"     <li>",
"      Unless there is a major complicating illness, parenteral glucocorticoid therapy can be tapered over one to three days and changed to an oral maintenance dose.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;After initial treatment, the precipitating cause of the adrenal crisis (as an example, bacterial infection, viral gastroenteritis) should be sought and appropriately treated.",
"   </p>",
"   <p>",
"    Once the patient's condition is stable, the diagnosis can be confirmed in patients not known to have adrenal insufficiency with a short ACTH stimulation test. This should be followed by tests to determine the cause of the adrenal insufficiency. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/46/44777?source=see_link\">",
"     \"Diagnosis of adrenal insufficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CHRONIC ADRENAL INSUFFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the important components of therapy in chronic adrenal insufficiency is patient education (",
"    <a class=\"graphic graphic_table graphicRef78904 \" href=\"mobipreview.htm?21/30/21996\">",
"     table 3",
"    </a>",
"    ). The patient should be told that they can lead an active and vigorous life as long as they take replacement therapy and follow a few common-sense precautions. The patient and responsible family members should be instructed about:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The nature of the hormonal deficit and the rationale for treatment",
"     </li>",
"     <li>",
"      Maintenance medications and adjustment during minor illnesses",
"     </li>",
"     <li>",
"      When to consult a clinician",
"     </li>",
"     <li>",
"      When and how to inject a glucocorticoid for emergencies",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Glucocorticoid regimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ideal glucocorticoid replacement therapy would:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mimic the endogenous cortisol rhythm, with a nadir at bedtime and peak values in the early morning before waking",
"     </li>",
"     <li>",
"      Have little inter-individual variability in metabolism, so that the correct dose could be predicted",
"     </li>",
"     <li>",
"      Be amenable to easy dose-titration",
"     </li>",
"     <li>",
"      Be easily monitored",
"     </li>",
"     <li>",
"      Minimize the risk of overtreatment, resulting in iatrogenic Cushing&rsquo;s syndrome (obesity, osteoporosis, facial plethora) (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Monitoring dose'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/48/22282?source=see_link&amp;anchor=H588675624#H588675624\">",
"       \"Epidemiology and clinical manifestations of Cushing's syndrome\", section on 'Iatrogenic Cushing's syndrome'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Unfortunately, there are no head-to-head comparisons of various glucocorticoid replacement regimens. Various regimens have been advocated, using short-acting (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/16/39174?source=see_link\">",
"     cortisone acetate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    ) or long-acting",
"    <span class=\"nowrap\">",
"     (",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"      prednisone",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"      prednisolone",
"     </a>",
"     ,",
"    </span>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    ) agents (",
"    <a class=\"graphic graphic_table graphicRef64138 \" href=\"mobipreview.htm?41/61/42972\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Short-acting glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest replacement with a short-acting glucocorticoid,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    , in two or three divided doses as the glucocorticoid of choice for the management of chronic primary adrenal insufficiency. We suggest using the lowest glucocorticoid dose that relieves symptoms of glucocorticoid deficiency.",
"   </p>",
"   <p>",
"    Short-acting regimens roughly mimic the normal diurnal rhythm. The bioavailability of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    is nearly 100 percent, and serum cortisol concentrations rise rapidly in the 30 minutes or so after ingestion. However, after a large dose, the corticosteroid-binding globulin (CBG) capacity for cortisol is exceeded at about 25",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/2\">",
"     2",
"    </a>",
"    ]. As a result, the serum free cortisol increases, and is rapidly filtered into the urine, resulting in a rapid decline in serum total cortisol concentrations to 25",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (690",
"    <span class=\"nowrap\">",
"     nmol/L),",
"    </span>",
"    after which the decline slows (average plasma half-life about 95 minutes). One study found elevated UFC for 24 hours after a single 25 mg hydrocortisone dose, but a decrease to the reference range, when the 25 mg daily dose was given in five 5 mg doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To become biologically active, cortisone must undergo hepatic conversion to cortisol. It is either largely unabsorbed or not metabolized after intramuscular administration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/4\">",
"     4",
"    </a>",
"    ]. Because of these shortcomings,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    is generally considered to be the better choice for a short-acting glucocorticoid regimen.",
"   </p>",
"   <p>",
"    In general, the replacement dose of glucocorticoid is aimed at replacing the missing cortisol or its equivalent. The average daily secretion rate of cortisol in normal subjects is 2.7 to 14",
"    <span class=\"nowrap\">",
"     mg/m2/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/5\">",
"     5",
"    </a>",
"    ], and the range of replacement doses is wider due to interindividual variation in metabolism of the steroids and the fact that a single dose is less effective than the same amount of steroid administered in multiple doses. Based on the known secretion rate, we recommend a total daily",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    dose of 10 to 12",
"    <span class=\"nowrap\">",
"     mg/m2.",
"    </span>",
"   </p>",
"   <p>",
"    Because of its short half-life, the total daily dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    is divided into two or three doses. Thrice daily administration mimics the day-curve of cortisol seen in healthy volunteers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/6\">",
"     6",
"    </a>",
"    ]. A typical twice-daily regimen consists of taking about two-thirds of the total dose upon arising in the morning and one-third in the afternoon to simulate the normal cortisol circadian rhythm. Three times daily regimens use decreasing doses in the morning, early afternoon, and late",
"    <span class=\"nowrap\">",
"     afternoon/early",
"    </span>",
"    evening (eg,",
"    <span class=\"nowrap\">",
"     10/5/2.5",
"    </span>",
"    mg). Most regimens avoid evening doses, because normal subjects secrete little cortisol from about 6 PM to 3 AM.",
"   </p>",
"   <p>",
"    Authors recommend a variety of replacement doses, including 5",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    given thrice daily, 10 mg morning, and 5 mg in the afternoon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/7\">",
"     7",
"    </a>",
"    ], 20 mg total dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/8\">",
"     8",
"    </a>",
"    ], and 15 to 25 mg daily given in two or three divided doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/9\">",
"     9",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     Hydrocortisone",
"    </a>",
"    has some mineralocorticoid activity, so",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    replacement (if needed) must be decreased appropriately. Hydrocortisone dose recommendations are similar for patients with secondary adrenal insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/22/28006?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment of hypopituitarism\", section on 'ACTH deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The interaction of concurrent medications that alter CYP3A4 metabolism of glucocorticoids should be considered when choosing the dose, as it may require adjustment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While some patients do well on single dose administration, we recommend that a split dose be used when initiating therapy, and that a single dose be used only if patients are not compliant with the afternoon dose. In one small study, quality of life and patient preference were greatest during three weeks with a split dose regimen (20 mg at 0700h and 10 mg at 1900h) rather than a single total dose in the morning or evening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/15\">",
"     15",
"    </a>",
"    ]. There are no studies comparing quality of life of two versus three dose regimens.",
"   </p>",
"   <p>",
"    Advantages of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    include the potential for fine dose adjustments using various tablet strengths. Additionally, one study found that smaller fractionated doses of hydrocortisone (10 mg twice daily) avoided increased intraocular pressure found with a higher dose (20 mg and 10 mg split dose) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A disadvantage of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    therapy is the fact that a normal diurnal rhythm cannot be truly replicated: at the time of the morning dose, endogenous serum cortisol concentrations would normally already be at or after the circadian peak. This transient early morning adrenal insufficiency probably accounts for the symptoms of fatigue, lassitude, mild nausea, or headache that are often present upon awakening and that are relieved within 30 to 60 minutes after taking the morning dose of hydrocortisone. Some patients find it helpful to take their initial dose of hydrocortisone in the early morning and go back to sleep for a few hours. However, slow-release preparations in development may address this problem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A once-daily dual-release",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    tablet based on an immediate-release coating combined with an extended-release core is being investigated as an alternative to standard twice or three times daily dosing for patients with adrenal insufficiency. In one report, patients taking the once-daily tablet had a more physiologic serum cortisol profile, and lower body weight and blood pressure when compared with those taking an equivalent dose of hydrocortisone administered as a three times daily regimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Long-acting glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Longer-acting agents such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    provide a smoother physiological effect and avoid the marked changes in serum glucocorticoid levels that occur with short-acting drugs. It is not known if this is clinically important. The usual oral daily replacement doses are 0.5 mg and 5 mg for dexamethasone and prednisone, respectively. Some patients require 2.5 or 7.5 mg for prednisone or 0.25 or 0.75 mg for dexamethasone (",
"    <a class=\"graphic graphic_table graphicRef64138 \" href=\"mobipreview.htm?41/61/42972\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Long-acting agents may be useful in patients who are non-compliant with multiple daily dose schedules, or in those with severe late-evening or early morning symptoms that are not ameliorated by three-times daily",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    . Disadvantages of long-acting agents include the variable inter-individual metabolism of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    and, as a result, an inability to predict the correct dose. As a result, patients may be over-treated.",
"   </p>",
"   <p>",
"    Obese patients and those who metabolize glucocorticoids more rapidly than average may need higher doses; children or small adults and patients who metabolize glucocorticoids less rapidly than average may need lower doses. The",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    dose may need to be increased in patients taking drugs that accelerate hepatic steroid metabolism, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , barbiturates,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/58/16293?source=see_link\">",
"     mitotane",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/20-23\">",
"     20-23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h4\">",
"     Monitoring dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest using the lowest glucocorticoid dose that relieves symptoms of glucocorticoid deficiency and avoids signs and symptoms of glucocorticoid excess. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/48/22282?source=see_link&amp;anchor=H588675624#H588675624\">",
"     \"Epidemiology and clinical manifestations of Cushing's syndrome\", section on 'Iatrogenic Cushing's syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H483556\">",
"    <span class=\"h5\">",
"     Symptom assessment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The dose may be too low if symptoms of apparent glucocorticoid deficiency are present. If, however, increasing the dose does not promptly relieve the symptoms, then they have other causes and the lower steroid dose should be resumed.",
"     </li>",
"     <li>",
"      The dose may be too high if excessive weight gain, facial plethora or other symptoms or signs of Cushing's syndrome are present. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/48/22282?source=see_link&amp;anchor=H2#H2\">",
"       \"Epidemiology and clinical manifestations of Cushing's syndrome\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Osteoporosis is more likely with excessive glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Increased bone loss in women, but not men, with treated primary adrenal insufficiency was reported in one study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/26\">",
"     26",
"    </a>",
"    ] and in men but not women in another [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/27\">",
"     27",
"    </a>",
"    ]. Comparison of bone loss in patients treated with daily",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    30 mg or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    7.5 mg (doses that are higher than the recommended maintenance doses) found no difference in one study, but lower bone mineral density with prednisone in another [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42855?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis\", section on 'Effect of low-dose glucocorticoid therapy'",
"    </a>",
"    .) A study of 31 patients receiving three different regimens in random order suggested that morning",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    0.1",
"    <span class=\"nowrap\">",
"     mg/15",
"    </span>",
"    kg body weight had adverse effects on serum markers of bone turnover as compared with hydrocortisone 10",
"    <span class=\"nowrap\">",
"     mg/5",
"    </span>",
"    mg or",
"    <span class=\"nowrap\">",
"     10/5/5",
"    </span>",
"    mg split doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/30\">",
"     30",
"    </a>",
"    ]. Although this issue remains unresolved, it does highlight the importance of avoiding excessive doses of glucocorticoid, and may suggest that long-acting glucocorticoids are more likely to reduce bone mineral density. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42855?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis\", section on 'Effect of low-dose glucocorticoid therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H483564\">",
"    <span class=\"h5\">",
"     Plasma ACTH",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A low normal or suppressed morning plasma ACTH concentration indicates excessive glucocorticoid replacement in patients with primary adrenal insufficiency. The early morning adrenal insufficiency with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      results in plasma ACTH concentrations that are two to eight times higher than normal for several hours in the early morning and for several hours after the cortisol is taken [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/31-33\">",
"       31-33",
"      </a>",
"      ]. ACTH levels were significantly lower compared with conventional oral therapy, but remained about twofold elevated in two patients receiving hydrocortisone infusion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/33\">",
"       33",
"      </a>",
"      ]. Measurements of plasma ACTH are not helpful in patients with secondary insufficiency, in whom levels are expected to be low.",
"     </li>",
"     <li>",
"      While some advocate use of normative day-curve cortisol values to assess the adequacy of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/6\">",
"       6",
"      </a>",
"      ], other reports suggest that clinical assessment alone works equally well [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Mineralocorticoid replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with primary adrenal insufficiency eventually require mineralocorticoid replacement to prevent sodium loss, intravascular volume depletion, and hyperkalemia.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/9/21655?source=see_link\">",
"     Fludrocortisone",
"    </a>",
"    (9-alpha-fluorohydrocortisone), a potent synthetic mineralocorticoid, is given orally in a usual dose of 0.1",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"    A lower dose (such as 0.05",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    may be sufficient in patients receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    , which has some mineralocorticoid activity. Rare patients are sufficiently replaced with hydrocortisone alone and become hypertensive, hypokalemic with even 0.05 mg Florinef twice a week. Many patients receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    require up to 0.2",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of fludrocortisone to lower their plasma renin activity to the upper normal range [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The mineralocorticoid dose may have to be increased in the summer, when salt loss in perspiration increases, especially if the patient is routinely exposed to temperatures above about 29&ordm;C (85&ordm;F). Salt intake should be liberal, especially when exercising.",
"   </p>",
"   <p>",
"    Essential hypertension in patients with primary adrenal insufficiency should be treated by dietary sodium restriction and a lower dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Mineralocorticoid therapy usually cannot be discontinued without risking sodium depletion. If an antihypertensive drug is needed, diuretic drugs and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    should",
"    <strong>",
"     not",
"    </strong>",
"    be used, since they simply counteract the action of fludrocortisone.",
"   </p>",
"   <p>",
"    Mineralocorticoid replacement is rarely required in patients with secondary adrenal insufficiency because ACTH is not an important regulator of aldosterone release.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;The adequacy of mineralocorticoid replacement should be monitored by asking about symptoms of postural hypotension and measuring supine and upright blood pressure and pulse, serum potassium, and plasma renin activity (PRA). Hypertension, edema, and hypokalemia are signs of excessive mineralocorticoid replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest adjusting the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    dose to lower the PRA to the upper normal range [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Normal morning plasma renin activity for seated subjects ranges from about 1 to 4",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    per hour (0.8 to 3.0",
"    <span class=\"nowrap\">",
"     nmol/L",
"    </span>",
"    per hour). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/35/7736?source=see_link&amp;anchor=H3#H3\">",
"     \"Assays of the renin-angiotensin-aldosterone system in adrenal disease\", section on 'Plasma renin activity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is useful to measure PRA annually in all patients and in:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Newly diagnosed patients, until they are on a stable dose of mineralocorticoids.",
"     </li>",
"     <li>",
"      Patients with symptoms consistent with mineralocorticoid deficiency such as salt craving and intermittent mild nausea who have otherwise normal findings on physical examination.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In asymptomatic patients with normal serum electrolyte concentrations but high PRA, the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    dose should not be raised to normalize PRA. Although one might predict that this would be a physiologic dose (normal PRA in an asymptomatic, normokalemic patient), patients may develop hypokalemia and edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/1/37911?source=see_link\">",
"     \"Clinical features of primary aldosteronism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Androgen replacement (DHEA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many women with adrenal insufficiency describe a decrease in quality of life in spite of adequate glucocorticoid and mineralocorticoid replacement. This observation has led to interest in finding additional therapies, in particular, androgens, to improve well-being.",
"   </p>",
"   <p>",
"    The adrenal cortex is the primary source of androgen in the form of dehydroepiandrosterone and dehydroepiandrosterone sulfate. In women with adrenal insufficiency, serum concentrations of DHEA are extremely low. Therefore, DHEA has been studied as a therapy to improve mood and quality of life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Mood/quality of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical trial data suggest that in women with primary adrenal insufficiency, replacement with 50 mg of DHEA daily may be beneficial for outcomes such as mood and psychological well-being.",
"   </p>",
"   <p>",
"    In women with secondary adrenal insufficiency, DHEA appears to have a modest beneficial effect on psychological well-being. However, the available data are from women with panhypopituitarism, who have combined adrenal and ovarian androgen deficiency. No data are available in women with isolated ACTH deficiency, a very rare disorder.",
"   </p>",
"   <p>",
"    The best available data on the effect of DHEA on mood and quality of life in women with adrenal insufficiency comes from a meta-analysis of 10 randomized, placebo-controlled trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/40\">",
"     40",
"    </a>",
"    ]. When compared with placebo, DHEA resulted in a small improvement in health-related quality of life. There was also a small beneficial effect on depression, but no significant effect on anxiety or sexual well-being.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Other effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Twelve-week crossover studies of patients with primary and secondary adrenal insufficiency did not find significant improvements in vascular markers in men and women (arterial stiffness and endothelial function) or metabolic markers (lipids, HOMA-IR, high sensitivity CRP, adiponectin, plasminogen activator inhibitor-1), physical performance, body composition, protein metabolism, or muscle mitochondrial biogenesis in women receiving DHEA 50 mg daily [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/41-43\">",
"     41-43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the meta-analysis, most, but not all, studies reported common androgenic side effects including oily skin, hirsutism, acne, and increased sweating and odor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/40\">",
"     40",
"    </a>",
"    ]. Although serious adverse effects were not reported, the long-term safety of DHEA therapy has not been established.",
"   </p>",
"   <p>",
"    Other adverse effects, including decreases in serum HDL concentrations, have been reported. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/263?source=see_link&amp;anchor=H15#H15\">",
"     \"Dehydroepiandrosterone and its sulfate\", section on 'Adverse effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Suggested approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is insufficient evidence to recommend therapy in all patients with adrenal insufficiency, particularly men. In women with adrenal insufficiency (primary or secondary), we suggest DHEA therapy only for those who have significantly impaired mood or sense of well-being despite optimal glucocorticoid and mineralocorticoid replacement. We typically start with 25 to 50 mg daily for three to six months and adjust the dose based upon the clinical response (improvement in libido, sense of well-being, and androgenic side effects). Adverse effects and biochemical monitoring are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/263?source=see_link\">",
"     \"Dehydroepiandrosterone and its sulfate\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If no obvious benefit has been seen after six months or if adverse effects occur, we discontinue DHEA. In the United States, this approach is severely limited by the lack of product quality control, as DHEA is considered to be a dietary supplement rather than a hormone preparation. Therefore, DHEA supplements available commercially may not actually contain the advertised dose. This topic is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/263?source=see_link\">",
"     \"Dehydroepiandrosterone and its sulfate\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Considerations in secondary adrenal insufficiency",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with secondary adrenal insufficiency should receive evaluation and adequate replacement for other pituitary hormone deficiencies. Replacement of thyroid hormone without replacement of glucocorticoids can precipitate acute adrenal insufficiency.",
"     </li>",
"     <li>",
"      Patients with hypopituitarism who have partial or total ACTH deficiency and are receiving suboptimal cortisol or cortisone replacement may be at risk of developing symptoms of cortisol deficiency when growth hormone therapy is initiated. This is due to the inhibitory effect of growth hormone on 11-beta-hydroxysteroid dehydrogenase type 1, the enzyme that converts cortisone to cortisol [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Illness or surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cortisol secretion normally increases with the stress of illness and surgery. This fact has prompted the usual clinical practice of giving higher doses of glucocorticoid to patients with adrenal insufficiency in these situations. Unfortunately, there is little information about how much additional glucocorticoid is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;During minor illnesses, such as upper respiratory infections, the patient can increase the dose of glucocorticoid to two to three times the usual daily dose for three days without consulting a clinician (known as the 3 x 3 rule). The increased dose will decrease fever and malaise and will not compromise the immune response. If the illness becomes worse during the three days or if the patient cannot resume the usual maintenance dose on the fourth day, he or she should consult a clinician to determine if other treatment (eg, antibiotics) is indicated.",
"   </p>",
"   <p>",
"    As described below, patients with nausea and vomiting who are unable to retain oral medications should have a low threshold for injecting glucocorticoid. Further medical attention should then be sought. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Emergency precautions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appropriate dose and timing of glucocorticoids for patients undergoing surgery is controversial. Early reports of death after surgery led to a recommendation to give glucocorticoids in doses equivalent to 1000 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    daily [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/44\">",
"     44",
"    </a>",
"    ]. This is clearly in excess of the increased production of up to 200 mg daily. Prolonged postoperative pharmacologic glucocorticoid therapy can mask symptoms and signs of infection and cause undesirable side effects. For example, traditional doses of 300 to 400 Solu-Cortef for a few days can cause significant hypokalemia and edema. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17384?source=see_link\">",
"     \"The surgical patient taking glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Current recommendations for glucocorticoid supplementation at surgery take into account the severity of the operation and suggest lower daily doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. For minor procedures such as herniorrhaphy, a dose equivalent to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    25 mg is suggested for the day of operation only, with a return to the usual replacement dose on the second day. For moderate surgical stress (eg, cholecystectomy, joint replacement), divided intravenous doses equivalent to hydrocortisone 50 to 75 mg are suggested on the day of surgery and the first post-operative day, with a return to the usual dose on the second post-operative day (using oral or intravenous preparation as appropriate). The authors suggest a total daily dose equivalent to 100 to 150 mg hydrocortisone for major surgical procedures (eg, cardiac bypass) given in divided doses for two to three days, then returning to the usual dose. Alternatively, the dose used on the day of surgery can be halved on post-operative day one. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17384?source=see_link\">",
"     \"The surgical patient taking glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Emergency precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major risk to the patient with adrenal insufficiency is the lack of a normal serum cortisol response to stress and, in patients with primary adrenal insufficiency, of a normal renin-angiotensin-aldosterone response to hypovolemia. Consequently, the patient must anticipate these situations and be prepared to modify therapy to meet these needs.",
"   </p>",
"   <p>",
"    Every patient should wear a medical alert (Medic Alert) bracelet or necklace and carry the Emergency Medical Information Card that is supplied with it. Both should indicate the diagnosis, the daily medications and doses, and the clinician to call in the event of an emergency.",
"   </p>",
"   <p>",
"    Each patient should have injectable glucocorticoid, such as 100 mg vials of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    (Solu-Cortef) or 4 mg vials of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    , along with vials of sterile 0.9 percent normal saline and syringes. The patient and one or more responsible family or household members should be instructed on how to reconstitute and inject the medication subcutaneously or intramuscularly anywhere on the patient's body if any of the following occur:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An injury with substantial blood loss (more than a cup) or fracture",
"     </li>",
"     <li>",
"      Nausea and vomiting and inability to retain oral medications",
"     </li>",
"     <li>",
"      Symptoms of acute adrenal insufficiency",
"     </li>",
"     <li>",
"      The patient is found unresponsive",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The entire dose of medication should be injected (100 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    or 4 mg",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    ). Patient and family instruction should include the need to get medical help",
"    <strong>",
"     immediately",
"    </strong>",
"    after the injection. The patient should be instructed to have a low threshold for injecting the glucocorticoid: if it",
"    <strong>",
"     might be",
"    </strong>",
"    necessary, it should be injected and medical attention should be sought. It is unlikely, however, that a patient will need the injectable glucocorticoid more than two or three times a year, and most patients go for years without using it.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Critical illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal cortisol secretion increases during critical illness, but the increase may not be detected if only total serum cortisol concentrations are measured. Some critically ill patients may have \"functional adrenal insufficiency,\" but there is currently no consensus on diagnostic criteria or indications for treatment. This topic is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/57/16281?source=see_link&amp;anchor=H12#H12\">",
"     \"Corticosteroid therapy in septic shock\", section on 'Relative adrenal insufficiency'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/20/24905?source=see_link\">",
"     \"Evaluation of the response to ACTH in adrenal insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy complicated by primary adrenal insufficiency has been reported in about 100 women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/46\">",
"     46",
"    </a>",
"    ]. Before glucocorticoid replacement therapy became available, pregnancy in women with primary adrenal insufficiency was associated with a maternal mortality rate as high as 35 to 45 percent and fetal growth retardation was common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. At present, most women adequately treated for adrenal insufficiency go through pregnancy, labor, and delivery without difficulty, and babies achieve a normal birth weight. The usual glucocorticoid and mineralocorticoid replacement doses are continued; an occasional woman requires slightly more glucocorticoid in the third trimester [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/38,46,50\">",
"     38,46,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During labor, adequate saline hydration and 25 mg",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      should be administered intravenously every six hours.",
"     </li>",
"     <li>",
"      At the time of delivery, or if labor is prolonged,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      should be administered intravenously in a dose of 100 mg every six hours or as a continuous infusion.",
"     </li>",
"     <li>",
"      After delivery, the dose can be tapered rapidly to maintenance within three days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An occasional woman with severe nausea and vomiting in the first trimester may require intramuscular",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    at a slightly increased dose (1 mg daily).",
"   </p>",
"   <p>",
"    The regulation of plasma volume during pregnancy is complex. Secondary hyperaldosteronism is normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/52\">",
"     52",
"    </a>",
"    ], associated with increased plasma renin activity and serum aldosterone concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Serum concentrations of progesterone, which competes with aldosterone for binding to the type 1 corticosteroid (mineralocorticoid) receptor in the kidney and has a natriuretic effect, are increased throughout pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Plasma atrial natriuretic peptide concentrations reach their nadir late in the third trimester [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/57\">",
"     57",
"    </a>",
"    ], when plasma renin activity and serum aldosterone concentrations reach their peak [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no studies of mineralocorticoid requirement during pregnancy in women with adrenal insufficiency. Patients should be followed closely throughout pregnancy for electrolyte abnormalities and signs of volume depletion. Plasma renin activity may be used as an index of adequate",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    dose, but should not be suppressed to values less than those in pregnant women without adrenal insufficiency (ie, 20 to 25",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    per hour supine or standing) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/53,54,57\">",
"     53,54,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis for patients with adrenal insufficiency was poor before the availability of glucocorticoids, with more than 80 percent of patients dying within two years after diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/58\">",
"     58",
"    </a>",
"    ]. Subsequent reports after glucocorticoids became available for treatment suggested that patients with autoimmune adrenal insufficiency should have a normal life-span and can lead a fully active life, including vigorous exercise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/50,58\">",
"     50,58",
"    </a>",
"    ]. By contrast, a study based on the Swedish death registry found that patients with adrenal insufficiency have a twofold higher mortality rate than the background population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/59\">",
"     59",
"    </a>",
"    ]. The reasons for this discrepancy are not understood and further studies are needed to evaluate whether these patients have premature mortality.",
"   </p>",
"   <p>",
"    Studies report significantly reduced subjective quality of life and increased rates of work disability in patients with adrenal insufficiency. A Norwegian study of 79 patients who answered a postal survey showed impaired general health and vitality perception and an increase in reported fatigue. Self-perception of physical functioning was low in women. Working disability at ages 18 to 67 years was 26 percent, compared with 10 percent in the corresponding general Norwegian population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/60\">",
"     60",
"    </a>",
"    ]. A German study reported increased depression scores and reduced quality of life scores in 210 patients, 18.3 percent of whom did not work because of disability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/61\">",
"     61",
"    </a>",
"    ]. It is possible that improved therapy that better mimics the normal diurnal cortisol rhythm or additional therapy with DHEA might ameliorate this problem, but data are not available to address this.",
"   </p>",
"   <p>",
"    One study noted the presence of heart failure in 7 of 22 patients with long-standing primary adrenal insufficiency receiving conventional treatment after a mean of 26 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/38\">",
"     38",
"    </a>",
"    ]. However, the causal relationship, if any, to the adrenal insufficiency or its therapy is unclear.",
"   </p>",
"   <p>",
"    Linear growth and pubertal development proceed normally in correctly (ie, adequately but not overly) treated children with adrenal insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. As noted, over-replacement can lead to bone loss and osteoporosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/47/42745/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/26/20898?source=see_link\">",
"       \"Patient information: Addison&rsquo;s disease (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/19/11570?source=see_link\">",
"       \"Patient information: Adrenal crisis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/0/9220?source=see_link\">",
"       \"Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adrenal crisis is a life-threatening emergency that requires immediate treatment (",
"      <a class=\"graphic graphic_table graphicRef67329 \" href=\"mobipreview.htm?8/56/9100\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Adrenal crisis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goal of therapy is treatment of hypotension and reversal of electrolyte abnormalities and of cortisol deficiency. Large volumes (1 to 3 liters) of 0.9 percent saline solution or 5 percent dextrose in 0.9 percent saline should be infused intravenously to correct hypovolemia and hyponatremia associated with mineralocorticoid deficiency",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      SIADH.",
"     </li>",
"     <li>",
"      It is essential that treatment of patients who present in possible adrenal crisis not be delayed while diagnostic tests are performed.",
"     </li>",
"     <li>",
"      In a patient",
"      <strong>",
"       without",
"      </strong>",
"      a previous diagnosis of adrenal insufficiency,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"       dexamethasone",
"      </a>",
"      , which is not measured in cortisol assays, should be used rather than",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      if biochemical testing is performed. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Adrenal crisis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients",
"      <strong>",
"       with",
"      </strong>",
"      a previously known diagnosis of adrenal insufficiency, any intravenous glucocorticoid preparation may be used because diagnostic testing is not necessary.",
"     </li>",
"     <li>",
"      Mineralocorticoid administration is not necessary in the acute setting. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Adrenal crisis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest replacement with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      in two or three divided doses (total dose of 10 to 12",
"      <span class=\"nowrap\">",
"       mg/m2/day)",
"      </span>",
"      as the glucocorticoid of choice for the management of chronic primary adrenal insufficiency (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). A daily dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"       dexamethasone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      may also be used. We suggest using the lowest glucocorticoid dose that relieves symptoms of glucocorticoid deficiency.",
"     </li>",
"     <li>",
"      Measurement of early morning plasma ACTH concentration is not helpful in patients with secondary adrenal insufficiency because values are expected to be low. In patients with primary adrenal insufficiency, measurement of early morning plasma ACTH concentration is not necessary for routine monitoring, but may detect over-replacement, in which case the value will be in the low normal range.",
"     </li>",
"     <li>",
"      Measurement of urine cortisol excretion does not assist in dose-titration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      The vast majority of patients with primary adrenal insufficiency eventually require mineralocorticoid replacement with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/9/21655?source=see_link\">",
"       fludrocortisone",
"      </a>",
"      . We suggest adjusting the fludrocortisone dose to lower the plasma renin activity to the upper normal range (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Mineralocorticoid replacement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest DHEA therapy only in women with impaired mood or sense of well-being despite optimal glucocorticoid and, if needed, mineralocorticoid replacement. However, this approach is limited by the lack of reliable source of this compound in some countries (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Androgen replacement (DHEA)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For minor illnesses, we suggest two to three times the usual maintenance glucocorticoid dose for three days (known as the 3 x 3 rule) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Illness or surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For surgical procedures or severe illness we suggest coverage with graded doses of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      or its equivalent, as noted above.",
"     </li>",
"     <li>",
"      All patients should wear a medical alert bracelet and have supplies for emergency glucocorticoid injections.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/1\">",
"      Taylor RL, Grebe SK, Singh RJ. Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clin Chem 2004; 50:2345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/2\">",
"      Derendorf H, M&ouml;llmann H, Barth J, et al. Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharmacol 1991; 31:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/3\">",
"      Bliesener N, Steckelbroeck S, Redel L, Klingm&uuml;ller D. Dose distribution in hydrocortisone replacement therapy has a significant influence on urine free cortisol excretion. Exp Clin Endocrinol Diabetes 2003; 111:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/4\">",
"      Fariss BL, Hane S, Shinsako J, Forsham PH. Comparison of absorption of cortisone acetate and hydrocortisone hemisuccinate. J Clin Endocrinol Metab 1978; 47:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/5\">",
"      Purnell JQ, Brandon DD, Isabelle LM, et al. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab 2004; 89:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/6\">",
"      Mah PM, Jenkins RC, Rostami-Hodjegan A, et al. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2004; 61:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/7\">",
"      Crown A, Lightman S. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf) 2005; 63:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/8\">",
"      Wichers M, Springer W, Bidlingmaier F, Klingm&uuml;ller D. The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism. Clin Endocrinol (Oxf) 1999; 50:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/9\">",
"      Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003; 361:1881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/10\">",
"      Esteban NV, Loughlin T, Yergey AL, et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991; 72:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/11\">",
"      Arafah BM. Medical management of hypopituitarism in patients with pituitary adenomas. Pituitary 2002; 5:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/12\">",
"      Grossman AB. Clinical Review#: The diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab 2010; 95:4855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/13\">",
"      Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab 2009; 94:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/14\">",
"      Jacob, K, Trainer, PJ. Topiramate can induce hypoadrenalism in patients takingoral corticosteroid replacement. BMJ 2009; 338:1788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/15\">",
"      Riedel M, Wiese A, Sch&uuml;rmeyer TH, Brabant G. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes. Exp Clin Endocrinol 1993; 101:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/16\">",
"      Li Voon Chong JS, Sen J, Johnson Z, et al. Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism. Clin Endocrinol (Oxf) 2001; 54:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/17\">",
"      Johannsson G, Filipsson H, Bergthorsdottir R, et al. Long-acting hydrocortisone for glucocorticoid replacement therapy. Horm Res 2007; 68 Suppl 5:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/18\">",
"      Debono M, Ross RJ, Newell-Price J. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol 2009; 160:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/19\">",
"      Johannsson G, Nilsson AG, Bergthorsdottir R, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab 2012; 97:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/20\">",
"      Elias AN, Gwinup G. Effects of some clinically encountered drugs on steroid synthesis and degradation. Metabolism 1980; 29:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/21\">",
"      Kyriazopoulou V, Parparousi O, Vagenakis AG. Rifampicin-induced adrenal crisis in addisonian patients receiving corticosteroid replacement therapy. J Clin Endocrinol Metab 1984; 59:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/22\">",
"      Robinson BG, Hales IB, Henniker AJ, et al. The effect of o,p'-DDD on adrenal steroid replacement therapy requirements. Clin Endocrinol (Oxf) 1987; 27:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/23\">",
"      Santen RJ, Lipton A, Kendall J. Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism. JAMA 1974; 230:1661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/24\">",
"      Peacey SR, Guo CY, Robinson AM, et al. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) 1997; 46:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/25\">",
"      L&oslash;v&aring;s K, Gjesdal CG, Christensen M, et al. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol 2009; 160:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/26\">",
"      Florkowski CM, Holmes SJ, Elliot JR, et al. Bone mineral density is reduced in female but not male subjects with Addison's disease. N Z Med J 1994; 107:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/27\">",
"      Zelissen PM, Croughs RJ, van Rijk PP, Raymakers JA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med 1994; 120:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/28\">",
"      Valero MA, Leon M, Ruiz Valdepe&ntilde;as MP, et al. Bone density and turnover in Addison's disease: effect of glucocorticoid treatment. Bone Miner 1994; 26:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/29\">",
"      J&oacute;dar E, Valdepe&ntilde;as MP, Martinez G, et al. Long-term follow-up of bone mineral density in Addison's disease. Clin Endocrinol (Oxf) 2003; 58:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/30\">",
"      Suliman AM, Freaney R, Smith TP, et al. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2003; 59:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/31\">",
"      Scott RS, Donald RA, Espiner EA. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin Endocrinol (Oxf) 1978; 9:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/32\">",
"      Feek CM, Ratcliffe JG, Seth J, et al. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxf) 1981; 14:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/33\">",
"      Merza Z, Rostami-Hodjegan A, Memmott A, et al. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2006; 65:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/34\">",
"      Arlt W, Rosenthal C, Hahner S, Allolio B. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf) 2006; 64:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/35\">",
"      Smith SJ, MacGregor GA, Markandu ND, et al. Evidence that patients with Addison's disease are undertreated with fludrocortisone. Lancet 1984; 1:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/36\">",
"      Oelkers W, Diederich S, B&auml;hr V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab 1992; 75:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/37\">",
"      Jadoul M, Ferrant A, De Plaen JF, Crabb&eacute; J. Mineralocorticoids in the management of primary adrenocortical insufficiency. J Endocrinol Invest 1991; 14:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/38\">",
"      Knowlton AI, Baer L. Cardiac failure in Addison's disease. Am J Med 1983; 74:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/39\">",
"      Flad TM, Conway JD, Cunningham SK, McKenna TJ. The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency. Clin Endocrinol (Oxf) 1996; 45:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/40\">",
"      Alkataib, AA, Cosma, M, Elamin, MB, et al. J Clin Endocrinol Metab 2009; 94:3676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/41\">",
"      Rice SP, Agarwal N, Bolusani H, et al. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial. J Clin Endocrinol Metab 2009; 94:1966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/42\">",
"      Srinivasan M, Irving BA, Dhatariya K, et al. Effect of dehydroepiandrosterone replacement on lipoprotein profile in hypoadrenal women. J Clin Endocrinol Metab 2009; 94:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/43\">",
"      Dhatariya KK, Greenlund LJ, Bigelow ML, et al. Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function. Mayo Clin Proc 2008; 83:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/44\">",
"      Salem M, Tainsh RE Jr, Bromberg J, et al. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg 1994; 219:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/45\">",
"      Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA 2002; 287:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/46\">",
"      Lindsay JR, Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 2005; 26:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/47\">",
"      O'Shaughnessy RW, Hackett KJ. Maternal Addison's disease and fetal growth retardation. A case report. J Reprod Med 1984; 29:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/48\">",
"      Wieacker P, Alexopoulos A, DeGregorio G, Breckwoldt M. [Pregnancy in Addison's disease]. Dtsch Med Wochenschr 1989; 114:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/49\">",
"      BRENT F. Addison's disease and pregnancy. Am J Surg 1950; 79:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/50\">",
"      Irvine, WJ, Barnes, EW. Adrenocortical insufficiency. Clin Endocrinol Metab 1972; 1:549.",
"     </a>",
"    </li>",
"    <li>",
"     Burrow GN, Ferris TF. Medical Complications During Pregnancy, WB Saunders, Philadelphia 1988.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/52\">",
"      Corry DB, Tuck ML. Secondary aldosteronism. Endocrinol Metab Clin North Am 1995; 24:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/53\">",
"      Wu SJ, Tsai YL, Hsieh BS. Sequential changes in plasma renin activity and aldosterone level during pregnancy. J Formos Med Assoc 1991; 90:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/54\">",
"      Fagundes VG, Lamas CC, Francischetti EA. Renin-angiotensin-aldosterone system in normal and hypertensive pregnancy. Response to postural stimuli. Hypertension 1992; 19:II74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/55\">",
"      D&ouml;rr HG, Heller A, Versmold HT, et al. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J Clin Endocrinol Metab 1989; 68:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/56\">",
"      Funder JW. Aldosterone action: fact, failure and the future. Clin Exp Pharmacol Physiol Suppl 1998; 25:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/57\">",
"      Thomsen JK, Fogh-Andersen N, Jaszczak P, Giese J. Atrial natriuretic peptide (ANP) decrease during normal pregnancy as related to hemodynamic changes and volume regulation. Acta Obstet Gynecol Scand 1993; 72:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/58\">",
"      DUNLOP D. EIGHTY-SIX CASES OF ADDISON'S DISEASE. Br Med J 1963; 2:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/59\">",
"      Bergthorsdottir R, Leonsson-Zachrisson M, Od&eacute;n A, Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 2006; 91:4849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/60\">",
"      L&oslash;v&aring;s K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 2002; 56:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/61\">",
"      Hahner S, Loeffler M, Fassnacht M, et al. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 2007; 92:3912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/62\">",
"      Grant DB, Barnes ND, Moncrieff MW, Savage MO. Clinical presentation, growth, and pubertal development in Addison's disease. Arch Dis Child 1985; 60:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/47/42745/abstract/63\">",
"      Urban MD, Lee PA, Gutai JP, Migeon CJ. Androgens in pubertal males with Addison's disease. J Clin Endocrinol Metab 1980; 51:925.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 155 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-92133E1D40-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42745=[""].join("\n");
var outline_f41_47_42745=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ADRENAL CRISIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Choice of glucocorticoid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CHRONIC ADRENAL INSUFFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Glucocorticoid regimens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Short-acting glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Long-acting glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Monitoring dose",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H483556\">",
"      - Symptom assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H483564\">",
"      - Plasma ACTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Mineralocorticoid replacement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Androgen replacement (DHEA)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Mood/quality of life",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Other effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Suggested approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Considerations in secondary adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Illness or surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Emergency precautions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Critical illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/155\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/155|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/56/9100\" title=\"table 1\">",
"      Treatment of adrenal crisis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/61/42972\" title=\"table 2\">",
"      Relative potency glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/30/21996\" title=\"table 3\">",
"      Rx of adrenal insufficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/35/7736?source=related_link\">",
"      Assays of the renin-angiotensin-aldosterone system in adrenal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/0/40969?source=related_link\">",
"      Causes of primary adrenal insufficiency (Addison's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/1/37911?source=related_link\">",
"      Clinical features of primary aldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/0/33800?source=related_link\">",
"      Clinical manifestations of adrenal insufficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/57/16281?source=related_link\">",
"      Corticosteroid therapy in septic shock",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/263?source=related_link\">",
"      Dehydroepiandrosterone and its sulfate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/46/44777?source=related_link\">",
"      Diagnosis of adrenal insufficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/48/22282?source=related_link\">",
"      Epidemiology and clinical manifestations of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/20/24905?source=related_link\">",
"      Evaluation of the response to ACTH in adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/17/25876?source=related_link\">",
"      Hyponatremia and hyperkalemia in adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42855?source=related_link\">",
"      Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/26/20898?source=related_link\">",
"      Patient information: Addison&rsquo;s disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/19/11570?source=related_link\">",
"      Patient information: Adrenal crisis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/0/9220?source=related_link\">",
"      Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17384?source=related_link\">",
"      The surgical patient taking glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/22/28006?source=related_link\">",
"      Treatment of hypopituitarism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_47_42746="Cutaneous findings of Stevens Johnson syndrome";
var content_f41_47_42746=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F76141%7EEM%2F73805%7EDERM%2F59418%7EDERM%2F68458%7EDERM%2F82150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F76141%7EEM%2F73805%7EDERM%2F59418%7EDERM%2F68458%7EDERM%2F82150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous findings of Stevens Johnson syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF7AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDQaR2RTKFwq4Ac/wAqrOolKRRFQqLjPTJ7nFWn0+/ZRusbsjG3/UtkH8qjfTr9nIisbwJjBLQN/hXmeyl2PofrEO5CrM0SqxVI0Uhfl60fun2BmdgB2Pep20zUguRp92e3+pY8flTotP1JZvlsb0KV2n9yQcflS9k+wfWYdyuu0kqQQp6EDoferUO1ZGkZgrR4ARR196emnakrp/xL7sAdCYmJ/lQNN1Hdxp103PQwnBoVJ9hPEw7jIIZJ38tBh5m3FgPuoOTmmrCgvBlt0YOSx4+laD2Go7THDZXx3Hn92RnseaW40bUp3kC2NwjHHHlkg4461fsn2M/rMe5l65AsSRKowGG4sf6e1ZkQEe1Dyr8tzW7qOi6zL5SfYL2bauMmM4HtUZ8N6sVGNKvM5/554pOjK97GscVDls2UsRySBtpRVGCR3PtUafeKbd205961B4f1pM40q7bI67Kemga6xcjSL0sxyW2YJpexl2F9ah3M99sSphxv6lR1FSJOkRdlXDEY3nkj1A9zV2Pw1rmG/wCJTdAtwRs/rmp08K67JvzpNyq9RjGf501Sl2E8VDuYRd5ixXIGME4/Ska2wF3LtzxgnnP+FbK+FPEiouNKujzk7iP8akfwb4gbDLpl0cckswyf1pewl2D65DuYkkY85i8QkKJ0H3frUa+X5Y8xhhew710jeEfEHknGkzE9AoIH580weDPETAFtGOT2DrkCq9jLsL65Duc5JvMcY2lFzlcdx65qyoyrHcD2GeprZk8EeJXbH9my7V+7ulWp18E+I9oVdMx9ZVpOhJ9BvGU+5z0ZZN5BAP61K0ISTchCqffOc10DeBPETA4sQowBjzl59acvgLxD822yRR2zMpzS+ry7B9dp/wAxzwiMaKW+XPBJ6AfSqly5YxtvZXQcZ4/SuxPgbxISv+hwZXBG6defrUcnw78ROz/6Lb88k/aBnNUqMl0J+uU+5yjsjRYII343Ed6imAZ8IrDb19TXaL8O/EBb57a1IxzicDJpV+HXiIIQYrItn7xn/Sn7GT6DWNp9zkohiN4lUfOcc+lPDsVUMfMC4B3DJI9K61Phz4gUdLLcB/z2p3/CudfBIU2QHqZs/wBKSoTXQTxtJ9TlZbhmELSjO3IyaiRCsPVcMcHHUYrsR8N9dxgPY8d/MP8AhSv8N9dYHbLY8/8ATQ0vYT7B9dpW3OJnUZxhflO4kDikKAgDGOfvDvXcn4b62RhpLA5PTzD/AIU3/hWOt7gften8c8s3Wj6vPsP69S7nIFYlRNgw+Np4yAaYqEkqx+TgIO4rt1+GesE7mvbBWzk43VKnwz1TcCdQsRj2aj6tPsJ46l3OHkUKAoL/ACZ6+lLGkbqxcYCgYXANd2fhnqTOWOp2YOMfdamp8L71eDqdp7nY1H1afYX16l3OEkCgDBGBjpzUc4GTtwAvdulegD4W3wK/8Ti3VQckCI81KPhdcE/Nq0JHf9yef1o+qz7CWPpLqee5IiOMEAfnUQk+ZQTjI+Y9gK9JPwul2bRq8Y9MQnj9aaPhVJ31pfT/AFH/ANen9Vn2F/aFPuebsNoJULGuOM88VG3AwWB9cnivTj8K89dY4/64f/XpT8KlI+bWmz/17/8A16Pqsuwf2hTPLSWz1AAGRt7+1RAPySAPUbuRXq4+FKgjOtNkeluP8aaPhPEXYnWpOTz+4H+NP6pMf9o0zygkA46D0FW48soCBQep9a9O/wCFT2+CP7ZkIP8A0xH+NPX4VWoXDaoT7+QM/wA6PqkyXmFM8o/jBJxg/n9afN842pu29R716o/wstW5GszqPTyhikPwqs8/NrN1+EYFNYWYnmFM8lUEMAAOfXpQJgSd4JU8c8f5NesP8KLFhj+2Lv8A79rTW+E+nH72rXhH/XNaFhJEvMKbPI5m3lN4Ygeh5+lLETweq9efXtXrq/CvTVB/4mt7yMfdWhfhXpC8nUb0n6LT+qyD+0aZ5RA8JiO5ZPM9R0qIjeBuI2jj2Nevf8Kt0jcS2o35/wC+f8KkX4YaMFwb2/I78r/hR9VkR/aMDxtVKruAB55BprI5zkhFz24Fezj4X6Fgg3eoEZz98f4Uq/C/QAD/AKRqB+sg/wAKf1WQf2hA8TUbWXdyBzUyH5GABI/hr2f/AIVh4dyMyX5x/wBNR/hUyfDXw4i4/wBMJ9TNQ8LIP7Rh2PEVjBlxICEx29aghjJJ3Z+hr3cfDfw2p+5dn2Mxp6/Drw0rBvIuSR6zGh4Ri/tGPZnhaqGwDwe3tSvGV2kNkfyr3U/D7wzu3G1mY+vnGnjwD4Z6mwkP1mNJYSXcX9ox7HgxAORgZPWivek8B+GAcjTAT7yMaKr6pLuH9ox7HUmVsfeP50nnN/eP51ETxSda7zxrkxmY/wAR/OkMrYPzN+dRUUx3JDKxxlm/OjzGz95s/Wo6DSFck8xv7zfnR5h/vH86j7UUDuSeYfU/nS+ax/iP51FS45piJPMb+8350m8j+I/nUZoHNAEnmH1NG8+tR0tIZJ5h9aTzD+FMFGKAuPLk9z+dG8+v60ykzQA/zDShyO9R/wA6BQK5NvoD1D3p1A7ku/FKZPeoc0uT6CgalYl35FOD1EGIHTpRv+lAczJd1KGqENRn3FIfMybdRuFQ5NGfeiwuZk2+jdUO73pckZyCMUWDmZNuo3VDu9aTdRYq5Pvo31X3GnBuKLBzExc4oBqDeaUFmPAJoDmJt1G+ocnn2o3UCuTbhRuqHfSFhjjrRYLkxfpzSbqgLc80FjmizFcmL8Um49qh3ckZGRyQDyKQtzQPmJXkOO5/Gm780zdTT60yeZkm8880wv600005waAux++kL1EGUsQrBiOoBzj60nmR4B8xNrHAO4YJ9AfWmK/mSl/ejeaZjFApBdjt2KXf70wUuBnHemIXzDS7zUCTwvM8UciNLHjeqnJXPTPpUMOoWU901rBeW8lyn3okkBYfhQHMXN//AOuk3nOc81GkiP5io6sY22uAfun0NLQK9x+80b6ZRQFx++ioZpY4IXlmdY4kG5nY4AHqaKQXLlLUclzbxxzSPKoSH/WH+59aUzRCVIvMXzZFLIvdgOpFAx+PzpOM1na9cKfD+ptE+SkbIxQ8q3GR9auRyRxC0t2cCVoxsUnlsAZNAr6jb67t9Ps5ru+mWC1hUvJI3RRXI6D4ru9V8Vw27fZINLubYz28ZkDTNg4G49ieoXrXWXc1jPZzfamgltUfZKJACgbPRvfNVINC0WDXYryKytotQWPC7VA+XPLBemfeh7A9WS6XcTXEmoiUrsgumhi2j+EAdffmr+KydEljhsdQuJ5Akf2yVmdug5ArW8xBOISw81lLhe+0d/pTYJ6IKUDv2qIXUBtftIlTyM7d+eM5xj86pyB28U2+Cdq2T5XPGSw7Uh3NE1heI59aivNPh0WNTFLv8+TYrsmPu/KSOK2PtduLdZ/OTyWYIr54JJwB+fFU9U0rTdVuoo72MvdW67lKyMkiKfcduKBS1Whk2esXM2j7/tIkvEv1s5w8AjMZzyhAJHTv711DgBiO1c9e21lb6do8GmoqWrXyFdnO7qSSTyTx1Nb3nI1zJErAyoNzL3APQ0CjuxaKhW+t2t4JxKnkzsEibs5OcAfkaLiePy7yNWBliiJdf7uVJGaCromqvqVybLTLy6VPMMELShfXAziq2jyRQaPpUcsmHliVIweSxxnFXBdW4+0/OCLb/XZ6IMZ5/CgV7nE+HtZ1CY6Hf6neXQg1Q7FjCxmIsQSFCj5lHvz711mnTSy3WpCVwyRXHlxj+6ABx+dQ2mmaJZXsFxZ2ltDcXOTEygknjJ2g8Dg+1GmSJbrrM8rBY0vJGZjzwAKZKujU7inVCbqFbi3hZx5lwpaNf7wAyf0NMe/thDdTGUeXbOY5T/cYY4P5ikWixkZAyN3XGecUv51mtGD4sjbB3CxYdfVxVn7dam1in80+TLIIkOOrE4x+YoEpGL4xdLG1bUZ9W1C12qIorW1dR58h+6qgg5YmmQrqul6DpMWoXss2oz3kYuJGwSobkx/QDit2VbSe9VJYopbm2AmXcmTHnI3KfXiqGrTJdQaPPAxeKS9jZW9etBLSWq3Nlupx0zQKhNxG1zcwq2JIFEkgx2OSP5UxL+2aCzmVmCXhCxcckkE8/gDQaNllmCqWYgKBkk8YoBDKCCGB5BHQ1n6rLFPpmqwHJMULJJ6DK5FSWsyW9np0LZBlRI4wB3C55/KgV9STUZTBpt3MpZWjhdlZF3MCFzkDvXnPhq+u0m8M3cupvM97IVuo0u/PMmQcZjx8gHf0r0b7ZEq3bbmH2XiU4/2c8evFRQJYQXML29tBFcXSlleOEKzDGTk49DQJq5HpJkM2p+ZK8gF0yoGOdqgDge1aGazLGZYINVnlz5aXLscdegq69xGt3b253eZMhdMDjA65/OmJPTUmzxTTIglEW9fNK79mecetVW1CAWk9wQ4igkML8c5BA4/E1GU/4qlM43fYSM/9tBSHc0M5xXIeOXI1XSkuLpBYMknmWhuTbmVuzbx2HpXQ/wBpQmwN6EfyfMMeO+d22p3khkvmspYw7rH52HQMuM4796AlqtzkvDE+oy6JZteSS7F1Mx2zMxLPBzjLfxD0Peu0Pf61k3lzFc2umXEYYRvdIFBGCOSP6VdW5Rry6t9j7rdFkY9iCCRj34oQJ2LGabJKkSM8jBUUbmY8YHc1Ui1GN7ewmCOFvGCoDjK5BPP5U27nSaHVLYK2YISGz0bcpIpjuXEkWREeMhkYBlYdCD0NcvBBcR+LvFH2AyC4msYniZySvm4IGM8enFbFhcLBpujRFS32iNY1x0UhM5+nFSyahGq6gTG+LH7+P4/l3cUCbuefaTFCzaAmkQX0XiVLhf7QaQOMJ/y180n5SD2x7V3Wija2qYOR9ukxz24q79tHm2UZVz9qUsp/ugAHn86zLS4Fna63csN4hupH29OMCkTZI2aQ1A1yBfWltsP+kRtIGz0wBx+tVm1RBptxeCJtsMxgKZ+8dwXP60F8yLZnj+1C23gTFPMC/wCznGfzp4OCD6VQdCPFEQ/6dGH/AI8KR9UVdN+1+UxXzfJ2Z5zu25oJ5rXuZnhjT1tNc8TQ+QyWs1yjqWJw4ZPmIP1zWVo1p9h8KaRbSQPH5erkIkg5C+Ycdfauza4H9prY7Tu8oyBuwG7GKyNSuhfaNY3QRkH2yM7WOSMORQS12Nw8E/WkqEXG/U57ULgxxrLuz1BOMVUXU92m2d35P/HxMsZXP3MsRn9KCnLqX5WEcbu3CopYn2AzTLWdLq1iuIsmOVA6EjHB6VGZ/MvL20ZAEjgD7h1bcDx+GKpWF19n0PScpuWXZDycYznn9KB31KlhYmz8X69cpbOlvc2sT71HEjjO4D3rnNGjkl1XT7i58OXmnpaysbe3t7dQsZbjfLKTluucV3LXhF5fW5jz9mhWUHP3twJx7dKjbUCbPTZvLBF4yKRn7u4ZoIditpAK6v4gBA/4+1Ix05jFapIAG445rNtiIdS15wMlSkgHr+7/APrU4ag722jymJCL5gHH9zKFuPyoGnZW/rc0Mc1XlvI4r+2tHV/MuFdkb+EbcZB/OoWvXxq/7tc2Zwn+18gbmoZpPOvdCuGABkD8f7yZoBvaxpSokkTpKqvGwwysMgj0NFVBdyMdUG1M2pwnuNmeaKBcxUv1xofiRsZL3TDn6qK05EB8U2AwPktHIP8AwICs25+bw9qBBz51+QD/ANtAK1yD/wAJbEOyWZ4/4GKAWv8AXmY1wP8AiktYYYBkuJPx/eAVqTRhvFGnDoUtZGz+IFZj5fwY+Rgy3ZH5zVrsAfF8I/u2bfq4oHu/uMK5QN4XvxtyJtQ6f9tQP6VtMA3jJCACUsjxjplx/hWUvz+GICePM1Ecf9tjWtGpPi65bslmn6uTQxLb7jGx/wAUbeY58y5kH5y4rZ2A+K92DmOywT9W/wDrVkwqG8G24wcyXa/rNWwpz4kvxj7lrH+pb/CgdtjG27/CEG4L+8ulP5zVsnjxTLn+C0H6sf8ACsuJQPCukr2kuIj/AOP5rVBP/CRakSPuWaYP4tQgjrv5fqY0cefCmjrjO+5iP/j5Na0WB4m1OQAfLaxj9WNUIQT4f8NrtOWni6fRjV6F8atrz8fuo41z/wAAJoBf19xkWqbdF8JR9N1yh/8AHWNa1moOt6y+eVSNf/HCaoQoBa+Eo8dHDf8AkM/41etf+P3xG3QqVH5RUgX+X5GZbjOheGgAPmuY88dsOatsdt14nfHIjUf+QiahjTbpnhVOn75Dx/uNU8oxH4qf2Iz9IqYhgUD/AIRdD127vyj/APr0kpH2PxS2APmdfyjFTbR9t8MLjJELn/yGtQSgf2T4qPfz5R/46BQP+vwRK4H9o+GkI6Rufp+6FVZsDQfEbdCbibn/AL5FaDqf7b0Bc8CCQ4/4AtUZVP8AwjGttkZa4l6/7wFAf1+BauVH/CQaEvXbBL3/ANkCqN0NuheIT3a9fpx3StO5B/4SnS1AGBbSnPp0FZ12AfD+skch79s5/wB9aBPS/wDXQ1Dx4rIHRbH/ANnrLt0H/COaSDnm8U/+Psa18Z8V3Gf4bJfy3H/CsuEf8SHQcj710h4+rGgfUvxn/ie6iMdLSM/+hVnQjOj+GgRwZ4z/AOOsa01x/bmq47WsY/Rqz4P+QV4WwM5lTP8A3w1A2v6+aLcR/wCJzrhPaCP/ANBaqUA/4lvhQf8ATVP/AEBqvIoF/r7dxEg/KM1ViXNl4V9Q6n/yG1MGh033fE5J4Cgf+Q6mcAvoAz/ED/5DqKYfuPFJ6Eev/XKp5lzceH8nGDk/9+6m4W/r5kDD9x4lz2OP/IQqcki90Icf6p+c8/6sVFKuLXxKTyCT/wCiqmZcajoP/XF//Ra0wXb+tynNzo+ufL/y3k6f8Bq5KQNe0oYOTBL/ACWqkgP9i6//ANfMn/stXpVP9u6Vxx9nl5/BaBLp/XUy7jnw9q2/p9tfp/vrWowH/CVIQP8AlzP/AKMFZ1zz4e1Y44F63H/A1rUYf8VUg/6cz/6MFIFuYxH/ABSTf9fJ/wDR1auf+Kok562Q/wDQ6zP+ZUb1Fyf/AEbWrtz4obj/AJc//Z6Yl0+Rj252eH9F/wCvtQP++2rUi/5DerDp+4i/k1ZkQYeHdG97xM/9/GrUiGdf1UEHH2aE/o1A46/h+pnWw/4k3h4jnEqfyaraj/T9fPHMSf8AoBqpa7RoXh85489B/wChVdiA/tfXF/6YIcf8BagVv6+RWiwbTwyc/wAa/wDos0sylh4mTPDKMe37uiE507wyR3dP/RZp75+0+IwecRr/AOizQP8Ar8AJ/wBK0BuOYm/9AFVZxu0zxKP+mr/+girCf8y4/qMf+Q6ikH+g+JwDn52OPT92KBMuNzrWjH/phJ/6CtZlzz4ZvwB0vW/9GitXA/tXRjjrA+P++VrNul/4pvVtva8k/wDRgoA0pVA8T257/ZnGP+BCshlH/CMycnC3pyf+2orZnU/8JLZN3NvIP1FZcwC+Gr8Lj5bxv/Rq0BI05B/xVMOV4a1YZ/4HWM4x4ShYnGy6H/o6tyY7fE9l/tQSfoQax7iML4RulbkLck/+RgaYPr8zURR/wlM4Ixm0U/8Aj5rJT/kWtNK8hbtP/Rhra4/4Sk8cmyz/AORKxyuzwva7Tjbdr/6NNAT6r1NMD/iorxeObVP5kVmxk/8ACPaOQM4uIhz6biK1hj/hKHUDg2g/H56ykGPC1gRxtuUH/kQ0DbLmD/buqL1DWaf+zCs9cf8ACPaAXzlZ4Bn8xWsVx4luRjlrMf8AoRFZIJHhLSWOTtuoR/5EIpEvZl2JT/bWuoe8MZx/wBqoxEnR/DLHAxNGD/3yRWrEmPEmq4Xl7aI/owrKjP8AxTmgOOi3cS/+PEUD1vf+ty5s/wBL8QjsVU4/7Z//AFqgjO628Mv2LAf+QzV2LB1fW4yMjyoz+asKo2xX+yvDTnkeYoH/AHwRTE1/XzLduu691pSPvFT+aUVLbD/icaso9IT+amiixSWhTUg+GrQsc+bqSjI/67H/AAraQ7vFN4cf6u1Tn6sT/SvL38QayttHFBLF5UDLIR5Awr5zn8zmnz+JdeVhcRXkazSjZLI0S8qOmPzNc31mB6Ectq2R2iDPg7Tg3PmXcZ/OUmtYEnxbP0wlmOe/Ln/CvLoPEWsNbWlrFdoADlY/IAEZBypHrSt4l19J2k+3KLhx5bN5C5IHQY/Ol9ZgV/ZtU7uBQvhzSBjPmXqkf9/GNakGP+En1Mg/ctoh9PvGvMRr2txxQxG6jCxHdGpiX5W9aki8Ra1iS5+3FZZdodhCvzDnAP60fWoB/ZlXb+tjtoxnwno4x9+5hP8A5EzWquRr2sydAtvGP0Y15q2uaw6wQwXZjSPBSPylwpHQ0v8AwkepmeVjqD/Ou2TCLlyBxn/Cj61Af9mVbHcoo/sPw4gbG6aHHvwTVxnC6nrjjgx2yAn/AICxrzOPX9c8qHN9nygHjj8lf3fYH2pV1/XXumVtQKGYjeSi/MOnPtR9ZgH9l1VrdHoKDZY+FI+pMiHr/wBMyalLhZPFLjnYo/8ARNedx6zrU0ny6gxjtBkMUUBO3H4VRm8Ta0wmaG/lMDH98/ljDdvTnjij6zAFllXv/VrHqKqPtHhaPv5bMPwiH+NEbfJ4pk64Zs49oq82/wCEh1pZIn/tCTfFGVXMYJQn044GKkk1zU4reUjUZN8pG8ADDnvnj0o+swH/AGZUWzX9Kx6II8Q+FkHHIbH/AGzqGZs6b4rYdpHX8kFefNrOteSkn9ozkw8KSANnbA464qFtZ1txIovZljk++oA+c9yRR9agH9l1H1PUXUDVvDq4ORbydv8AYUVSnOPD/id8ZH2qbgj/AHRXnH9v60LiPZqdy5TIDsBwD6exqa11bVZY3WS/kCZJkDn5Xz3P5UfWog8rqK93/VrHqUoH/CT6OvdbWQ4/BRVCTjwpqjAj5riQ5xn/AJaCvNbvW9VlvWlg1C5ij24Rc5YeoB6gZot9S1j93Hc39z5LN8w3cZ68ij61Af8AZlRq7f8AWx61Mh/4TCx4JIs5DnH+2tZ0kZPh2/ByM35P/kQV5vNrOpiJj/aN0ssZI8wtyw/wpl/qGowssa6tcsBhmVW4Y4yT9c0fWYiWV1G9z17Df8JNqDDtZJx75as+GL/iT+GB83M6H/x1jXl51XUmhQx6jemVgd+ZOT6c+lVRqerJKivfXR8sggF/lH09Kl4uK6FrKZu7ue0op/tfWDzxbx9unytVK2Q/2X4XAB/1if8Aotq8tl1K82lk1G5bzMFdshG72PtSyaleTLCiXtyssbAFhKef8KPrS7C/sud73/q9z1oRkXPiInP+rUfT93USxE2/hjG7Csp/8hmvJILm+uZJF+33YIBYs0rfOf7uKhEl+ksYbUJ1OckGVvlB/lTWJj2G8rn/ADHsVypNt4lAUk9APX90KmmX/TNCBHAB/D92OtePXd9e3JJhmliQEL8sp6gck+vFUlmu5IkIvJy5YgFpDx+tJ4pdgWVT7ntE6t9j8SAAkszY9/3Y6etTMD/amhcZAgkyf7vyL1rxfdchWK3FztPGfMNRJcXKYJuLhs9MyNg+vfpR9aXYayme9/6uexSKToeugDlriXHv93p61emAOuaS+7hYJAeemQvWvHLnEUUX+l3EiyHcHZmXj2HvWTrEk+4qZZ4xgbU8w8ClLFJboIZXKT0Z7Rcp/wASDWF/iN45A7kb15+lahKnxUjbhj7Gec8ffHevEbAt9nbzppnZQCDvP5Z70sEZM5UyShW+ZhvPHvS+trohrKpdz1ggL4WlTHz+efl7/wCtznFaO5P+EoaQyJ5f2Pbu3DGd/TPrXi7xOu4B5PMOAvzHgVJJGTED82ecLkhRx1+tH1xdgWUvfmPTolC+H9KR3G9b1SRuGQPMY5/KtOF4hr+pu0sflm2iUOWGCRuyM145cRxx2oDFsjjO44HtVRQgaLazOMbghz19KHi0ug45Q/5j1iN1XQNCQyRq63MZdSwyo3Nyavi4txq+st9ohw1tGFO8fMcNnFeLiAyyBFXDHOAx9exNTyQHYQAPlGfrS+uLsNZQ/wCb+tj1WGaEaZ4bRriEPE6GQbxlPkPWpnvLVbzXSbm3xJCgQiQfOQhBxXj8kQwgVMs3znnGfaiG3jgZ3AUsmD+FCxnkDyn+8etx3dsIfDxNzAPKx5mZBlP3ZHP40176z+z+IF+1W26Zj5X7wfP+7A/nXlF5EHhUGPPzbmUDjGPX8agkt433hfukAH+hpvGJdBLKb9T2ZtQsheaNILy2KxoyyHzB8uUH9aqXN5YjRdXhW9tt8k7uo8wc5YEV5ZJFHJyir8qhW46H2FQraJ5IWLYMth17n/azSeM8h/2R/ePYpdX0ttd05hqVr8sUiuPMHBIGP5Gs64v7A6Dqlv8AbbUyy3TvGvmDJBdSD+leWS26CQbYxsXBJAx8o6GpDYnyvMwvygMSeqg9KSxl9kN5TF7yPXrjWtL/ALesJRqNr5UcUqu3mA7SduB+ODWdNqmmt4c1G3F/bGWS4dox5g5G8Ec/SvMUtEWAZA+XJ2j+H6/hTmgVWCuARtxwOCO3H9aPrnkDyhfzHrja9o6+IUnOpWvk/ZfLLbx97fnFZ76xpf8AYZtjqFr9oFx5gQP28zOfyry57dehVVOecdwO9SCFVjydrO/8RGPwpPGeQ/7IjvzHrn/CRaINfFx/aVt5P2fy92ed2/OPyrN/tzSk8OxWv9o2wnSYNt3dR5hPX6V5qkPly7ZIgwA3Hbxinz2yArxsU4ZR1Ao+ueQPKI9z1f8A4SPRP7cN2NRhNsbby9wJ+9vz/Ksga5pQ8NWtr/aEBnhnSRlycYEhP8jXn4EaMHQ7MA/MRkk0hgUWr7sksQRtGPrmhYx9geUR6yZ6kPE+hDXLm8OpRm3e3WPIB+8CeMfjWWmv6QugWFo19F58F0srKM42hy3X6GuACh8AAbSNzADH1NMnhMKIgIPzAjjkE/z4o+uPsP8AsiPc9QTxboS6xfznUkMM8KIuEOcjdnPHvVGLxNo0Gj6TDJfJ5tnKkkm1SQFBPT8689WIRuwZSrBd3+9ntikMIKFY1+Zlzx0NL66+xX9jw7np8Hi/QY9YvZmvSVmSNUAjOcrnP8xRXl4iDQx7hnHLEjoKKr64yf7Kh3Nm5jntriNiWPn9v7y9qksrUM4eY/Ls4w38XpVsutxdyXU8kbrDhAzD5RjgnFPsoY5bllRjCGO6MudpKdzXHuz2H8NmZ90YhqcKRh128ks33cfyqSJgs4upCzOgKrkZVm+vtTH8ky3Ny+8KDsiRP4iP881Zs1iIgS73Oix7sL0HrU8zbK5UkQW6phTKCzsCWyPyxTn3yHyTEoBbJx2qZg7yOI9gaTDMueg6BgaXyo953MdwI4U/eHf60rjStqNMJhbazvtIx5hHr6VFcDNy8kSIiDbhBxk/41blEkpiQsBkH7/G3FRTrHHJEgyREAzA9yTRe6FGKvdisFj2vKwk3MGbH6A496gmiIiSQKN3UADjHr9auPIzII02oigkKo+96c+1MgZkTe7M8sgAjXqcdx+NO/QSh1KkkEKooRTIS29wX6Z6rin3HMMsMXz27Sgkou0sPT29KUNMu6L5AuSpAGcHOSM+1TGPzP3jny4cY3dSD60+cHC2pDbkpeSFonV5SWAboB0H6UsY8nYkkGG5k5GQc8D8BU5DRMshHmMMNuLdF7AU2JXuH/eljt43frtNJSsHKnqyCaKR5II0RC0x+VS/cdzS2lqbmeRpQXOSrRxjHC9anuFe3MM6IBJklXJ6n19vYUlpKjWrpEH88naXBwBk8l2+nanfUlpuOhn3zqtx5agHcxwQOgHQVea2TNrFAMhVLMxPDsOv5UzULWLYbrT2M1nFjYx6s46kD0FT2SvbRyz8LJIMKM5K555Hai9nqOSTimilZN9nugyBXkyxGUyWyOijtR5KTxNIYmTEhwAfvEdzVu3RoypI2yLlt+eQPWo5ZPl2lXMTFizDqV7YoUhOLvoZ1wRIhVifMI35HT2XFXdW0uO30yC4jJ8xlCyjurkf4U+JQL95T88anJdhzyOuP6UtwZmt4bZNxEkpkfd6dgfwp3umNxd1YitIYFiRwQ1wqDKAcAelUryIzaiUgByV2tn1PWtu3PlgtAiGSU4CDsBxgms6R3hEiQuRhlQuRyT3/Ck9hwjqxbG3JniXCuoYxhcdGPHJ/WoLnTCnmwh1WWKc/ODwAB+tX5JjbzxhMCSAcBRjcSOpqvLHHOUjlAj3SjfKSSXPocfjTQJO/kUgh8ySeMDy8Bgc9xxnHvUl8XgmM00K5C5KE7Qff3PfFaN4xtI7iKBo5IRHh8KMuCePyqkh81Fj4A+9K2MkD0BNO9hpdStdWxGkrKzbBJkquMH3NQwp9k8xTFvdUBAznYTV29nW8htbW2Rvs8Cnvz1qIpLJvjk37BhumCefX0pNjjHTUbZukRQXHmfOSknPAyPlq5rEcFtM9rgSSJGFATohPOSe9UJ0fzGjQgbyFZcYAx0PvWlamGaCRJ5mVI1I55Lt60k1YcoWakUCJrk23myP5ajC4GSMdgKpajCUuZAwJOeO9dRYW0Vo1pI26VpCWTjnOOwrK12Xz7i1KKImbO/nJHP8XvU1F7oUZXnZLQoWDN50QI+bcBt/vL9av25USFgdoBIDEd/61nCNjGk0IYgZ78ZzWpHbzIFLbEUc7hztOaiLNJxSBwqiN58hXOCcdPpQys8f3RwvyBj+uKWYlpJkm+Rk6jPSpFb7MWd9rleCCO/oKpWZm1ZGfdQ3E0DPtPkoe/Y1nyq8csYT5nPzCum+0xC38iTeoKDai/xOTz9awNRiMN7JHgYQ5IznH40pq2ppSvJ2aLaJvcbiC+BuLDHvRkOWfJQ4yo7KfT6VTtL7nE7FkztU4yw9qn88M2GVj5fdR1HoaV+octtC6gSREifLZIK4wDu9Kgu4RDdxSQsGyOhHWpydrHYV3MAGz/APrRdqGCSLvO35SCeh7D8qq5CjqVlCvb3Gzdvzwq9OtQIcx5VMkqcH0wec1p2Ese4HlQsfLL1Yeh96qSwLDqh2EragBgxPUN0BpPuVG12hF2rl4I/MKjcWJxjipZAhjVWTZJIoORUewo7EJ+63eWATnaP7tSLy6bzkjjOeEwO9K4ctiGVVjjWJ1KrjDHOT17/4VIdwiG4Z2twv94GpZDmNiwBbZ2GeM9ag3SRwbEznHQjn60NglcjnOxBIBkMPur/Dj+fFSSKhiWSNn3cHDYI29qWE4i5cYUYIPaq8eESMOoJyc80XHykvDXJb7qbQjL2J9KRi2YwwViOVPp9akeNnmELgR7mADE/L7ZNVWJQSZ4kD7cDoT3xTuKxLJlXLLIhIHIHQe3vTX/ebA+8Z5G2iRMzE+WB0+imkiZdpIBVUbJI6ik2NIiLBWKsACxxknpUlrOZNwCliORnp75pzBDKZEUShcMVH8Qx1qtB5ccwl35LscjPY9jTDfQ0IozIpdQCyLghht8weopkW428YAy8bZzj8qYkkjoJAx2qxXAPQ46VagcuFCrhwep7rTuQ0VPKd5ZGYYbbnJ/kKmVPKCkgK4AOPTPc1OqzFh5YDIqk5/vc5olR5I0L9WQn5R1FK4PsVZFO7AI+QlVx/F3op6hlkXJwmOM8kf/XooQrG5JtWCO3jLLFu+Y7cfTnvVWaNJZXkRCd3y5Y9R3IqxcESXDO3zLndgc4H+NECqp87buUn/VgdR6mqvdhayuxm6EyouzaNoAC/wg05Y5Ysqz5K/KAv3QvXk96nuIIoblAzBpGAY46A+9QbXDFQpQZIBzw3vSaBWauKWjnkkZ8uigFQOMAdqnjaB4ricDYAVVABnb9D/WkgiECNuKrJgMSw4+n40+W3SKFC28vlmAPHPpQk7CumSwr5BSUBbiTbgnoMmqLAG6uG24MgAVevJqSVX3Qwpk/NllIwQfT/AOvSSqYi5jG5I/vN/ePpTbCMdbir8scQCkso/eMT29B6U28LhhKBHsbkBeMUwRShFO8nzTygPKg9/pTZF8tywiHljCFC2Se5x70ikiWSN08qJykcOB8/pnk/WgvbzT+RChkjLhgzttGB/SlYb3kyUywAVQO/ovvRGIIFkJcibIXcsecDHp0HPeqsToJKreeSMI7nbn+EenNODkI8cMrbACwb+IvTE3AKrYVvm37unsfrTo4VSFWLqjZzu28hO+D60IbSQSzRzxW+wNgZG1uhf6e1RXS250jy7V5nkkbAULhSwPJ9+KberAqXTQkiKNQIueWY9ePT1qWFxcNbw2hkVEgIUkYBP8R56Cj1EtFoSxMPsbQwKY0C7ZOOqnk4HtTLeF5C0Y2uMZ9M+/4VPpBIsHkkZtjozAn/AJZkcCow6hw0eAFTqe56cehofQSSV0JHCHuyjyHPCMfX04qG9gMTFlykYynzck47D0q69tsKgKQ6DDMDglu341BdO86xwq/Kg7yo4HYk+9IE30IxGUNw5KGFVUGQ9z7Cmy5jKBm2uxAXPPy9eanEjJIkSZcLzjA5PbPtQbV0t/LneNpXlbaqcsD659BR0uh3s9SvsXakyAeWPmXacHr2pqMsqNIxG0szrg85/rTY0eZ9nyHBKnbkknsoHp71Ut1ktNVMdwqq0OWZSe3cVLdrFKO/c0LW2SRnkZ/k3AJgfK/HI9sVXmhLSpHJIoWEbmKHOOev1qxaTqbZcsNwz5USdQSen/16heJrcFmQhVQeYM9yeKt2tcUbpu5Hqq4W2jtykMZBYyNzvGeGb39qJbuN9HjsI3VSeS6JksCe5qaG1a6kdHVBGGDBnbPy/wB3HrTYLhlcQxRqJEbb5uMcE9h9Kadh6JJdivpGwS3VvFnepATzP7vfgVb80zX8NwXUxq/kNsXG4e49M1UigW01CSQvnzEd0fqQ3YfWpLBHMMDNIpjjYNlR8pc84/z3ov0HNXuyG4sLqG9uJHjG9JNhLdFH0/GiC3muZZnOPKXEc4Trgelbfm28byG8AO5Wmmyf9a2eBn2qvFC0cW7d5bufPnwvCLjge9FlczVRtWZFqOomJ4YyEYRwFEB/hJPXPqBWTfpzGpYSTytls/3j05+lX7gQSSPcRRhwD8qHqSect/SqU/lmNAiAiPJ5OMZ6k+pNTPU1prlLJ8uzs4YJpWdPvbFGDx29ue9Q3V3tk2jeGUZ4PFVXLSxq7bSfujnJyPWql1l4BKcgE7QvcCpei0NI003qbCFHj8zzEk3KBhu5NPgR5nTdHuCEbyOvHY1gQSHeVJwFH8Qz+FdCjrbtG0LgLIg4zgv70J32FVg4ia6ii8iKLkDJXaeDnnisi8jUefKzea0jDa44Ct6e9adyzeQsuMgHgdhUdjpT39lPcKzFYSfk9fenJX2JhLkSbMRh5e4gZK4HFPgmYsdxOCMD0P1q09iwgTCgI+TVS0cQ3BlbJVRyuMjrWXkdF00y7YzlpXV85LZGehPcVdk82O4ZY2O4ZDMx4J/xFQwxW6RXkkYLs83lRDt0yGHvVmNG24lkAaPBAbuR1NX5GEt7j7VVW1bzQE/hG3qWPb6Ypvnq7rLNFGIWAQKBuwAMZH402JPP4wI1b5lBPOB1pjsUHkAxMsZYrKv8Q7U29BcqbIoAyRggksx6dSf/ANVWI7NnCyRlE/hePqdw56fSmRqqRKcIM/KDkk496lkwpHz4UjIZRyR7H+tIb8hHDs8jcADt6ii7dGjjjRflD5V+pYdqccRSKRyzYAwcbTUeHaSJ3XaxJXaThcjvT6E2e4yJVM2HwQSVyfU85okRgxSRU3qMoT60SlHXf5eechhxkipCT5mZQFZjlSemR2pFXHQSARSRSqwhVPMOR/EOmKpvG32zDNgqgYtjGDirUsnmIHKk+YpJx0BqnJNuuERjlHO0NjBB/vH29qbYoxadyaVSsrRhduSAcmqyxZ3p1JJKFuM+ualmj89vvlgDuMh4z6mmzMwCo+fLMe+NyMY9x7Gi19R36BbskMsiJjckYO8dAT2PsagRQuN6oGBww69ehpbHzBBcIMedIAV3LneM9PqOuakA8u4ELkSrgoWA/X8DTewrWbTBCBLIrIcFgdoPQ+tWYZE2jaGGVJOO59apxKzFt5Jy2eO+O/0q3GuxRuOzcre2DU3E0SBXQBewxz29hU+0Ex+W2xlJYpuzt45/Co8thRIflCZyw4qS1IjIl2o8gboRxz2oIZXiCFEPzMGOT7mipAjpIxdQFZz8o7D0H0opDuXHfO2WVRtRiMZwG9//AK1XIlmMbvBlduFAHvzj3qvdfuYotreZKoyqY4TPY0jS8RqVK7eWAJy57/nVg3zLQhuXbcFMqnszEevbNWPNLGONTlQ6ggn7qj1+tPIX92LgBSH4iTGAmOpP1pH2xIWjAVHAOcdvT86EgunoWY5kKmaQbVOdoIznnj8vWopsuy3X3kz8pJzkdDUv2KeGLDshhUbWOcn14/Cm7I5buMb2MKkM6/dJ4p+pPmiy+N7byAAfMOTz06E1n3EmYY2/hD7mXoOT0qWRhNGYoozuY+acHOMH+dRDaIRJE4dwcBMc/wD1hS3GlZj5xGY5mkZd27lQ3t0qnHG00e5kBTOIyx27vUCp7eKRkaXcPKGWDlclmA9KsPYxT6VDI0qqQu6Rd3JJPGBTSCTS0ZFjzLp45HUmNSxYcZP/ANarEzwrYxpIEfdgkeg+v1qlcfaY4rjdEhEZQOe59uKfDctLkyAeUOAr/dAB/Wne2gcrfvCIzG3AYiQv0yOvr+QqWyVZJ45Z9vPVM8AD1pjCSOZJZDmFV+7jBwalV40UquHDNk8YYEdOaBy11IC2bp1kCpCRtDlfuDPNLdTSXDCCNyD91sDPyewqSA4mmEkO+buxOdu7uB3NSabGtvGcqZDK/JPBIB6/hRu7E7a9RrgbgqDerAcZwCT0FSQwwKJg5UshBABLBWPX60izNPcSM6mJRnkDAVe1SurbR5MYPmkL164HPPpR6B6ixiSeRWyhXByM88Dr9KgmZRbZibCpyXXjr6+lWGjLYJYoVQhwOBj+lVjh7fDrhf8AWZUZzngA0yVuNd4Xn3AMyIo5/vDvj/GmXEitbzXBBETDauDypPc0+beIU8whCuJNuPlwfWhTBx8p8tidwJ5fjr7c1PkV5jEmh0+CH7LuaVRlXQ4yT6+tQ3Nm9/FPfycbU4U9WH9735qCZZJJIo1jCeUBEgTqT3JFdGt5aySTxReTHH5SoWJwpIHaqjaSswk3CzSONs9ouyrFQUTLA9/atWxZZI5pHDFiysI+wUdBTAvlXzD5gJUcBiBnAHpVjTybnSmSNCrt1CsAeOpqErOxrUkmriXUDmRC4xKihUUdOec/40+7hcWcUlw6kgZHG1mVfTHaluAzyR28nzNsDJs6AY5qWSGK4tEnQKigBQrNkkdPwqjHXQzrQPNPE6MS6RkDcuApPpUscXkiCGU7TEx/dqOjdjTsyLH0DP1wx52568U51cJLLvTfI4jDep9R7YqUaNkDut2ZmlHyFtyg9QB2H1OaszbZo5hGVZzIqiRTkbQuT9fTFV55EWQIFEakbAo/hPQlqks0MqhBIDFv42nDN249KaYpJKzZTihklsoZ1AMpuCuzOOg71BM6yu4kc7eg2jp65rRuw9pHLGpCpK3TqFb6/T9abaRsFCGMBbnjziuT7AChroVz6XMmys96OZF2pnjnBP0qK8ij+0qkbHyWBHzDJU9vwrbuFdY3kCJnHllnOM/Qe1U0gEuLhWAMKhCo7uB1HsaGuhcan2mc9brIbtgMMqj7w5FbejhpjLbBCWZgwOMlfVahsLFWuJ2Ch3/1vBwu0j+YNTaEyrHNI9zsMjgSJ3I7Nn0zU6Jo1qyUo6FrVFjht5vIB2SMFbPQN7VZ0CecaXeeVAXRCCWzhVz3PrVfVpX1a+SKyQHA2qF4Vj689BXQiSPQvCbWj7Dc3EmMqAeO496uKu2+hxVG1FRtdtmPbQG40zUJjgi35CDpk9vpXLF1hQhAWWRt3PBArasbieKK8jimAhmhZpQeMY9Kw7KOS6k5B2IMMewrOTulY6aceVyvsXdHgJtmlCpIWYscnBjAPWr07kDMbnKsWVccqff69qggCRqRLE2Fj2gqcAH1Pr9KnjUNGX3N93LKB97IwAKZMneTZXaVla3nliIUgjcMg59as2qqbd/lQYBUZPJJPUVLqhNwttFKfmiUCRV/IAUlnbiKVcjKodpbPTPSl1C943IvO2OQyojL8pzyNv8AjU77IwD5TMUj4Ge3+1VdlR59pO4nP3T3qWfbsZwABkKQTkgj1/GjcBIpA8B+RAyZIUnr7Cq0jNM7sVztXaCf4T3x7ipZQUUJuDc5YA47fzoDFvLVBhEIb1I9M/Xmne6sCVth8O4wyxzBfJzhWB4U/wCNRz7kf5lKyjBIPPHrimy7BJm3yIpGClSeAM01pFE8jElyB17Y75pWBIYkwRWYZdVO444yPWnhAwLvlWxkjsFqaFVNngRkY+XOep96ru0buwiG1UI5znd70W0BO7sOADRbMkHOQCcfjS3jK8CovDZwUB5J/vH29qkuGEht0ICrCu5DjlgfWofLV0cqV53Ek9vb/PSmIjtwBIJVcAKNowfug9TT2WNEAw2xF+90yD3J9aZbh4wzqNqM2M46cdx71JMHEe2TcQF3FR90+lMJLUbZsEnMYAbHTPc/4VbiUmR3jiwMFgCc4x3qvHGYmD7QSeCw6g4q3GiiNcOxbaSSB7Z6etQDZDcSjczFsPGp7fpimWkzFEVsctgnqMVcT7PHIq3G4bfuvjPHf8azrcussqbsxrMWVivtx+FVbqStbl24kkWIR4GFfd9B2z70U2Ulc5x87YI96KWoJGgsri8HyKN/IaQ4Ukep70RM5VdgUyythGzkn6U0r9mjHmmR5EiIlV1+UA9MU2FjBHHdBvNeNRGF/umqC3Ye8GQyFybln2hzyu3vVuJ1Qfvdv2gABcgkZz19hVaLzVtRFuDvvHAGdvOetSjzIbh5mkDSZyDjOT06dhQK11YsrGZpBDE5EbFjvYdSB1pnlZnUuo2smMZwMdR+dDTsj7g4LTYx32HuMepp/mxYTfj53wVPTHoKrRkJNehBCWij82JlXcCdoHTHWmSW6x2xKPGpuGUSSA42nNTt++nC+WZcARqE9BUVzE10wiP+jsrnKk8naODQnZDTLEa7LGKGMMdpKuv+xnr+NRXDLBLEDGwdFZCF4IXrj8u9LHI6XG+IGcCE/Oxxn1471XSZ57gXU0reegEgGOCcYAxV8yRMYu7bImnHliKNs+fuYIG+VR2NPMey68gyLII9nzdcs3YVWSSSS6Nz5al5G2BccAgdD7Vfjt1hmgWMI0mdxXdwSe59OKzNXaJalSWW+UsyqiY8zHIHBGDUbwtBKJSozwdvcHufypt2Bc3ZS3I8qQDcCcCP2FXbvy3dVEe5pAC+WwAe34U9DJN6FYJK87sqjduDISccUrqCiOCIyuQSRkOfb2qTAlcRx4WNTt+X/GrkUJYjcgMKLlV7HnrRFMJStqVvICw+dCWeMHaqvx1/ipk6qkYJkOEUHBPRs9M+9WTI8g2HHlhCUzwB9agnhL4dirAMGCduO5py2Jj3Y2aKT7GVcDerZJHRieQR7VCzqjxPIqygqQQRjNTh5BFtjXcBkAH+Ek5z9PeoZ1jjgkyPMeQDaSeRjrmkyk+jIbi5EtjJa+WDeuFiTsSo/wAPWq0duCrkqUtk2oD/ABGrsYwj3Ep3kLwAMnFVZJUZFAyvz72GOV7D6UPe7KjZaIdcsVhmuEjQ+cBtdT8yAVEgtAYZzESTnKDnJ7D61f1Zli8tV279uGGM7vTpVSJolnZSGV9iKAcAgnndSej0BO6uVdsl7O8sxAUAne3BOOMVr3UkMVhGyqytKVCnHII749O9R29sszhg+2MDLbuhbPTH86gv5EN5GVDSLHu3gD5Qo6EUJWTYXUpJFhRAsKuVZQQVdgfmwP5c81S1aaOK3Mx2qkoHloeWJ6ZNZVzqJZAY8gYIzn72fWqDvLdSL5rbm4AyfuiodSysawou92ag1QNK5myrsAAyjHy+la0yr9kkcOnnKRuGcnnp9K465LLKUwx28E9auWl5LFkLj5sdOv40oTs9TWrQurpnRwxsjyzNhZFOxhJwBx/Os436JIi2uRGpKhcfN+fpVWe5Nx8jzSeWT8+4/eP0pkyBYN4lIYtyMduxzTctNDOMP5jQu5/ttxDAhCQou3rnHr+NW0zG9kgZ2jRywxzyoNY8Dg2Uk7LlUJUt74q5Yu80dvNGStuOA3TccdKq+pMofcWNZWNInlTdIpGC7cDd3HvUensIdIN42d0yfZ1Urj6EH1qDVp86e0UYb55CcE8LRezrHbxWrl3C7X8vGFLYp83vBGN4JFETi2urnyCBG0fksD9Op981a0jSvMsZJrqRY1wM57LVTyftV2ltI4RXAMjN3xzWvsxAotzJ5JcBiT7dD/OpSuaVHZJJ6sdcQxx2RksJBiOPLs3BPzYGKxr25mup4txyARwp5HFXZpDBvRf3sxJyFGQx/wAMVSgtxb3LpkPJIuC3QAk8Y/rQ7vYimt2yCZ5JY5mEeFRcM3QCrWn24e1ijkUIv3nZefx+uKW/tHUxbIX8pAAAc4eQHOR6irlndmSRZ4lifadxDjqx6gYotZlylePukdwr7JbRB8siq6KD1GeCfTFEeIrlIp1D7Dzu4OD71YLLdpNexp5Zkk8ssn3fyP8ASiUMDHMY1MSL+7XqT2NMzUtLMgG0OQZSsiNwCM9O2fTHeoyHMCFOYwCzoOqgn9fWmPMY5d8TEhhtzjhgOoPvVuNoJRIyytHE+NpUeg6+47fWluVJNIbdCJJItqDlP3fv/tUyxzKHO/c7g49SR1qOWzedEjDEzHJi9MDt7msm0ne2uCjuFGdoznKn1/Ck3YcYqSdmbkxh8hJAP36yqAD1YY+9UKRPHNK4b5n+Zh6Lnn8aeMHy3UJiRssByQP8T6VMkXmSu6nkfdwcDaOoNMle6RCPysvI2AgzyuN2egFU7jcqAsApJ2BfXPTNXFfM0jeYDhxwwzgf/WqBttxbzYYb42DMuOWAz909vpTsCvuJK0iNGCwDgGOT0x1B+tRWrEs5Cg7mJz3BA6Ae9ItpeRSKI4wM4YEngHrz6CmxTlria4wI5cEOi9F9Wo2K6aFtE3tHCmFZ13O8h4XB4+gqFH3pL8o44IB4JJwXqxaFo5DIpR0jADRseGXrn3qqVlNxcyA5j27to4BUnrRp0EuzLBiUxKUmztGCgHb+9ViN5JLcActvCHP973qAqAJmKldiDoMcH2qSAMjDaGK56+pxwTUk37lpG+bIQckrs/CnOBGgyy/eBGOuQMUkbq4VGXAVMZPrSMyM0QjAdW5yPUdqaM3qxb6AyDKEHgH6+9Mhi2TL8mVdiMZz+NWYIjdXqIg3u7HYBx9Pw9asRWzf2mkcV3biaJsxuclXfuB+NNRbYnNJWMqWJ3eNiu8rknPc0VPO0rXE6ONrBiJCTjqckUUFKTsWr6Se4M014rZ2YSNVADdgazbcSKRuDBn/AHmCvy7QccetX7ucjTUij3o0rbvNfhj6YHfipbALHq0cTuxtYrfbHzzjOSfxq2tQi+VbEILbBIIWR2ZmBJ646gDt1p/lSNYSywOGwQCrHB68c0t4gl1BLeLa5IOdpwOeetSogS6a2O1l2hsp646j0pWs7C5nZPqRTb4boMPKdOBkcgseCM9qsRKYYo1k24nBUvjdjnp7VH8vzWyxCBCSAGbgdyzHvVqGUO6JEF67t8n8KgcChWJlfRDGTZcSiNFjbiSPJ6g9uKoXaMH3huEIUM33gO9XQJXmN6i/ugpAbOApz1quyorSM4LSL821h9/PWhocZWYrT2tmhuJIpCWOxVDHIPp9KiadxMkw2yXW/AIGI4uOPxxT3tZDI4lfAjUMNy5Bftj86R7cRTRNuZxJjAIwAx7H3ouy1y3KltbP9piWR2fcCzIg4HPGfXNXom8qBgR+8lfIP9KbN5bTEx74wjks/t2H4npU0weaV2liEQTCMMjgAZJyO9FtLg5XepIsJk8tyR5rEs4wP88YxU2n7WR7i5bzcjK5/wA/hVaOAy2L8MyFclkP559anVkyixAGNI/LVh39TQtCJa6FuNC0owMblJIAwB9KVAwOFYg5woHTB6/WoDM4VSSQc4PHbFLbugDspVfKTkE8lqd0Q00SShYlRFIkEvUDt6GkBRZMohKK2zHb/wCvQgkM6sgAJBA44A9KislaS4jLthVY45/X+lMEtLkUoKRt5xYK2TyScA9vem3KErnaTHENm0jt9PWnTItz5gbch8zeBngJn9DkVGCZUFxvwpcnnk4HGaTVtCo6q4lyTBCwUl2Vfndjj6ADtVYMBEYpFKFU3nj73saW6kBjdskQBNrSocbhngfnS39x51tGqsfNmKqwC8hByWajTqWrrQi84yzgQAR7jhSwzt9G/AUk8y5MisXvB8kkhAwR04H1qTS7EXV9K1w5jgRR5SbvvtjiqyRg3SQtKoeYMC4GAh7AmlZ2uN8rlZdDQhgWKOSMSF2fGOM7SMcn0+lZuqSfbbi5uE3pbphGUcBiO1WLu5RLe4aTbLOcKAAdrN0JFV7SGS8ghs0idjECW5+Uknkn8KTb+FCjZPnZRsLKa9n2iEtCp+ZgOntV+TT0MkULmKFEZvnHUn1PqT0xXaR2Mej6RFBbrvmL+YxXnJI549BVC/s1keC+bbFCg2r5i43OT2Hc1p7Cy7syWMc5dkef3cZWbZxuc5bjGB6UW4Vt+8AbegHcVYv2M9/csp+RXMaGl+zsskcQBLKmW2jqK5Enc9Fy0Q7TF3XDxnad65BxyD7U7UkaOAsiY6RgjvntV7TIBdaldLFIsaqPvNwBntUuuHzvCjmPYGt7j94BwR6fhWsY6GLmlUSRlTLFDBG7ltoDRyKf4sjr6cUzTJTFoRedyNjFUQ8ZX296k8V3MNxNZpZspjS3G4r0Lf407R7WF9MNzdOzPG37uLs3oB7k0l8Whb/hqUupGJZbiWAY/dZySRyPQGrD20ksszCQEKPmcfxA9QPpV6KBzBNDFGdwHnOB0UehpltJK8KH7tvjAlcYJVeMe5p2sZ892+XZENvbeQssxXCxyYJZckeg/KrqlFuXiEZEUnzN83QY/nTI4JCoQTFLYyDduBJBPcnuRTNStksJFuU/e2q9nP3ucHmq2Rm3zO3UdapJvZ4nSKYkoynkFf8AD3rPt7SSWGcQp+9lOY3J7g9F/Cr7tLcvH+72hyzgJwdp6D6e9QzYkggiUmDkl/LB446L65o0HHm+8bby3EiXF3I+77IDH5ZPA45x6VXs0WPSLYmdQXYuAB9w98/yxUsLH+zZLdwq7wFOBkr/AJ9apRRNAIzM6m2eTLAc/N2z6A029S1G6ZdIZnCwkASnaye/b6Zq3bFfPjjI3xsdrITgB/SqrFFmeKUKojUSfKcgH6989PapLWc/Z55VARmOSDz8vt/jS0uRJXWhXmRop5VuEzHIjt0wSy9MfSm6asH2OGQFvtAyDj7rD+6nv3pt1JJcRw7/ADGtYThG6sxPb6e9XFjaB4SNpGzohwFbHYevvQpa6FO/LqT217G9/AyDy0tU6uOF9Sfeue1218nUJ1B3MGyCDkHPOavXyzPLjGZD9+TcMN6VBPCt39ngAk87P7yR2GCPQVM3dWQUlyPmJrOaI28LuGCJxIc87uxFTxorRbCzFC3JxjJNVgPOePytohiUpHHjqR1JqypVY40BbzmOOTgFu5NNBNAzW8Uput0kiLjfnlUPTI9TWddlFumcShUJUjHb6/1qy9ytpKYLuBuHV3QHcXI6Y9uc1Pa2+R9nuxGsciMyEc7SehaqtcPg1K1xeXC2QtIsF5co8+7IYdc1BbxrHGsEId3HzFxyWHfj0p0UGyXBfeiqMc45xzj+lSW6+Qomg3SfaAVPsmamQ1ZKyGxKuVVHKy78Fj9wZ7in2zEiVCikZySeh9vpSSs0jW5ZCSVKqRwu0Hr9a0YkXzMbSBjCgjn2B96kL6DNyxiRVB3OA2T6etSxsrsECkIvIz3ohYK244DJmJeMgmoVYooeNScfIM9s+vvQZ+o67kfKxhhsQ8bR29Kt3C/Inlpg5wQvRh7e/rVIzj7T5ZVASSu4dmx+tSwTuFjUhflJ2/NnBJ5zTQmtC1b3j2V8sy4cxMdyhfvA9q0Ioba3uEuI9P1F5CBIkJTKg5zjNUtPYDW0d1DESg4YgZOOvNaTW2pgybr1X6/MLnaT6d+MVrBaGFRq9tjnZZZZ7q6ll3K0mSwA5OTyCPaiopm8p5fNyzrxlX5Zs8kH1/nRWbbOhLQupdQDcs6BZ2yIy/zYBHGT7VCZPMUx7gJHIRXQ5yg9u2TRNmVTIyKuSckcNJn+lW4bm3ZwsRjgBXanHKHv9ad7jtbVIjtC1q6rbQ+ZLLnGTwFB9fpV5ArXca4URup+YcBhnnHtUE6wq2IMl2Hlo2eR/tHHrUUUZhvokmbfjbGVGQF7nmjbQn4lcswW0Mscsk75mkb5PmwFGeBikuSzzGOIq7RqFcgdPQYp7bAsSoio4J3tnOzJptvazRySAsFPQyE5BJ6Z9TRvsJO122OgULBcRSSIoU8ZbgH2qtayzTaiCMYzy/UEqMFvxpXjH2hraJm3R8Tbh8uO5JpumMI4/tJgMqAFAmeFUH+dNO7sOySbLARCJnhlllkH7sFhnk01HZ5/NGzg/Mu7jP8AjS6hctPIGEaJGDvKoNoaTHHNTTTCaeI2SZcJiVQPlDAck099iVdWuQyzNFZwyOp8ncWc4wreh59KI9s6JJsMhlXzAOQGHeq05mFgyz+ZI8jeUpz8oHXp3+lSwyxR2xVJZmXYsJ3LjaSecD0FCZVrLTuWDcbLB4of9QCFCL0J6k59qSHyraItJuEqspA9h0596ZNHtnMIUrCQHfHUjpTYdhl2EMyE7lOMlgOBUu4klbQttOzKpiH7ySTLAj16Y+gqaKCJYXcsWuJjudf7q5qmscl0VZuNjk5BzgelKzgyMnLoM/Ko52j1qrpCcezLsbujT4DKAuYlz17ZrO8xoYFXd8oO8HHO4dfwq1NIX+csFRx06FRTLZAd7SMqrGgZlIwD7+9Ld2QJJK7B4HkYs7gImARng56VmXlzPse2gceYsjbwOm0VduSzRuwSUo6LuB9+n4Gq2kW0lzqVxau/kyygAkjnjqB6U3vY0g0k5PoWfKgMtnbIoeKUeY6K2SW7AfjVGRgviWKzjZpNsZSaRuoz7+1dFc6XbaFpbXV1MPtH30I7EdMVjeG4JLyO8vIQhuJSCBvAJ56c1bjZqJFOpHllUWy0+ZFcS/ZLS5SYf6YOUdhzweNvsar21wVFqwjUSIC0jHncx/vU+/i33L2ksv7zf8qE5cfVqnVRbWkznY8m0RRYHBI6nHc+9TO5orKPqVnnEt5BBuCJlnAboGx0qzo8skBlWFDmZwgPbH8VZ0Qa2v4nYllZsq5HBJHNJBdSRXG1JCv7xuvv3rK7TKdNSXKj0S1hF/ZPMVCJHhC+7k/3v8Kz9W23tzZrOwSGOKWbPXAAwuK5iLU3+xrbCTZGCzMAfvZ9asXN15lqBbPhhEIWDt1LHkr6V0OrdaHAsPKMt/Qn0LRFvJ3uog0dim1I/MHzEnqxqzbaejeIJ2mZUgEO8SI3yhVPJ+vFIdTd/stpbRbbeEhmOc+Yw7D1yazdbupUa7Wddl3c7VCgY2oOvT37VL5Ek0aL2s5NX3VkO0WZBLqd5IFVbjeYkPQ49PfFc5PdH+zXhOQJZd7Hd19q1taurQW+mW8XzQRREvgYO5utcpcvkbUJ3Z9M1hUdvdR3YenzXm/6sSF2dME/LjYgPaurtrdYVtYFfMu7YC38RxyT2GOgqhpdkkHlyzKWUfdQjo3qfatgxozoGGZAN43rtBb/AAFXTQ681J8qGXMrW7slup+zMCvzH5pGX+lVbONZIUIlLRKwZlPTd6Yp11DNHbwT3DKGf5ohnG1R1A+tM051jtWJiCpK2WjBPQdBn2PWlLcyily3ReiaP7Jskmbyid65+8PXP41E0PnJGXEflFv3aljgAdcj1NSwRqswbhix2vxkkeoHp71C8akD7saKQpXcPmY/xUPYlaMcVykWWMaE8sOqr/dz3qK6CJexKu9EUgBycjPc/lVljIS1sWDDG1Mdz6fSoZF22DIwaa4lxsRDgR4PP40xJ2ZHdO1ltt/KUSy5PTIwemahvisujlFdRcSXC5iUcAgfyqdXWTUYyN0giTBPXzCTyv4VXMpju2mtLcGVgUUEZxnp+NNstLbuQNPbwXlxGh37FVIyBkM3cfhWhCm2SRApeFF5DcYY9qzbWwzaOTGu+N+ST155P9KuApI0jElQyjCZ+4uev1qSpJdBkLNIx82MlJJASq87cd6nkO14wxG7JIyO3qf8Keo2Rtkn7vRR1HqfemzFZRmEECLGD6nuaLkPXYhiQMs7qkcsCnbk8FeP50Lb26ybCY4WlxtP3uMdKfBEhind1278qFQ8L/tfU1UZXnuQ5jVc4Uc4A96A3ZGzNbXCwx5EpO1nAwCvY47Gnw4jCFfnZsxqHP8AF6/lTLxS4ikZ90m49GBLHpmrMBVYpZR5TsflbuAB3X0xQnrYp7FS4jYXcd1dyFbgvlTGOEIHFXIzPfIqRqDNI/zYXlTnlvpUAv3hjExjjuAwIELc7D/ePqaIdRnhTfYokMscREspOQwzkYHrWl4oUlJoZrtounSzReaDMoHyqMhj3Psaq2mSUVCdgDHdzyfQVBNJNNcbpsgvyCece5rUs41tTFukKAZLMo/i9R7Gsr3dy/hik9wK5RBJHgFMpg8D3x79KmhZiqykMN3zdckj296rzgxmWNfmYnDYH6ipN5a3Q3RKui5VfQDp+NBHQuSEeU0iKdzjew7L6Y96iuZdyOsDnywy5wPvmowp8poriTLAq2zP3j6fUUzJ3XUvywbPl8pgSW9cf7VNLQlWGp5McTj52nZipDdj6D2Pr2oilZ9u87hkfL3x6ZqKZjARFcYKxpuznkqf4PrUUQd7qRdrqiqCI/Y9BUl2N+yvbVYWWexFxKW++XK4A7fUVa+06Y7AHTlKuflczHB/wrFhgPlnYw3A5x298+9WIv3syplERsHzJOFH/wBaqUmjCdOO+v3sbcFDLIIl2xvJwAMkfQUU2WJVedo5ImjLYEkZPyt6EdQTRRsUndF9rV3kEkkqDyvljyPv+9MghkjQyRhZNp+bIGSe49qlgkFwoRQNxUkuei461IhT7GRuZU3lt3c/hTQNtKwxjcXAMjRRKUPm7UPUnoffHSp3mNwLgqRG0qLgEZwR1qGyjaQEthTkyLnqT159sU28kVbkFsEuOYh2Jo13E0nKxHFOBOXVVLH5ixGBge1XEnjt7CSW3JaVxmRduSPQj0qnHC6zCNQ0pI27ccsKtTKsG6KIq6nqAfu+pNEW1qOSTIPtjW8k728ZLmDLI3JHHU+9P0mE/Z9soOyWMBmB5Gfb1qvdW4abdK5RSMMx4U/jS308XmxiGQCIKCxB5yKIu243G6shlzGVuoYQpKxLltxwDzwT71JZ3RgZpLdyNq5Y7eCB0A9aLeGPZPe3TsY2YqsROTjGAx/GpV8p4DDFtkjiVU3ZwR6j3p2KbTXLYLSNhdR31xd+WzKzs0gyFzxkL6ioYbkzyM6l5Eg+XkjLuTgfhU80CybEMZLgEldw4IpLiIwqgj2Kmd4i7Bu3NCfcjS93uGuXM8c9rC8RVSSSf4mwOn0qSe1ntoUUu6XUnT+7jrjPriqH26efU1uLxVSSNFg3ycrn1xWtG8hUPO7SCA7o+OG9xV6SBpwUUMsP9JjjaCTbHHnzYwMFf9of1qtamOSRpIXZFdynBzgjpj/PeqFndTSwtbxEma4Y5dQMhM5J/pWokSwGHyUVUQl09iOrfWpvewSi43RZvAABHGP37gs3Gfl64PpWfdiVohK3AkBGQM4J7Y9P5VdeNJCdilp2Xdu3ck+/oKimnkMawhGRuoYD7p96TVxQbRDDcPHaoikMgXdn0I6Vnw6isOrJNKhaOQjeCeSK1LtbYyCN3cCMfIqDIIPUcdzWbrFkomR4IiiqcmPuPxpO61NYOLvGS3I/FN/c3928IMkqkZRU/uj2p9ratFbJNG4gjRBKGUkkHoB707SrmIvcqQsbMgAc9f8AdHrmmXLSWiSiQsJ3ABj69en0+lVzX1NNl7KKskT28MqXcV+eAy73ZuSWH8J+tNu2miMUsDhb+c/6hR/quf8ACq0t40cAtoQzyEhztJPPpVqzt542F1K5jPOZSMlieuP5VPMQ4v4mO1a2eKwgPniRo26gcDPUVgMG3F1GB3yeRXUscxTKUO7Iwjep6ke/1rO1CwhYlomlY4w2Bg7vp6VMordBRqW91mJvPmLkEA9h1qyZY3jTCsQOXY8D6VDdW7wyFWODxg9j9abEY32rMzKjHGRUbHU0maNtqTm2JDFdjAehHpimLctJcu7ZUKuRj5iOOvNZzRsGVQ+3HQd/YmrtmuIGeVOBwWPf6VXM3oZyhFXmipfT741AwXChenC45zVfSIDNfGUjMcXJJ6Z9cd6k1dzKZJExEBhVjHBxWposYhtWwxERTfIGX5t3bFNK8jRz5afmals/nXDSzn5FwSG5wT0BHp7dqtP++RskEEbSGHKnsPpVJECo5Qsx9Yxk5PVs9/6Usybo0g3NAjLlV6sPqfStL2OJq7VircFrqRn3lyPkRgcKoHp6CrarDFbXAIzLCMKQcr7CmQItrCYgQ5Y8hhw4z0JpZgJ7hTA43SEBVK4MSj+dSu5V76dEPtizFUDbVPBfpgH72f6U7ZCjPEUwrHbkjPy+xpQEM7DAMaHBUckDufr3NJbx+ZkZbYrcOD91fTB7GkjOXciE32SCdljd3lwihhyB9exp9sjBUkD7FQYcJ1xTZ0z5rbnSNRnBbODU5YqHS0GxHG9s9SMc/Snce+xWl4R5IwFU5AJONmeoApkpQSRmFWTGAST044NSqAXVWBWML5v0HanOCmG2k7suF7nPb6UmVsVosSzeVyETcWkxjoOlPtV27COGcZORwPf6VKWVBCib2jDb2jYYH0NTwlg7yNCBNIwJjY/dz0/CgnmGPDsaX5JGUkE4FFpGfm8sqkhzghc4PpipGd1jTezFi2N4bimje0jEgoAd5AOMn1pNCTIAXQONuxH68dh1IqqdocoVdsEqADzj1rQw8pcOCFwFQjoGHOT9arSxps3uBvkPzKp6HtQ0WpFb7Nb5DSLl1Uq204yeoP4VXR2mtpZli2x+YBtAwD64NWpIgEzLk5GMgZINRMkqMVkx5YGBjow7EDtTvoVeyGG3QK0jBQqH5n/uj096geJS6GMF1ydi9z/+urTQvliuTGFAbB4I9aeYSshLRhIQOCOCPf6UgT7srKrW4ZpommEhKCM/L82OfyqaNjtVt4mIG1FP3h7Y74pJbZVKsScqc7sngH+IetOCJ53yLu52rznHtn1osDYgkUSbGwWRenSpIlRnEaISMkNnqfYZqRVjTzHZRvHygMemPemw/MC8pJyMqx65oaJuKCcSfKAg+ReOTz3qsxeBfMWQhyflz1OP4j9KfLNhSU3eXwQO+ccmqm9i2JEby24IPf2ouCXcZHuYiSRV++S2eevcj1qeMfO3P+rXCt6jOefU094zEflwXUfMR93PY471HllyFQmRO38mFO1yr3LGnRfa763id28mWUI23rk84I9a2raO3EUUs1j5j3UpgihZjuWIcEj3yc1y8NndX95BFbsRM0ihXztAIOck+3WullcT3VnPHqt0WnMluJ2QDaRxgDspPetYJW0MK+6Sf5+f9fIy7+EWdy8KSs6NIUUg8nBwCaKrXBMU80U+37TExRiB6cZorJ7mi2N6Y/ZiIXQOIwI5DjjnsfWn3CjdIuA+MOXTgYx/Kk2xwvjh9yEzeYMlfTj1qtbSXK3TRRqmGjy4kPG3tk+gpkb7FtHeWBUi2BHj2jccbcdSaqnG9Ztg3jABxwOetVjcfvpFt1eQJ8okH8Y7mrbuGtfORDsLeWBnjA54ouNJp37k8rP53nYBdj95eMp/jTViQXMs3y+WMjdEc846VFc3OY1QfvblsDCjIRR3zRMscFqBu/fTDGBxtI7/AI0BYe8Cx2+2aRxHt3K0h+Vj6YrHtYxOrSOsUCA9GBPfitO4hlmJRt7uAOFOR+Ht706MCJmXCJx5ZON3HtSdmXF8qZVt7cy3TiWXazDkA/eA/pVyO2yWQKoZsKCT2759qAqRGViylnIi2jkgdyPQU57fzbpkkV2VVJyrclR0poUpXZHNtijZS26aOQjC/wB3HWoAsZgDFj5eN2Cec+tWpYfPQfZVZZUIXYvIx7mi9CpDNvMjSuyqy7Noc+ntinyslSWncwb5Lm+c7XUKvzOSeBngYqyk92WWGWb96yeUrAcYrYFtbrIGzC4IZiqj5QDVfTTG2uWsMeQiOGZSMH2HtSSZs6ya0Ww3T3itZIkeHYjxn5jySQep9s9qmE4uPtDkkCM4wOMn1Wk1zzFvJ0h8sRxt8xP3VHoKh0srdbDaBktYMgyyfeJx/Knb7JmknHn7lhriWJCdo+ZSI1cZ3N3GR0pdJTdE8jSHEhKlnBIAx/j3qpaq098YXZsbHJKnGM1BeyTKiiz8xLdV8p3xwx67fwoXdj5b+71LcE8Ud20Y2bUcv5pOA59Kjj1NpJTE6L5bMzBj1J9z6Vb0rQZr7TkeCMkhjlscCrp0JGtnWMjfDwxYfePcD2pqEmrpEOpSi7X1RgDyPNjkspVSUkn5+SG709kSWZYxIHfiSWRT3/uj1I9aXWNNtLGa2VLhZPtC7iRxt56n0pYrq3j1f7TaKpDNtRmGEiAHLD60rLVM0T5lzR1LNo1qzCRY1Ks24xjjafc1Pt8y3mkMg2ZJUn7o/wBkD1rMsf3ElwZI2MchLJK2cYz2/wAauecyrFDgK8bbh3yvqfWhOy1JlF308h9wxgEMHMqMRkbfmB9/8alliKSRRFAsjYVsNknPOM/zpbSNriwO5lSFRllP3iDVWzVoZFZGeQl9sPH+sb+6PQY71XLsRzK/oT3en+YzLeGMRrweeST/AAj3rCurJo1E0US+WT8isec1r6tLNblxdGJ53f5tp4jX2/lmoEijk37SdxG7APP4VMoroaU3KKu3oc8FdWfzAd+cY6HFCXGxlbcQqZIJHOfYVs3lmJrcSwsrsp2sD1PsfeqemacZ/M3/ADXBwIsnCofU+tRyM6lUi4XY6x0m4WA6jcCOSbO5Y3bOwH+I+9TqjxzJDIGcMwMwC87e/PpmpV/0W3liluGWckCTaNwcZ6++OuKdHGywPKrOyFTveQ43c/Lj1yO1a2VtDBzbvzMnEsqXMhhCiMK0abuh9duO/bNRyxvDNBEGZ8nd8y8gDqPp6VVtrtgPmYbVGEHTOewP9KvRJLIGMjMbhgAZccjA4RfpRdMmS5XqWo9kUXlyMkjlvlduVUH+tMtY1a5md3dpEUgMR/nmqULFmj3FyclSpGPwHpSzlvOhNtNmXOCinpz+uPWklexKhZ2uTOE850J8sx4Dkep7mmF08gkcSZ+UE/eQGi5m3l4ECOwGx36kEnOT6mnRCG2iF3cubh5ouCVwq9vm/wDrU0hbRGLPIjKojf73Me3lvr/jUp2SROzMVeR9zAHkAf0FUtadknVraZyqosYYHoamt2VrJ8W266PEhz8uPX29feotrZFNWSlYlVFjR5xK29ipRDzlc85pZLgx4CAJI3JJ55z69qjdjCV2EzkKqgqOHGe1SDLyFUjAjjOOnIPU0iWJFNvn+zuxPUnHUgdcU2RxJGCnmKxz8o7+gotwjSNuUHrtz0I7Emo3uMTuI/lfZscE8HPQj0NBVtdESQzoohIXGAWIPr6VY5kl+crkL8x7E+lUNPZY32yKrxxgseep7Y/wqZJW3+YsSnB24J7kd/pR5iasyw7buRkocZVeB9cVDiSSPKxthfmGB19M0iKIxHHGWkk3b8ofvDuKfLLGk5SNZPMJyQr5GfQUCvrZFdldY/NZiI2fCfWlkZUBD7VwcKW6Z759qdLBsnQsDgnJVT096Nq+au8IwOQec5FINWU2dpGCoMKnBA6H/wCtU888twzqrMwwBuPJwKcsUrSMVUEN8vHANMaFhuYD5iQOepouPRlOeRHb5ZGWULsbzOufXHpTbCaRp3QIC2duE6MfX6e9WZ7fzECTDMZ44+8PpSPZmyh/0Yhxjb7496e5d1a3USVxDMI5AWkMm5c9GHpUsqNLEXXGWydmcDHtWLMZJJleTKsTwM5yf6YrTjVsLGXaQEHDg4z36+lIJRtYmu5QGXERxtwipyQariJElDOCGU5wT0qxFtglBaUBcbt4GcH0xWfHlZpnZi2TuI6lRn+dBMdS7JCy/IWxvG5SOcioo0jhh3bAWOQAcgsfb2qWzcncc5UNwf8ACp5iJMblJbJyKZN2itY3Jiu7d7OFjchsLHncCfQj0rfVMRW5TQb7fA7SxKx/dhyf4u5ANYGjwJHrMN1cs32eNxnHQ+mPYGugtrfUYb1by61FDbq+55fOyrL3GP6VrB6GFe19O3n9xzdzHdxX8736NHMXMjArwSf6UVt30yz6fa7WEjvM8sK78skXYN6fSispR1Nqc7x1RH5Ti5X90MFSpctwT7mq0rxNcRs4eZFBVkxgn/Z+lWrG4iijJnDtARyCucenNMuZWvDIbGLOwBRn5SfU1Q1e9iWa9t3jljhjkhMgU4HSIDuT3HtUYa53C1jwkDZZSVwM98fhVO4t2hmaL5w21WdS2Tz3PtV/UEu7mz+1XU221hUcAjLN0GAOtNLmG+VNWG2kXlMRGuPtDlA7HICAcn86ckZMjEZdo26Y6j39qgsJpp5t+pu4ijTCKnfjAX296mtJoyjO+4EjG0NyfTFJpLQGmrk8QeWaTdHnK/KpbA/LuBTLqXYcqcyIoBXHA/8A11XvJ40lRdkokx25xUv+tnjwrEEgkkcg0b6CSt7xGIJGDM5VZhycnAHpT7bznmU3KlI0ziUEFifT6VO8Yilm2HdGzckjoR149artChAWN3aSRgEjXggHuaSTQ7qQ77TcQOWhcRIQS/y9fQfWoYhcSK0txcBI1cTFOpLdvoakZnaSBHZSiHG4jkeuMVPPd29tBcKmwO/3mODu9ABT1DaySI3jkJXe7Llyx3DO09jx/KqasltPHIZt8rkqyjsQavLbyfZ0eNv3jrhVXnHv7fWsa/jkM6vGhGBuJJxuPrU7asqCUnYtazIl9emKGVorYKXkPXkVa0yPzLJZGCJbcDZn5mHr+NY53TP5SYaQkByhyMdcVrBhdTGQhYLMnb5X8RPqPY04u7uVONoqHQr6k8kFwbmD5C6ZJIxx2qXTdS26ZLazhZA/zru6hqu2sJazuWUK+7hDIOTgdB7Vy0kXlxPMZcMvQMOW9hQ7p8w4KNVcr3R20/i1rPSorW1AR0XDHbzn1rEl1eSYskTuqMmWVmyM965aW58wYVWye2aUSFHIJCfXtQ6k5aXNIYGnDpqya8uHnuI1kOFJC81s2lk/lpeIAzRMAm7oR3wO9Zum2X2zc7NJtJJR0TOAO/0q7BOY4I0tcpGThwDuZSPr0+lOMXuy6rulCJd1WSS6u7dHmbY3ztJJgAD2HpVy4gNhaW18AfK3hFBPzEduPequk3Vhuna/R7mRiVcdAc/ypur6rHLpyWEn7vy2DKZD8xHpx3q9LOTOS0nJQS2EvLpoPMeR3VZmO6PH3MHnIp32qaY+cmIw6+UV7hO/A6VBbqLm7SZmyiYVFbkE45ZvXHAq7HEbdFEHlzOzNGNx6HPJA9KFrqVLljpbUpRoViuwYzJO2ABkkqPUipLO5L2TGNds4JG4cB8cf5AoleWGyurgFk+1Dy0PVsDqPaqthdgw2yRoXmtlI+X7oz3qHoXy3jctxyKsWzeGIBYAdWz1Y+mKRZZpB5ERjiRQQVHB49D3NOKSnYwVNv3nA/i+p9KJX2JiVZAzc5K4yO2PShPqRZDJPLmkhh88zMQS7L1UgcVXgnfy5BMA0tvGVUHjA7MPf2qdIzDO0ViGxImWGANvPc1bl0/7LcRSXvyxK5/eDrnrwO49601C6WjMyzhlimCPAHmVdwhH8LHuT+tX7hnslY3KyTu+fmXI2E/xD1pksxjid4wRFLJ8i45X8f50y5nlSLmZS2cLnnA9vapskPWbuTmSGNiIHV53UBi38eR19jVd9Q8icLFBHNNGQWRl9OBz6d/emIAySrCge4k4QgZ4PU47UkkapGsDkvdqcGEcA/U9z/KmlYFGN7Mb9umDzZDZcb5nXHzMegHp6UsM0scCfatrQqcxx9lJ6Gn28XmsN4ZpmcOsQOBx2Pv61BeoysTIwLyFjs6CM+nvSk7ao0929iC8ujLcbR+8OfvLwCfXFX7aWSGMRlfmc9+AD/dPrVSO1lgeKRsAj5jjqpHc1ZgZC0qgsQ7ZCn7uOpC++e9ZpPcmo1ayNGJN0cizbEGNzdgnrUSqJYZnSUyMzbUVTjGOp9xiobnzZFjVnR4ZCCw6Zx2NRyyuEeIKqb8KqqP4fb0zTMFHQWVhLIQ75UcH1bFAQyIolQsm7HHBb0NDN5RKIq5UcE87TUkMryfebZgYxjke4HpU26FXsh8dvGsflOMEnLoBwvoaZNCY3hj3DfI+7/Dn171M7ZcwwMiJwWdzyx+vf6VTvJpIpIwp3JEpHy84z3FUloKLbehIxMCkNuO9ssRxg9seufSlDvvRVYQuSQCVzx3PvjpVRSsvk28Ze4kVt8jsePz7GkLI08vllnj5CEnBA9c0NFONiw8kAlztZUZcgsfumlvZoEFq1uS5ZR5qnPDZ6f1qnJKroZiC8CAIDjgt6e9NEoKDD5fooA7Unog5Nmawc7sDPC7jjoR60qbZWRwdqcncx7D09TUaB0j5IZgMA/3T6fSoTIVyQffkcIfakZ2vsWQucM4C8Z9Cf/r0SCPdtjYCRuBn7v41RYsbzOX2EDO4dfarrquRHxnsSOnrmgGrEK26/M4SPkfN2yfWnLCCuGwrJyUzxJ7j0xTyihx5gZQvKntilmkWEbSCiH5s45ZaYrtlOZNx2ozEt7VC0flId2QT94D+L0zVkyDqgCEAleelKhbzN4wcEDigeqFghaSRYwn7wjLAnAx7UrPMNylFQE49SKWZtpOHOwtn0GaYMMr8ttJyRnn8aLCLWl26Xd/bxuQYmYK6jjHsPrWtFLYeVDKdLhAe4MBUAkhuMf8A16x7KN7i7t47dikjuMP0wfWtpL2GKeSQaru8w5Ym2yNw43D0Naw0RzVrt6fr+hg3cP2e7uoiqAhyGK/dBz29qKLhRJI3lsWYsSX6F+etFZM3UtC2sv2i3MRCwxgbiAfmfHfH9KqXa5lRpW27xxs746CltmhKuLpGLNyGXgxgdqryxmJ0lViUPTawYrmqv3NYqzLcaLpzyPe3SLJMimNU5z7A+3eqk8I/tH7pVFdZFPKgehOaqmZVmj3FgIchQRuUZ6gfWrFxfXj2bQyYaGT7zFe/17+3pT57FqMkyxdambu4jjCmLzD82DywHerDIIjgLtbopPVu9ZUNvLFcxvkFpFwoABZAO59KuSpO0x3CTaOFzyPc/Wovd3HJJWSJ5VjmuVEOECjLhurE1Jcs8CKI5MtuXllwQR0zTGjAyfNLOxAZQM4Hp9faiXdDtnx9oZ5DGok+8wHHSqRlfoOudxunWQu8qjJbd8nP93+tEAaN5EtU+0soILqcbievPt6VmajJLJcG1kfcvmDJBz2+6W74qb97ZQypahTC2NrlvmX2+uardmvJoi/YyvGqlF8oxfJk8sT3OPSo7iMzQTyvCDChwAWGffFUrV5YYxJOFMmcybfmfj19q07ljPppa1Bl3qTJKB3/ALp+lCV0yZLkaYrQR/2dBeqCktwfJUZ+WMD1HUmquoeUJoUiYSGZMliO/rTvDupIsf2a9jL27nCsTt2Ejk1QvZFXUAykNEgKoc8BPrUyehFOElNqRZt4YI2LRI3mK23bGflHqM9z3q3YmCSRUuJisA7epHvULeT5ESWruwK5RAPzY/jTifnESKoDAKN3INGzKfvLUmufN+zGd28yMv8ALEOvtxWFdxyyXUkAwhY7/mO7nvjHete5hAgJkLjB2pg8p6kAVktIQ4t413IgyJSe/rTdmaUPIj+yQhZGgLfu1BffyzMf7o9B3pbWOCVZfNjfbwxk69O2P8inwrGlpFNcRNvDdFO0sO2aVIYrjapQtI5bEQc7XHX5vp2qklsjZyvoySK7lS0JRyYnJARVB3HsOO2KYkZtxGphZ2lbeoP8I75+tSrcNHHJDJGm1MKHUAeXn0x1NOSC+to/OnYZkJG58Hy8dPzqib2v5mc1tMsjPbwTbWOQpHGPX6CiPS5ppFNwAvz5buQPWr9w4S3KW0skl1dKN2WwEGefrSsHsFW0S5cB13sV+bcfXPYe1TyoaqSexErraXLW8EweAHG8D5QOvFX3vxDA/wBnREgdhHuc5wOpqhZ6dFcRSBJnypOWYYDH0B/SmyRxrNHv+do1+66YVfY+pofuojlhJjLyd72cRxs4AGBkcgepHpV+0hggjVAuEQ8jPLN6/hVW3jVbmSS4IO377ZxknoAKsxiN0Y7ynGAAOeD3+tZ2Km7LlWxdgZVklXL4PTIxn1yPelKK6LLGxYfelwMhD05NRpbvInO1W6jB+57/AI1FIZYYtikgnp83AHfj396cX3Odq+zCUXHlSbGcfOPlxyf8iqkIm89pWYspyVkc5I98Vf2ExgSykBOgIz/k1A0ShcugXJ3DPV6Vy4y3QhcOypIv+q/1cUZ3KAeuT3PrUlxiSEKAvmjAUKAQ3oB9KZi3jKt5b7/4UB/zmn+QsciAxSi4KkqvQL70+orpajIr17RZpIXEMi/LKGx+9HbHv9KqidBKjThU2gkt2GemO5NSXAWAFcI13Gdy7xlc/wCFZ8V1dJiTyY5drHJZRnJ/zxVmkYp6l/yDKnnSSEO/MYY/e9zjofakuHQSxRxLK+V+bzOSc9Qfc0Rsq2qfu1j8zA3jkKc54qaINb3DSb/mdCSxHH4UpdiX3LCRusb+eq7yQqo56e2O9Pity900cavKuwu2RgBOmfY5qu5VX+1CUymPG1mznHrioZL8QS4UvscbpmU4z/sg+lNRTZlyzl8I4TZu/KeMmVx5QwMbRnqPenXkWAPKICrJs54ZvUVjy3hMwuojsIOxstkkexqzA0moSbsu4j/gP3VPfn1rPyNHTad+hf3xZdYmxv8Akd8c49KbbyuHC7ElKnA4xn3NQ/aw5VY41XYdo3dC1PnbykDEs0jZBaPv/n0pPcVnsx8yorSCbLt97K9vYetV/wB0kxZy8pQA4UY2/WnJFsRPOd3PUBTkqaiZmUuBtTb8yqRy3qBTTBaCOWSPOCsUx2pGvJPufenrJIEbaFDIMkkZPP8AD9MUihhkoUyxwOvAA/SoreMmXCA5VstI3CsfpTuVfTUeyuQoVCyL+8wo4z7Uy3cG6kldMgDAA7UlwGRd0au7bufTHoBS2qvy0kWdxw+04x7D3qXqJ7F7zUMhy2Xb5CAOP/1VAGG4xs4cAZyrZKn0NSyWz7Qykgf3lO7dUMEJEoVV2rjBU8H/APX70GaskXoZCxPlqcHAO45x/wDWqSANs2yyhgxwCo6D0qAD50VCxQjPzcZH1qyAvyCMHPqTx9MUzNjWMm1YRvdUOFCj7wrOvvNyY0Ksx65B+U+1aJLRuzq4XjDYPIB7iopLh1X75MeflO0ZI9aGNNpkELYj3RlWcDBLdSfXFOMcpDOkRUMR8ueM9yT/AEqIedsZ0LZPGOxx6VCLiWSUKTGpUHaGbCr9aaRVn0FNwAFJHPq3X8v60R3LMwOFMKvyyn2qo06tJtQliOMsMbfYUGQhssq4IwQOAAfUe9Mpx0NvSXiOrW5aZ1BlHzAY2/Ste4uIRI6vpMQIY7l8xuPyrG0aDzFWeLUbWCWP7qMfmGO9bkcuoFsnXbQrjGQ/Q/lWkFZWOGs/e/4f9DBmkV5SNzquCQMdPbPtRTbjfl2LrI7O2Tn7/PLfSisXubrYclvcSySAJvPUknoKVUhWMxqG8xXJHHJGOhqVZcPICQiHrknDUxykS7/uJuHBXAPuTQkbtshcs+zcwEajkFR8p9xUc0H+pJkdlft/gPSteeWF3kvHaONWUQwqqY3+p+lUisMgKjAfJwQMbR/gaGrBCbZDDbuQJd2z/pox6H2HWrW0sybd24jJwc7fpUH2iSdwrL90/vNo+UnsKnGSqS5G5jgY+XaPXikDutxUlEKlnlWPa+WOMnHqR3o02WM3Mvnt+9PEbk52g9T9abNalvN8yUnK7coMlj1Ax6VkRSpF95vnDY4o5uUcYKaZrXsMMEj/AGYNJaW/EchH35D2Pr+FBa1lR5ZobhJD/wAtpF+UN7DoB9apTajEbOEbXcxElR0VGPc+tJLdxXKMkry7mT5FTu3Ykf0rSM0NQaSv0ILYOhkkEyqj8MVT7nofxqaG/W1ceS7LG2GeHplv/r0ocxx7HjQIvG1+rMfXHemPboZnGzam0Ngc4PYZqWzW6fxFW5u5Jpn3Iqkn7g+6PwqCeeWbyoDnBOBxwDWvDp6XDRvE4EzMRsc5OPr2quNNlWfPnosaA5kYY2/Sly3NFUp7GnaTSNfPDb7AVQDceBgDmrMgR3Yw7mPQM3yg+v1NZlopeNplUlnwqBjgY/vZq9OfLMJkfMQPzbTyT/s+g9aNTkmtdB1wkiDG9mLYUhemKqXoeRgvyJGv3MLtJ9TirUUrIwkIKFjxnt/jUbAu8gbEgdcZYj5R7HtQEdGV4kjl3NdbmtlIUlRyCOg9agfYXKxugikHCL0UDs3fmpJ3CuQQWONvlE4De5x1oeOFCqqQsuMpk/ePpirTNlKxC7GFkcP5pz5ce4cL6tj07ZrRsnFsZo7xt6uQAo+bHrjHT3rPNpNJvLL5ax8IVYbj7VF5W1klTcrseUBxyPXPeqTHNKatcsmL7EtymwAhcGZuSFPQAdqj0pESR45HWTPysGbAJ9AfSomlkm3SM3lRFs7uu5h2HrRHbrkZ2Qw4/wBYw6++P0zSUrjs+XU0brzIbVlaVY1VtvllQd2DwF9TUNvbuklwbrduC78FuEz3Pv7VJHcwkbfMjKqBl5lzsH+PpVJWVws/m7mmlOXbOCo7ketOViVdaMerW8EPkWqPPKz5LSDBzVuMQicwtt3xKCTjOT609o5TdCVIY8zL+69ceuO1UjMZXk8shSh2hQvTtk+tS0now+LYuyyP8zStmQgHaTj6D6VLv3sj85ADEheFPt6iqrWpVcS/MJGHJ7VceR43jUKSFONx5JHpio12MpW6AYmMwboH+Z2kbAz647/Si5jgEu9HXEeAXJzg+vNOWNZQxcjC8YJ5JqKRfIf93tJAJXPP4U0Qt9CZ2QykyAPuxsK8H6iqkioJD+9YtnCrycMaIgXBlMxTA5Jxuz6L6VLHFLldscZYqXMxPMY9Tmq5SnaOhRlhV8eeWURr8yqATQjhjuWMGMkELuxnFWzKHhAOxBIfv92HsfSoEjS3kZT8+7g7uApo1KTvoxHmE0hkniCIPlG37oPsP602OLc8QcoCScLI2AfqewNE0CBMSsADyARn8hTpYAyBNpePhiGbJ/8A1Uk0F0OmuIYtyyxMdgI5OD9B7CsF4vtN4kMbmNCM4Y8KfStG6k8xgLgGVk4WQnt6e9QgbcxlAzuPuj+Af7VVc2h7quiKR/JiW3coQpJwADz9afabkjWC3kbbIcuynAJPYen1NI0aQnakYubiTABx8qj6VJJGsYWO4yJCfuIOCewFLqEnZWJZ2WSMKihLaPoGPTHUZ7mppZdxJc43KAoxjI7VXCGNMvIij+FSM7B6AUGXdufaSxbkscnb6AUmjO19i38wgR8JhePlONv1PqaOWfJKgEZ3YyaqwxvI7rndA+MLnvWhEpjmCNt2twxC1LRnJ2GiH96hh2/OepPI+tSfZwqbnlRWTgd8n/69TmNGChtqnHykHhvqaaYTLC5xnA25I4H+NFjNyZVhmDFDwSw2/L0x6U4SeVJkoGUcAA/rVWG0fz3d3UkDCknAH1HrVqYFY/3GHOMjHAahFPV6DkYsG24RTk4A/WqnntHM67dqH72/uKljmYxMoABBJIzyB/hUa3Mhdh5qJCMMRtBJx70xpeRa+0K0ZLNnsAemO1NzlGGS27kn/CmLcSSMSdqsF3MNo6elQJK00oyFX0jB2kL6g1SVyeUWWZiCqMFcAKRj72KhkecqAGVQPvDP8qtnarKUmDk556Ej39KbJJEI227N/dQufxzU2sCkkZpuF2EL5hXO3cTwp96ZcZP7vhnzkFOQtPltRkmAttHJU96rFXTIQsobkgcVUXrobKz2GhmEjlgQ2eFxy5Pc+1OdmdcD73p1zUUuQzrjLlQefT2qxYpG+HlLJnhSvX/61N66ilLqXNM0u8ltxNFazuzHDMikj6Vqw6bfBlH2O5U56mI1HpjzXV5Db2s7wK78hXICDuSK3La2s5RDJ/a2pBZZDGpZsZYfyzmnGCZwVKsouz/U5y4JV3JVkcEqQeuff0op1yRFdSrKsgDMflbk9e/vRUWNU9C0xjCsVd2XkbtvBqLUHiuFjjWQiMLnLnrVnaZoOEVeM47Mf8RVSQh4ZPJAAA2szc5qUbx79isNRf7THtnVkj4EjIMAHjAFWInA3M2wuR69B7/SmGedCkQkgcEfIVjGV9fxqT7K0UexQUwQcMQSfcj1obRo2kTxCRZACwPODGgJJ96kBeISMuFGec9Sfp2pYixj4bIU8kd6kmYbSXLbj0yowaS1M3LWzK86h8l5hEJB8zDkqe30FZM9mZJFjSUmQA/P2xWvNZBiHmDAHGD6j3quLeNXZQjFM4/yaNy4ScdmZ8WnvK/lmbKN94JwDj2qV4PLURJMiBuoAyavOg3E7drLw/qR7UsakFjFBvDDBB4AHtQrIp1JdyGO2ZApEigFcb/X1OPWrE0awiMIUw4zs7t7+1DR5f8AdqY2GOAOgpt3C627BblWy3zL/eH17GmiE7kV+oVGMqBSRhfmwPxx3qS3Z2cJdsJI4lyox970/AVXSD95+9QvvXKo/X2q3EHhVZHyyE4zn7x+n9KNQe1hgVjPkyZzztB+X/6wqZbcyF2L7WA+YjgY+neluSWQI6jLcrgYU56mnxRq07NM7iFQAGRuePb0qoq+5LdtRQPJhG6TMZTKMyEk+w9qjmmk8olOZioDOqgDb/dxUcc4+0eWiMi8hfm5/wDrCiWERMWYnHViD1z2pMFvqRSyIzKSEIPXHGP8+lI8aGRobXaySdfMXBH49qSS4MIKhREHBCFhnj1zTnQvbEtEXUYAk7mixe2pBFPHFdq7IxK/e7Zx2HoPeoLvUI3E3ygmQYEYGSee5q1eRNKmXVUGQoK8tmqkF3JZuiSBXCMVCkco394jvjtVLzNIpPXqXLTSppbcYDB2YRyk4yDjPy+gx1pL7TnMkcTyCdTxGEPzEeme1JFdG2UyGNneZdkRRsM2eufSmWCCOeUTxuZQMlgc+X7N/jTsuhKlNNybIZLELNst1aeJRucJ0HqPcCp445hcm4eNTCn+r+TKj8PSp3vrmdTa26x27SHMs4OFC9BtpkYjPmgPIsanYVTnPvn3pOFh+0l9ojvdRLRtbLF5bAfvDnIXv/kVYsrV/IEhiCGJdy/9NM9z/hVCa1aOQwgcFt2XOCB1qSe/upYUSSQ4TmJs4UCknrdjaukoGm0jRxoZhtbPEYPzOx9fQYqP+EvI+8OcgdMD0rJCzTyNLJK1zwMMwxlvQCtaSNUiHnOjMCAzL90nFJ6vQzlFR0TJD5Z+Z8bV5GD19sUNulXYCRkclh0PYVX2vDlih5+YDG3PsajvpFjjbkEsck5yQfpTQuXsT7IgwD4Lg7TGBhfqTUcl/HFujx5kSkhTJkb/AGCj+tVvM2W/mQM2QeJW6/gPSqfz3MxaVt7N95fu9PervZmkYK+pcuLi1SCOW3QlUGxVf+Jv4iB2AqGS4aVkddwJYe4A75qu8H+kNgRyEsEAVvlWtOONIunlKcclmxk+g9alvUbUYaIbJ52FCBWByoBPPvmnxgpGVxuVeC4/xpyKJIdzc4PAxjH+NTbpM/vQQrEfIvAJ7YqLGLldGNNeIW+zbEjJOCCMHHrU8RQYSTEakZYryWPbJ7fSp3tFmuCSm3bkDqzH3HrTVtgEYpCiqgGXY5OapM1c4tWRXR2UMII/LyQC45wP8aaiFoRFtdmJJDnr+farvlqHXDAvjDRg9fcD0pJzaxqqxSu4zucEEdf4c+vvVOLaJ5rdClK6IoEj5kzyO4/+tUyIFUK4B3/NufqvtVK8jaSVUWNhk43Kc/gB3NagcLGY/LwMYznp7Ugk7JWCFcSZbmPjJUYx9KsovmZKBwrcbB1H1NQQALIPMU7WwGBPB9KsSMOS2Rz0P3RU2MZbiwlfLO0fJjBHY/WpBIYkOGPljChT978P8ao3JxHzJukyQVXp7D6VFYzS+cJDE2zOHLHj/dA9KLhyaXZebADkrxkEgcgH3NUjLvlcNE/lr1ZQRkegqxcwlspE7sWPAJxgVXcNEFjDlQvbPb696bQ4WsNmcqpCr8o5Oeo9BUcBMjbVAEnAKIOAaguVMhULkjPUjGR/WpNzJBiVSofIyGCjI9e5q0kaNWRNJJEzpHG8k3l/fA9frVJZEk+bzCAGxjuB6VWaeRJ2WIiMjGQOtWElhgUMy4nUHy0HPzHuxp2RVrCSSCMDaOv3iOT9DUwKO67Gw2MkoOeKpx72l3ugZc5J6Zb0qyrNJIBlRjgL2+hqLdEKVmiwhjVS0jks+cHPNZu3LfMxdiTwvYVovGFDGYEEfMQDyB7e9UhdeY26OJvLIJ5HQD1NPlsjOErLQme3i2rmZQR1wM/hUpj8pN5JO445HB9hVeNmwCxCnpjHQHvmnCVw4/efJ03Dr+FFu5nK5Y0u3ubXVIbmHKzK4MduvzFj2BrorN5P7Qnsxp8MjpL9oSHz8bJABkKf4h7e1YOl3otL6G5KNJtYM6qea0IYtLiuY7oao7QpIJPL8oiViDkL6D61UFY5qmrs1+ZjX88rzTSS5DTSFmboA2eTRVq7kkuLu4kliVfMdm2jkAE5oqGtTRS0NlyyeYi4eKXjbGMEY9M9RVQrG9uss+9STx5S8yH/AGu1OjvGScOEkDJ+6UMeSP6UPd5gaNVKMW2rhshR3/GpOhJxdiFEVJBM0ny4+Ug8r7VNGhnQ/vFDZyST29aPMRdsSNHjnaW4U8c5NSx+W0TNHGAwXDAH+VTa4N6BboCoaTAQHB2fxfWrZ8t41AG5VfkdCP8AAVVsgkYyQqkAjOcgVZg2RS5lOUZMbgep7ULQlkM6srCPI2g5BAzge5pj22WVR8644HRRVpgxXEeAQvzEnvRErojMGXOO45H1pjvoUpIIoneWRmYKOAGx+VNVXWJWJKbvulhkGrE6eVEZMsyHnB4qAXg2MSYyzAgJJnGKFYpO6Ed2SMZzuVuT2Off0qZ2aRYpn2Kh4JGOPqKqbGRFmdXaPGw+q+hI71ABGd5uGZVzyVPSrQ1BF+RJXPkxjMe75S53OwAzjiooon+VkdpOOHJ2+WvcAetQaPMLe7mjtpGS3lXa0h4Kj/ZJ7+9SW0aXAdIhJ5+/CZPyhfUgVWgWcb9gnaNLeOJJZpHDZZmPyj6e9QfaLszhrZpAx/jfAOPc1bFtKPMdMIctGXzhT/u5qIyNMrsuMrgbMcD3JqGVFq3cbbeYzyl2BY8Hjqae0pZVCRL8p5duaWHejKpYsOgJGQc9galliRpdgXJ7nP8AhUMTfcXidA77Ceh4HzCq5uEiBRwwjblRjgn+lOkjkxncq89AMD8KZKsTsrSxSvg/J/db3Jq0xq2zI7maGKEt5jLsHyr2z6E1Ak4MzPfR+YzDIYqQf+A1OII94UDG3OApz+OTxTJ55Yo0aDzCI2yGY7toP9KLq5UbbFRBIUl8thFuGN7HoP6VXu5ZvKVLQixjxgksS03qfetexSK6g+0XFzGJUbcVZeEXuT6/SqbmK8u2dlHJLefcHp6cDv7Cqigc+ljPt98WEjleSFcckYJJ6gVtb5IwkcocZ+ZlVsbV7CqrCKOPHnq7EAptGOasIz3s8cFkpOOWPr7k+lAc3MrslBV4yiQr5LHJOTk49M9KkkjiO3Kj0Ce1RzArMEkDYHHB4x3pJGVvlkV1X+FlOWNJbifkKmoxIxKxqJIl8pFJ++Sev4U2U8okgUuowdvTnqT71mmGNnO1SQ7ZDN8rZFXIIzHKFky5bJJ6Ae2aG+xpKMVsWsTS5YSRtHjJZzggDsfeoI3IUyIVYN0LDkj19qgkMW0sYiFU5Ku/3+entUqTtNcFhGoVuiZ6AdifSiTROyugkwykqACcEAnj3NNuSHiUoVYDgMo+UGpSv75ZRwuc7eWIHrVjzZnkLZxzkHbj8SKnchytsUbWFXQL9mY/3NpPzH1q2bMDC3Awc8bjk1MiOzbnmPmPxkn/ADxUKrGMlEkcngN0XPr7inuS5cz0L6QxwqAJFfjJXBNMVN6tKpLDacL3x7VH/q9ru4RTyuD96oGu9znEm18cMpyPpRYz5W9R8rS/Zw6uVkXswwfwqBvlX5mVO7BxyxPtSCVjglhubgjdx9KHLSzuGZiF5Kd/zqVuaqNtCneSSRRtLG6RSP1YH5mX+7jtVeAs7PcTSs0shwiHqMdz7Vda3SWIklMg9V5z9T0qMrFHu2RgHAX5jncfStehakrbD4WRV+UyAt0VBkGpknzhA4G44bAywPvVdMBi5yhx1PU/T2pYvKfLKDz6dakhrqXk8kMdrFlPUdFz+NNzIrsvykHoF549KiClYzufapGM1YhwkQVW+XOBz+ppGb3K0seSylTsJ4welNjfypMxD5yeAeBTJ2diRL8qj7gB6/WjzWGF8vcOoDc/lQol2LjYKsplLsncLknv+VVHkDuoYM4PClRSGQxSErJGM/xL/CO4NQvLll/esWHCYwMj3xVWBRswk3xHbMrqBwoPeoWXykYsCzMDjJ+7SSfIHfDSN0bfk5+lNiYGISxxska8F2+YFvb3qkiyJXVSGiVhKcLk9j60r73EgO1mb7xA6fjUhSORSxVic8DPygf1NR3MjBPIVQB3Kt8vtmnYL66EixbUgR3cdMJ1z9fSnLDG82Ig8r5+b58buegqoj8EhsMRnOcCrAwVRYtsijnCttz7k0JEO5ae2mQOsiwYQHCeZnb7ZqkoKBkinGxjk5f7x/wquN7Dy0baq5JA5A/HvTokIAy3mSfxMw4A+lMlKy3Lio5gyMTNnAPp7nNUw8rXB37/AJeAgXIalu7xppCF37BxzwBVdpngTMa4OPU5Wk1qJX6m9pV3cyz2drbzxwkS7kbbuAc8ZIxkjtiungfUZJ/s6a9pr3Ktt2iLPPp061wOk376dqdvdbU3RsH2E8t6/Suoht7CxVNTSy1kojeYsLwbQDnPL+nvVx2OOvCz/wCAN1O2lUxyGWK5jlZh5sOcFweQR2I9KKq3GqR3WnQwwg+c8z3E7sMKHPZfb3orNpX0CEnbVF83C20fkJEtwoHyyjPFVEjL4dc+STyc4c+tV5ZicJGw80A5kB5x6VZuI7FLNDEZPOX5dxbILfSoSueiko6dxwl3ybAgjgY53YyxWnqUgQRpINp+YE8HPp9aq2cjKjTSxO0DEqGA4J9qVJdhZhGqBuMAhmx9e1RITWtjVtyu12nkO8H5eQN30pz4jSNggJHAz0qG3MYmLMrKGGRkdf8A61TsgwWX5lI4UnIA9KDN7kG6R3J81CXOBGox075qwfLJGRiQDgE8fX3pg05I5Y5jGwX6549hS3EcbbVLl417noPalYbs9iJpX2nzVIXP3SM4+lQ5iDh3X2XcMJmpW2qAF2/MOCT0981WFwLdHUvPuPyqMAg/n2oQ12Q575oC0gjVT90bmzg+mKpXEskpV/KhiEYJBPRvrSXqeeSzxBW46twPwpgt0wpiVmUEEq5yWI7gDtWqdzeMYpXRWHmypJIzsvP3exzVpbpIIQIJSu3qvfPfmpp7XzmJ3/ZRjdiQg5qpswFkYKIVyoYfMSfem0iuaM9y7ClxfTLlIyFXKhnxtB/l6mrv2fBZZGikcfu1cnCg+o9fxrHgkkkVgSkYUfeY7cfh3qaZWPLbpDgZ9OfapukZyg2y8XjiU2z/ADMnbOQ/sPr61JbswTbKCgPUKMgVlwjdmGNTGw+VieuPStC2hMZLREkKOvYVG5EopLctm2GS0hj8s/7eDVUoy5WNtxXO1lPCVOgEqkyK5I6/LjIpJkjeJXjmIB5HAwfYUMzi7aMo4k8vMxcnqF29vWp4stKiMQ6kZKg8Ef57VHLDsZWDsR0Xd2qRoPLjDncZWxgAYYH6envVJGjaMiXdubJCxlicHtVxmhMKyum5gu1IuAAf730pkyoZGMkbNjO7HGPqarJI1s7bU+b0bnFEXY1tdDWtZmeNsFWZN+MZ49RVuO6WKLZEJImbGW7v7gVKt8krBZiY4DgylBl2HoKgvL52ZI45CsK8IrDp+NVpuT70tJIkglD3Um5ndAMKD1ZjVlhK1ysc4beRgbV4I9B6VUtY1iQSDe0h6gjA+oq1cXc0cSKkmITnCoMEH60LuxPey2Dbt3yPbgjOz58bR6Ee4pLmEQIJEmE8bkbgPX0rMe6kkJV3MqqOFA4HuaSK4UhVddqqQXx3980Feze5elhad9qjdnnAXOAO34U+0ggjJIkILH+LvVSSWTLqSVR/mWND933NTNeeQhG05YcfLSaCSb0RbRyX2LIu8tjao3Egd6mSPzD5aMzen1qhanzHBCsCBye9X4gNv7sMyDlQThsdzmk0jGatoOEewAblY4wRjoaiLAIV24bO0op6io55VRz5Y4x83fFQeYGmfDFwBksTg/SmokqLHXSLPtAYiMHGOhKinxJGu1IrdY2J4yTkD3qDzG89ftQLNLwiDgke/pShzLv2gKeQ0jNjNOxp7yVi0Ug2ttAZ+hx2qipjkkcToQCMKFk2gfX1qSEwq3zKYwf4VHGfWnsbePgb0z1JwT+B7VNhL3SBo42QKrsqA4J/h/Kobm4gW6VLNPMRduV5O445NOmlV4nCIAp/jbqe1Oiht7eBSbgpcHlY1X5v+BHtWi2KTS1ZDK5lBzuLE8+3sPapLDdxuJBHVT0B9f8A61RrIfM8yRSefl2nipRcInyxqJFJ+Udx7mobJle1kX5V80AfdHc5xmo2woC/upGXO5hzmmRyB4x5nykdMdRUBDj5o9qq3QY7+9FrmcSd5XBJkdASoAKYIIqoJGRmfLZIIHf/APVVR5SjP5n3wc9OB9KlSRiAHBKZ4UcE+5q7GvLbUS4VmhAB2rxyRyT/AIVWhcW+Qm17hjywHOPQVavY0EImN2pkz0HJUVRSFGZY40GXGdx4OPU1SQ00ldljzYcGadpDKeVCjIX3qKWaWaXczLGT944wo+gq/eQwRhIhKhCriMr1B7hvesSa4DXoLHcxG0ZHA/Cm1YiM09jQVEUdST0Hp+NVZI0bk4znIUdKlRXJXCFo2OCC2NwpZQUDeUo8zPKkgg1LFz66ldIwzYyB7+v+FSXKu7o8gCgYB2jt7Uy1WUSF5Gdi3B9B/n0q7Ih2loxtBG0nPP59qAc9bIqI55jRSIgcKCPve9PDgghAWY8EdRn+tQXD+W25MM+7HmdcfQU23ldSyvknoMcUxS7khjnnQKxYAH0wcfSkMBb5VG5vY5AHqfSnlSdihm3Hjk4qzDCVyhlVhjGU5GfT3oMZVbIf4dgWDWrGS7RDbrIGZyuR7H88V0drpmvQa8t5c3Mhh8zfJO0w8opnn6jHaufctuCHO3sB0FS6YvnahbRzltrzKuwnhhkZH0pp9DmqScncjvriMXkywBVtTK5RR2Qniin6nFBFf3cSRjCyuu0HooY4HsKKljUtCwkg+yuyJGqE4xjkn/CmPHCVBRZR6uxxk/SpbZ5kwiQh5HHDyLk49BUaTtPMkIt0kZBg9fxpRVkeqr3YqzSi08jLSQg5VAvT3z2q/iCVRIxROBwowR9aq5fjy5pGXH3IhjHsaUmJz825lHLj39M1DVyGr7FyEJvZSd+R8vr+dWwjxxYBAB4O3jms22lxnbGUxzns1TJcXGCMLlTwuQeagiUWtTTiZiMjiTHUHt6U/fmNmby9w5cbarLK5YpcEK2MHHH508owUosnAGQFHLU79zN7kMgEQIZQS3RSvGPXNRBVMO37pfk85qG5mcS5DEAc7cdR9KZaTmSaVeN78hiP84pJI05Xa412MLGNFiLdQQM/zqBJHSffEdsv3clcAVdyGIWSIFmbCMR1/GoJmJJ+XEgYknHBHofSmk7Fp9CtKpki2+XD5g4LbiTT/PZbctsLSA7VcqNuMdhQImkG548jOSQMBfoaR5SjK6KGYHp/CRVXL5uhKPOWEyPHAzOMbcAtj1NQ7VCkMWJA6px+VSJFukdmVwzckDjIqSAscgyJzgrjlqi5LZNCcoI1YEn1GD+NWdrxJtdePVBkk01Pnc+YFXJwvHT8aSQNFIf3jYXngc0zFybY2WGVuTI0a9SC9RsoUSoCApxuJHHsBT2ctD5jlOQc5HUe9U5ApnXJ8pSN20NuGKLXNIpsfKzGJXSZicYKEfdIPX2FUPt85uyZJ5HDccH5jjsPSr4i2YP3QRkZOSaht43+0H7IkaSuPvPjj2FWjaElrcaHJUkxMTjux/kKUMCoKRxYHdmyzVJbS7F3v5Tkkhhz196e7+ZLII4hu2cEDGBQokOWuxW+yPKQfmj3ttVAPmPuf9n3qYxLYnyJSRP/AAyL8yn3AqpLLLADsLeYykM4OSV/wpkLTw8SgBSvRjkkepoHZ2LayNKztISWIxvzgNTJVlMW/aWQHqKWKWSVkad9qqMqm35R7fj6UbmkO4AxBjzjn/8AVRYm9mU2ty6kkYV+FWM/MT6Yp0aiONlMOBnJLHOKnliJBmDRgdMBuaZuZwxPzlfXjHt70zT2mgiBEyFLEscYPAz9ac6vMy7ZcsnAIGcn0qNourMw55wP0p8i7IcZJJHPaluTzaksWxAwxuf2frVgk7USMAkj5snrWZbGKKXIDAnjPU/hWrsj2qW+Un+Ec4osZ1NHcgm2NuOF5GcA8DFLJDKRGUt5PnGUI44phc7jFDCzOvPyjmo7jziuGeRlzgjf0HpmmgVylcNKQwy21Rnd3JqeIAFDKThvXvTlUgbuw5HoKXzNoA5dx/Ef88VRbnpYkZ3MZHzAE525xyPSlIVSWC/e5WNjkn61XaV+rgHnqP4V9qdLIsqlYUCjGRl+v1NJK5m79B6XAiZ5iY1ccAEZwPYf1qqsbzrnAVc9c8k+p9qrqoFyfMQTAp8qIfunsRViIbgRK5ViOB/EPXIqrFN21JWMaI25gdpyxXkEetOU/Pl4wBtByozgH+tQOU/1SY2d8t1+tWLfzSFQP+6A6YxioaM3KyL2x1i+VNpH3QwP51VMKy8i5MeOocEc+nFWjLKxTL9DwR0/AVBPIHz0JY9uMmixkpu5VmtV34IUYGRIT1qBhLHKDC+1D/FjPHrUpkBZjKnmMCOOo/Go5X3HcIwr5xkdKpFqo9iv9mllbkL5Q6yEgH6mle4NpC6QthWxliOT6fQVIUMvGDk+grPulkMy+Ug2AYPqad7Fcyloypd3Jc7+Tkc565qK1aWfAChUB4IX5vzrSSESHcyxlsdx1qaKIx7ZGjVABjAGRSWu5MqiREkTgAtk7epNXYw0eF2qm48ORkmgJvI3Idp9+BQcq3KPjswNBhKpckiOSyghRjBdx3+lJJAjRorErIDj8PpUiFirkjjr9aZPOyjoAx53E0yObsVXEEQbL7dqgt8vJpltIJFDAngY6AfTNRyxxzygy8DPDDqx7jFWlhSKQop2nHCkYI+tBUp6WHMHePJjXGcZxk1KGhjiCsdoU4645qFgoyjy4LcADg1GhCxMXCtg8Mx5osZ6tG3Y63d6bbiK2kVU3FjuUEZP61YXxPqfyk3KKOuWiWs3TNPk1G0ku4rmyiSH76zSEFF7MeOnvUq6MHyjatpDbjnPmnP8qtKZjJQT1RUnnM5M6DezMSWI655JoqtNstpJEWSOUKSoKtkfWijlHc045TuYlWWBh90kndjtnt9aV7hCv7kyxSdOowv41GjweW6yzyxSbPkXHGfT2qu++RNkUWNi5cj09Saylue0ops0DH9ntzJJMszMM5jfgH0pIDIzDKblxuBDDr9KzoI5BPs2gAjoeFx6mrUUbR7WjlVByoZTnPqfpUhJWLsTec3UAIuTz0/GpCV3p5SqMLwd2QfeqYDOMMUYgYbZ97HvVtI32FFWMAgts3AgH1z/AEpcpm0SNNkq2TuH3jIe3t60rBppdnm7CvI560LaSshlZIgiADeW4z6AUwKyIDKEZwfkZTlsUuVom6ew95TJAQ0IjIPJJ/rUMMePmA/edPlPBHtU8Mv7sDbuPQk81HJchX3OgKxnAKnBB9aVrhrsiN4plRmiKleAQScfX60glVQCXfy+4x1P9ae8iMjuzYzyATgEf41TkaPcGjVpOQzHgZ9qtJlpFvc+35U3Rn5WROgHalh3yRsse5SmMJjpUVpLIxdhwgOPQKf6mpwfMc+W24j1OCaVjOWmhKsQkH758AjJVjj8KkhigjKtHExUdNpp0G9FZnSObK4G4cg+3vRA+4ZcmJB/GB0/AUcqMuZi+bIXUkfIeDyM0wT7G2MSozkdwT2pjoRJ87nJ5AB4we9Ry3It1YYifuAwzn3/AAotqWlcsTPGFIkU4YgFjxn6VURkjMiwRKSByxOMD+tRxzi4cs4DrjhfT6VI0Pl8XMRC44zjAHvTsXZR3ELRBtryqoIyAnzZH17VDPbRTR749/y8/NxT5QobAKMMZJBzn2pu4NvXaQOwzxQNPsREqjAQxoP7wz2onlZZZBDIBGRkkcHHpn0pIoDGW3D5G/izSKi7wfllK/wv91P8aaKbSZSEY5w4xjJB60vlbiTMhCHjKn9KuXDxKq8QoQSRtU7m/H0qtHiQ5PmFBy5HH/66pMvn6jpJY1j2ZbavOWGN3tUsUzYQyLnPPPApmYdy/wAZ67T9xaeTyoMqsM9fT2qWyHIdJhk2oxyfQYAppiOwmUtlRldoyDT2BXkSAk9FFTWWSpBUux7ZpEObIbLMnLoOnU8D8PWrBtsrgNjHUHt9Kc5KRkKgKjgEdKfD/qzLIuGfnHQ/jQZSm3qRvCBECF5x97GDQu1UG5ACTw5P8xU0aFwQSB3wx4NVriRFwShLZ5O7C0AnzCHLEGJW3tyQOpp02QP3qmOQjkY5PrkVGbkxEbCEdgMeXyAPc1TVlLMXWQu3PL/eNWkaJNivvZgmwFQc/e5NOjBIJGG45DcVHBL5m4bVRj+OKcr7GKrECV5Yk5IPtQ0DfQaJnkj+Ro+Dt5ONoqfy0RGKMOeFGOv0zUHlJJll3AM3zjHU00uQ+RkkcIOwoRLa6CR3TKgVEiQ4OZMZY+1QbFJZgSWPUDvVkxblLOm0ntjqaVbOSRHG0/KNy49uv6UEupYqbRkO6FTnGQOp96syI8G1nmyTycc8VLFB8qhHLDGVDdCf8aeEHA2cfnSM3UuOhaNWy07Slh8oWMgfmaWRU371Vo5BwAOcVGZclkC5AHYYIqSKXYqleAflJxyDQRzDSgijJjGwE7gPeom2sFLHYf4h60+adtzLEjZHp3qOJZXVS6EEHJLd6AuLtfzOAXTbtGDjGfaoRuDMuxQY+oxxUySPJMRsZiDg+tJKc7lJ2oDkKDnA96YuaxBGpk5VYlTPUvzSbNyn5ixB6DoKegjHzIqkdD2xSn9wAoVi3fimS5DPKlL7g3yjGMmpGBVlWQiRgc+2PSnIkjhXiRsnvn+YpjQyGNmlZcnlVXnNFib3HLGu/dxjpgNxTWChTu+b5uBjmqN3ctFgAbmIGc9iKdBdSFVz16kDjNOwNWVyyQIirRgBiclsc/SmMEO5sgynlgxzn8aj+0yujNtUqDgnuRSb90Z2BWHUrjoPWmkRzDWlVlJly7dF5x+FRSMz53Iqr2wOB/8AWpomAGEwVznBXIJ/nUFwGfBQsrMOQeg+hqlpuPnLVvc3FjJ5lt5rFkKNsiyjAjleRg1QWds7EgdQR3Qk/pW14e1u80iKe0kuLg20ynaYyC8T44Zc8fUdxQviXXVkRf7SuVLdN+Bz+VXZNGcqjbMdC275x8x6jHf3oqy0jzSyNI2ZXJZuR8zE8niilYjmZol5GC9HZegZOc0qmZsKMqTycDAqaSNoQXcybi3VuSB7Unn/AMJyUPAzw31rmufQLyJESby/LlcPCG4OckVLJICmShK9iOM/h2piwSbN8TqGBwvb8/epbW2lkc/KZDyWYnApidhfNjBEE6iEAfMycke9VA/lHMDFdrZDdASO9W7lx5fcc7XJA49qom6t4iY/KcoeF+br7GgcWuiHf2tPJ8shB3dPQVZjAlHA3lV69Bu9vWklVFj3wJFGshA278qv9aHZAfMZY0UDB8vvQwcl0RZj8xX/AHj/ACqepHTPapZlheTBDbzjJC9P8apNdFY0K3EUSt1QAn8xU0c00duSssRichWBGcehz2pKJm09xbtEWb5XICj5g6/lTI0lLqUG7eMgKvyj1+lO/tVktFtTZxGQNlZG6/X3qK5vIlkjWKUvMOGP3R+X9aoaUtmiyGZyfMUKo4CDoB60/KtOSgAGOMdzVaGZyzAEHPGRzVuNym0ZwR1J55qDOZLbAO+0uqkZ356Ae1DyIB8uANp69KjmcRk78FhyT6/WoXuAY+VQL3LDoKDNRb1JFu1MO9kWPjAI5B/Cq0kMkiPcSKTH3bI59sUkiLFgsUyDlBztx61nzOCRgHYQScdTj19KtI2hG+xeWTEQeGKJYcYILZLH1NUVmkllzLKRGoyepA/DvRGwnVAkX7wjli2FFSSWkbx7Wu1EmPuKDlfr609jVcsdxttdKznY7CLJxvUYx61ZeZ1YLGg3ZxuJ4/CqsdpFbxRPFIZd36VPnfFsIJwcgDpUMmTi37paCyeWX2hgOPb86jMDbSD5YxzknBoR3Q7IlIX/AHqTPmS7ZFcv2Cjg/wD1qDFyaYwxtktv3nHAPNRNG7pyGxjG0nj8KvGBtwGV6dQOlMFm4BLMpB6CgPaFWOPJIcZHdQMcVMg2ug+Qg98ZwKupDsTbkA46k8mkS1Acv8xUj8c+1BHtLkZtLdwrBvmByxc9fYUyCZ4nKhcddp9fSrRVCzeUGVgMgN3NIsP2hQ0hKg4GT3oZCl3Gwozvz8znkAcA1L8ylg+5QOq08KyDjaw7DPSkkkkIYIqj2AosRdjTKrRlZE2qRjcV7VRdog4AYuewVatOhkBBYgEdM8VVa3j8wBnMZUfeHQ+1BcZJEMqlVISJSx55HI+lUW8zh9/AP41clhkYlThWHVWP9arS4iADuCc52pzVJmsZ9EWIJII4y7xsJBxtzkfhS3dxCwZrdHjU9MsDkd6rvOzZ3uWOMAADIHbmojIqBdilsH7retO5PUtm5RYwwwEx0Dc0sLhnMobbn1XIb8KiM5mdWbAlwR8qDAquly5BWeaSNRyCoHahIWjLDBzIGQYHZSTVrz/JKYlYHHc8A96yY5Lh25LN6ljk4qxEnmfI2AvXJPINBlK3Usi5QkrbAhM9fQ/WpTdBMKpBz1YdjUECYBVWMgHXI+XP0qtJbSM+4MUycHHPHrQyLq5ooU3sUUhlH3vWo5Fwy/PySM7u5qvCvlgrIcJgkHPejzlxyScflSJ1ZdkB3lGGHHXtgVCX8nlmyp4+Y5qjNf5mVNoWLPUcn8TUEczTu3mYwDjmnYpxsX94lwE6dKkjj2yoysqFRgZ4BqGObyyqptcsPurQpcOrKgXBwAeTRYzbuSSgzfNk5J+bFLhiPuybV/iqvM7ln2ZDk888CjYPLRmkYzEfMhb5PrRYQ6CQs21FOc8Z/rT5t4UgOGDNyF6gfWopLgxJsSNMn+6ck02SUttGwDjls9aZLGSIEQtIc9SuO5qKF2O0bR83OOuKmcK38Jx6+tNKq0bEh0z0IP8ASmTzDX4crsAHT5z1qtLd7WKqoXPGAeafcr8vKt05PWo/3eNqoyqOeRzmtEg5kOZMKWLbFYA5Bz+GKgYl2ATPyt1bp+FTAIVDOyoc8gHkCh23LiMFSDksWwCKZFzoNFNxFoU1zotqJ9T8/ZOSgkkijxwVX0J7irmmX3iC6uYob2zlntWYCf7VbgIE7kkgbeO9YmmQWNtY/wBq391dxK0hghFp99iBliT6DNWbi2uZ73T1k1O5vtGv5VjjmMh7n5lYdmHpVIyZjX6QR6hciBka1WRvK+b7y545HtRUOpBIdRu7GBW2RTMiMBg4UkdaKVik9DqlYxIwDD7u0DbzTUzGFeVNm7BUn+lLKnmn5VnTaMr5nf3FRyKiKBKsnnHgDOcL61ys99PQY5XG2TJYnIK9CPeoz+9YDZIcZOVPT61ZZhFEQY9zY+9npUAnDREhAgJ27gfvfh60ItajY3liY790hP3scj/9dAjiniLNMsDZyqlOGPpU8S7kCYZlA7nqfWo8ujHaxYDue1ML9EM8rYqMWjlY9Vx39BTvM8yQuyqsoPpgD8KjCuWJB2ZO7ceoqSPcFEbHcOoJFIenUk2WxDN5ciN13J86sfcdqSQSpG5RyYZuD2L+2O1O2yGNvLACHghOn1qtLEVO7LbR2P3jTJTuxgkjbzAsUbFccuxLVNDDGULtFvncgqxbC4+lKhhJ33UQESjaEVtpJ7GoyC+TuwCMZB7e9A2+iLZjcKGcrvHHy/dAqVRKPkjUyDPHtVQeWMlZORxtINTxmJELKXYYxt6HNTYynoW13FcMeTwB15qKW1ddx2jK84BohnTysDcH7e1QedM8mIRvc8nI7e1CIV76Ekc20opfynTIBHO4VWuJHZsSvtUcgKBnPY1alkZSGdOvBwMZqHYtwu0YUf7XQfjQi1ZMi2CaAyW20Ju2y+m71qnN5jSBWff2BA6/jV8xosh2SqoTgtu4pQYzMWMm7b1ZRn8hVWNOaxBCkhQiWRQF9+n0FMmBDbAzEHpTlnjSWQRIp3cA96H3BVLqPfPJxSJvrdk0aNI6lmOQMcDGa0rYkIAuDnsOv1zUaRuYFwY9p7jqPapY4QzhXVgnB460jmlK5N94qxBKd8cEUyXDg4yRjvUihAG+8Bnj3FMZjtYcIvXJ70GVyFUZX/dHO4chuo9xT5SIEC+auD0yvSkdlb724jjAHBNUbvIU7SRlsEHr+dNGkVd2ZZMiMuA2/H8XpUJlkiRlj27icKSen+FUHdxI4lKgqevT/wDXUcs0QxvOQTxjmnym3IasMoKnfhH7gNmo5bvMgjEmB046H2qlFcQKhARmJPQmgiJl/eqRjnGaLE8qT1LrSO9sCp2nJ+9UhEQgXzVZuBnuM1QkulcIC+0AbcqOGq1HJhQNwxjjd/OgxknuWJdsgJMgkxgbiMcVTuYUb5HeJlPII9KbJcnaBlio5BHG7/Gq6TK8+4gDpx3oJtbUsQxbEICKwxkccgfWooY0ldgYw2VyAW21LlMhY84A+bn+QoaSMDckbAH7pIzkigz5mQGE+WMrt5+7mkeJhNsbbzggjt7VPL5rgOQdw/E4pzRsisVZXAxkkc0w5mV1twpcFcqf9rpSkbXG5UZFGAMZ3VJE/m5jTYTuwA3B+vpipDGoT98FzjscCglsj3BlPzqjH+AdB+NNQvuZcso7bhT2dTGq4TaPUdfxqpdXTlTCF3Buf9oH2NOwrNkzOcnJQvnHtUMiSynPIJOOF4NEUW0AF1+7yT2p+5mQpbFwCfvd6LBcqtbvuDI6Ed1Pb1pVgKMWCkwk/LnjHtUxJUkFRnuDSxGF42MrSCTPDL0P1ppXE5MaQhAdSGZeWCrnFK5QxoZSSRyCRz+namyXJVS6nCrxx/hVCSXKbWAwecDrSBaFyS+SFittv39ycdKqrLMz7R5YbB+Yrls1FEAQzn1wcHtVwDCDZwR26/jVWE5JBEGUKJG2EjJ3dSadKrEr5asR3Oe1LhIlkAQPIcdTnmnxyO1u25huPZR0osRzEIxuO7JYepzTgSVbDFVPcUeWVyRJGrepOc0peETYjJdgOSTwDVJCbGIqoqloyJCOS2fm+lNRi0uNw2AZJHUfQetSzSsmA7Z4+9nI9sVVYq9wvmM5QcgxjB/OqEtRsfzMxA5JOCRjHuageI+Wd7BwDwMcZqY3AJ/cBQcHLDlj9aqmVnbJfGOhIxim0Nqxatr9ItLutOvLX7Ujt50H8PkyYxuB9MdjVnQtdk0S4KlI57YsrSW7cgkfdYHsw9afpditxAbloGuHdzHDEZPLWQqMu7t/Cijr61HZC11e3kAsLW1xIIBc2jt+6ZuEMiMTlCeNwpmbaMvUb/7TqM8scbQpLIzknkgk5xn8aKqCG4glaK4yZo3Kso6BgcGigLnY3srzBDK23HKknhfrT7Oea5h2pAGH3nZRgDHqakjOJiRjJ65FV5GJWUEnA7Z4/KuY99Wa2JBMzbkeHyyR0z2p32SLyCqyeXnkDt+frSWwDQ/Nz1FPMabUG0Y64qWJtofb2hiQANlCOcHJFSfZCqhlZHycnPWotPdi7DccDIxV1mZVypxx2pGbk7mdPGZGz5Rz3OeBSK0ij7zdcAYzx9aszsS5JPOKbOOoHHTpQWpMrSMojwpdWzyVqumwlg05Tb6D/OfpVmIb5n3c4FRyRRmYAoOlWiiOC3Eq73ljQZ43HmpRE8hDEqCvYfzqCUAZA6CmW/8ArlGTg5oGTTEMwyMjOSf8KvWwRhhCR3J64qgv+tOex4q/YEtgnGee1SzOo9C0/lFlyy59e9NmFqsmHJ80dCpoChm+YA9apXUai5jAGB7GkYxvfcnm+42MlgOPWo3uAkOA8RcjBDLnFIRhRjII75quT8+e+OtUjRajbzcmyNTE6lBuEZ6H1PrSQg+WFYjI544FKUVW+VQOPSpgx2L9PSmXzaWIAgaQvsxxz6irZZByqggjknjFMHzA56YqWwAO1SMj0NQTJk1pKW+ZYyFB7jIq5mRgzSMI+2cenpWcsj4bDsOCeDinWk0kv+sctwetOxzyWpct5ldN6kqvqw6n2p7RPksV6c5zVaHo3vUso/d45xQKwyZ23bpJOvUnHT+lV5JYtvyoHGP4mqOb/VevPfmomx5PQflTRrBEReNv9ZEeQSdp6CqckanDIiv7Y5q1HxPtGAp7VTuiWc5NUjWLaYsXmhlEWI9wxkDJH/16c8r5CMVYjgH1qqnL4PQDNTRkm4I7ZFWxSepN5fyBeCepANSM5SMZILD3zioNxW5CA4U8kVLJ8zBSAQD6Vn1MpMRbeeULIgcKeE3d/pU622OXUIwIJAHWlhdhEVDEDBPXvT4fmQFuSR1NMwnJ3LDzxs+592fUAfrRLvwGYnZ1GVx+tVc5Tn1NWV5Vc9B0FIyFZgqknGwdT6UyWUMwByx9AKZd/ecdgKdbsZCqucjGKEIaN4Z8hUQ8Nu7moBdW4YAiRpOQPLHFSXI8sMiZC7M4zVS3kfydueM+lMEQvLvlOxXKDpxk0kbeWHV+uck45+lWYmMTNHHgJnpipCfmfp19KZUmRu0sgXdF8oXgDj8feoYrlg+U3J6kmnIMnnJx056VLKcbMYGD2HtQRcEEkhBBQKTy7cmpGjVIio2s5PJ9qSHlQTzzSRqrOwI4waDNyZQuIXYnaApHU4potWDB1OV/vVprGpAyoOM9earOdx59KFuDbGx4UHcoSM9SBz9akDiKFiYzLC/O7HJ/wpk4AWPFTRRquCB2rQhkaMIykiKN0gyMnOPrTJbgsSsbYbsVwKku2LIufQ9vesuThOO5waaGh8FyQGVxvYdT2FP3Bd5YA55BbpVW3ATKrwDyR71bhRWDFhk+9MHuE2VKvG5YHpmqFzKC5JkLHqR0FWgo3jgdap3v3iAAOnQUDi9BrTSSkFSw2DGAOKquJHcBgSR0LN0/CrMI3YB5GKtXSKixqqgA47UxOTua2hTiawW1ASa5h81DbGTZ9ohlA3KjHo4IBGetaFnpMOmxvvtby0tpSnnzXzKrlVbdsRF+8xIAz2rm5UUKmFHapWHzwnJJbIJJznmncwdw1Bmub+ecBd80hdvRcnOM0UupuyGJUO1R2FFISZ//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the vesicles and bulla that are characteristic of the cutaneous findings in Stevens Johnson syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Mucosal changes in Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Changes similar to those observed in SJS/TEN can be observed also in erythema multiforme majus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Toxic epidermal necrolysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple bullae and large areas of desquamation are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Toxic epidermal necrolysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diffuse erythema and large areas of desquamation are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Toxic epidermal necrolysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple bullae overlying diffuse erythema are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42746=[""].join("\n");
var outline_f41_47_42746=null;
var title_f41_47_42747="Evaluation of gonadotropin-dependent precocious puberty";
var content_f41_47_42747=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evaluation of gonadotropin-dependent (\"central\") precocious puberty",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Etiology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gonadotropin levels",
"       </td>",
"       <td class=\"subtitle1\">",
"        LH response after GnRH stimulation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sex steroid hormone levels",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical features",
"       </td>",
"       <td class=\"subtitle1\">",
"        Additional evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Idiopathic",
"        </p>",
"        <p>",
"         <em>",
"          (80 percent of girls with GDPP)",
"         </em>",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         or CNS tumor",
"        </p>",
"       </td>",
"       <td>",
"        Pubertal levels, with prominent LH pulses during sleep: LH &gt;0.6 IU/L",
"       </td>",
"       <td>",
"        Pubertal response: LH level post GnRH &gt;7 IU/L",
"       </td>",
"       <td>",
"        Pubertal values of estradiol (&gt;9 pg/mL), testosterone (20-1200 ng/dL), and DHEAS",
"       </td>",
"       <td>",
"        <p>",
"         Pubertal development accelerated, but proceeds in normal timing and sequence",
"        </p>",
"        <p>",
"         Enlargement of ovary/uterus (by ultrasound) or testes (by exam)",
"        </p>",
"        <p>",
"         Bone age &gt;height age &gt;chronological age",
"        </p>",
"        <p>",
"         Responsive to GnRH agonist therapy",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Contrast-enhanced MRI of brain to rule out CNS abnormality",
"        </p>",
"        <p>",
"         In boys, measure hCG to exclude an hCG-secreting tumor",
"        </p>",
"        <p>",
"         Skin examination and skeletal survey to rule out McCune-Albright syndrome",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LH: luteinizing hormone; GnRH: gonadotropin-releasing hormone; CNS: central nervous system; DHEAS: dehydroepiandrosterone sulfate; MRI: magnetic resonance imaging; hCG: human chorionic gonadotropin.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42747=[""].join("\n");
var outline_f41_47_42747=null;
var title_f41_47_42748="Infections with urticaria";
var content_f41_47_42748=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Infectious agents and illnesses associated with urticaria",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bedbugs, kissing bugs, ants, fleas, flies, and mosquitoes",
"       </td>",
"       <td>",
"        Bites and stings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coxiella burnetii",
"       </td>",
"       <td>",
"        Q Fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coxsackieviruses A9, A16, B4, B5",
"       </td>",
"       <td>",
"        Rash",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Echinococcus sp",
"       </td>",
"       <td>",
"        Echinococcosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Echovirus 11",
"       </td>",
"       <td>",
"        Rash",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epstein-Barr virus",
"       </td>",
"       <td>",
"        Infectious mononucleosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Entamoeba histolytica",
"       </td>",
"       <td>",
"        Amebiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Enterobius vermicularis",
"       </td>",
"       <td>",
"        Pinworm infestation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Giardia lambdia",
"       </td>",
"       <td>",
"        Giardiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatitis B virus",
"       </td>",
"       <td>",
"        Hepatitis B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mites",
"       </td>",
"       <td>",
"        Bites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mumps virus",
"       </td>",
"       <td>",
"        Mumps",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mycoplasma pneumoniae",
"       </td>",
"       <td>",
"        Atypical pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Necator americanus",
"       </td>",
"       <td>",
"        Hookworm disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neisseria meningitidis",
"       </td>",
"       <td>",
"        Meningococcemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasmodium sp",
"       </td>",
"       <td>",
"        Malaria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pediculus humanus",
"       </td>",
"       <td>",
"        Pediculosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sarcoptes scabiei",
"       </td>",
"       <td>",
"        Scabies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Schistosoma sp",
"       </td>",
"       <td>",
"        Schistosomiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shigella sonnei",
"       </td>",
"       <td>",
"        Shigellosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trichinella spiralis",
"       </td>",
"       <td>",
"        Trichinosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trichobilharzia sp",
"       </td>",
"       <td>",
"        Swimmer's itch; collector's itch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trichomonas vaginalis",
"       </td>",
"       <td>",
"        Vulvovaginitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trombicula irritans",
"       </td>",
"       <td>",
"        Chigger bites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wuchereria bancrofti",
"       </td>",
"       <td>",
"        Filariasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yersinia enterocolitica",
"       </td>",
"       <td>",
"        Yersiniosis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permissiom from Sanders CV, Diagnosis of the Patient with Fever and Rash. In: The Skin and Infection: A Color Atlas and Text. C.V Sanders and LT Nesbitt, eds. Baltimore, Maryland: Williams &amp; Wilkins, 1995. Originally modified from Feigin, RD and Cherry, JD (eds.): Textbook of Pediatric Infectious Diseases. 3rd Ed., Vol. 1, Philadelphia, WB Saunders, Philadelphia 1992, p. 771.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42748=[""].join("\n");
var outline_f41_47_42748=null;
var title_f41_47_42749="PVSG malignancy-free survival";
var content_f41_47_42749=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F67138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F67138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lower malignancy-free survival with chemotherapy in polycythemia vera",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 441px; height: 388px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Malignancy-free cumulative survival in the PVSG 01 protocol. Malignancy includes all leukemias, lymphomas, and non-hematologic malignancies that occurred on study. There is a significant excess of malignant disease in the P- 32 and chlorambucil-treated patients.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Wasserman, LR, Berk, PD, Berlin, NI (Eds), Polycythemia Vera and the Myeloproliferative Disorders, WB Saunders, Philadelphia, 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42749=[""].join("\n");
var outline_f41_47_42749=null;
var title_f41_47_42750="Midshaft greenstick fracture 2";
var content_f41_47_42750=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F70786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F70786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Midshaft greenstick fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 193px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Both the radius and ulna are bent and the fracture line does not extend completely through the width of the bone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard G Bachur, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42750=[""].join("\n");
var outline_f41_47_42750=null;
var title_f41_47_42751="Response to steroids in MCD";
var content_f41_47_42751=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F58623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F58623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cumulative rate of remission in response to steroids in MCD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 439px; height: 320px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The rate of response of minimal change disease to corticosteroid therapy is lower in adults compared with children, and more prolonged therapy is required to achieve a remission.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Nakayama, M, Katafuchi, R, Yanase, T, et al. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis 2002; 39:503.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_47_42751=[""].join("\n");
var outline_f41_47_42751=null;
